"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtAU_IN","meanArtPer_AU_IN_FIRST","meanArtPer_AU_IN_LAST","meanArtPer_AU_IN_CORR","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","InternCoauthorship","AffCoauthorship","meanCitationTrend","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_BONINOPULEJO",2000,5,6,1.8,0.555555555555556,0,0.2,0,0.2,0,1,2,0,1,0.2,0.4,0,0.2,10,0.220599698591696,0.6,1,NA,0.188291139240506,0,0,0,"GIUSEPPE VITA;PAOLO GIRLANDA;OTTAVIO ARANCIO;ANTÓNIO TOSCANO;M. L. CALISTO;FEDERICA BATTAGLIA;E. BATTAGLLA;P. DI BELLA;EMANUELA MAZZON;RENÉ HEN;ROBERT D. HAWKINS;ROBERTO GIORGIANNI;AI YAMAMOTO;SEBASTIANO CALIMERI;EDOARDO SESSA;CARMELO RODOLICO;DANIELA LO GIUDICE;PLACIDO BRAMANTI;ACHILLE P. CAPUTI;ROBERTO LO PRESTI","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GIUSEPPE VITA;PAOLO GIRLANDA;OTTAVIO ARANCIO;ANTÓNIO TOSCANO;EMANUELA MAZZON;CARMELO RODOLICO;ACHILLE P. CAPUTI;ANTONIO TOSCANO;ANGELA DE SARRO;SALVATORE CUZZOCREA;FEDERICA BATTAGLIA;E. BATTAGLLA;RENÉ HEN;ROBERT D. HAWKINS;AI YAMAMOTO;IRINA ANTONOVA;M. L. CALISTO;P. DI BELLA;ROBERTO GIORGIANNI;SEBASTIANO CALIMERI","0.54;0.54;0.29;0.29;0.25;0.25;0.25;0.25;0.25;0.25;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.12;0.12","ANTÓNIO TOSCANO;EMANUELA MAZZON;ROBERTO GIORGIANNI;SEBASTIANO CALIMERI;EDOARDO SESSA;DANIELA LO GIUDICE;PLACIDO BRAMANTI;ANTONIO TOSCANO","2;1;1;1;1;1;1;1","ANTÓNIO TOSCANO;EMANUELA MAZZON;ANTONIO TOSCANO;ROBERTO GIORGIANNI;SEBASTIANO CALIMERI;EDOARDO SESSA;DANIELA LO GIUDICE;PLACIDO BRAMANTI","0.29;0.25;0.25;0.12;0.12;0.12;0.12;0.12","ACHILLE P. CAPUTI;ANGELA DE SARRO;EMANUELA MAZZON;SALVATORE CUZZOCREA;AI YAMAMOTO;ANTONIO TOSCANO;ANTÓNIO TOSCANO;CARMELO RODOLICO;DANIELA LO GIUDICE;E. BATTAGLLA;EDOARDO SESSA;FEDERICA BATTAGLIA;GIUSEPPE VITA;IRINA ANTONOVA;M. L. CALISTO;OTTAVIO ARANCIO;P. DI BELLA;PAOLO GIRLANDA;PLACIDO BRAMANTI;RENÉ HEN","50;50;50;50;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0","EMANUELA MAZZON;ANTONIO TOSCANO;ANTÓNIO TOSCANO;DANIELA LO GIUDICE;EDOARDO SESSA;PLACIDO BRAMANTI;ROBERTO GIORGIANNI;SEBASTIANO CALIMERI","50;0;0;0;0;0;0;0","EMANUELA MAZZON;ANTONIO TOSCANO;ANTÓNIO TOSCANO;DANIELA LO GIUDICE;EDOARDO SESSA;PLACIDO BRAMANTI;ROBERTO GIORGIANNI;SEBASTIANO CALIMERI","1;0;0;0;0;0;0;0","MEDICINE;CHEMISTRY;BIOLOGY;PHYSICS;MATERIALS SCIENCE;PSYCHOLOGY","4;3;2;2;1;1","INTERNAL MEDICINE;IMMUNOLOGY;NEUROSCIENCE;PSYCHIATRY;QUANTUM MECHANICS;BIOCHEMISTRY;BIOPHYSICS;COMPOSITE MATERIAL;ORGANIC CHEMISTRY;PATHOLOGY;PHYSICAL THERAPY;SURGERY;VIROLOGY","3;2;2;2;2;1;1;1;1;1;1;1;1","NEUROLOGY;NEUROSURGERY;RECEPTOR;TERM (TIME);ALTERNATIVE MEDICINE;ANTIBODY;CENTRAL NERVOUS SYSTEM;CONNECTIVE TISSUE;DISEASE;GLUCOSAMINE;INTESTINAL PERMEABILITY;JOINT PAIN;MEMBRANE;NEUROPLASTICITY;PERIPHERAL;PLASTICITY;RADICAL;TIGHT JUNCTION","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEURORADIOLOGY;HUNTINGTON'S DISEASE;LONG-TERM POTENTIATION;LOW BACK PAIN;PERIPHERAL NERVOUS SYSTEM;PERMEABILITY (ELECTROMAGNETISM);SYNAPTIC PLASTICITY","2;1;1;1;1;1;1","","",";INTESTINE, SMALL;KIDNEY;NITRIC OXIDE SYNTHASE;BENZAMIDES;CELL MEMBRANE PERMEABILITY;CYTOSKELETAL PROTEINS;ENZYME INHIBITORS;FREE RADICALS;HYDROGEN PEROXIDE;MEMBRANE PROTEINS;MITOCHONDRIA;NITRATES;PHOSPHOPROTEINS;POLY(ADP-RIBOSE) POLYMERASES;TIGHT JUNCTIONS;ZYMOSAN;ANIMALS;BETA CATENIN;CELLS, CULTURED","4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 INFECTION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE","1;1;1;1;1","NEURORADIOLOGY;A-SYNUCLEIN;GENE EXPRESSION DYSREGULATION;HTLV-1;INTESTINAL PERMEABILITY;JOINT PAIN;PERIPHERAL NERVOUS SYSTEM;SKELETAL COMPLICATIONS;TIGHT JUNCTIONS","2;1;1;1;1;1;1;1;1","ANTI-HTLVI ANTIBODIES;CONDITIONAL MODEL;FAMILIAL BISALBUMINEMIA;FREE RADICALS;HUNTINGTONS DISEASE;IMPAIRED LONG-TERM;INTESTINAL TIGHT;JUNCTION PERMEABILITY;LONG-TERM POTENTIATION;LONG-TERM SYNAPTIC;NERVOUS SYSTEM;PERIPHERAL NERVOUS;POLYADP-RIBOSE SYNTHETASE;RECURRENT LOW;SYNAPTIC PLASTICITY;SYSTEM DISEASES;TIGHT JUNCTION;Α-SYNUCLEIN IMMUNOREACTIVITY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INOSWT MICE;NITRIC OXIDE;HYDROGEN PEROXIDE;INOSKO MICE;JUNCTIONAL PROTEINS;MGKG IP;OCCLUDIN ZO-;SIGNIFICANT INCREASE;TIGHT JUNCTIONAL;ZYMOSAN-TREATED INOSKO;AB MGKG;AB MM;AB TREATMENTS;ADDITION HO;ADDITION INOSWT;ADMINISTRATION EXPOSURE;AMINOBENZAMIDE -AB;ANIMALS ZYMOSAN-TREATED;BOWEL DISEASE;CANINE KIDNEY;CELL ADHERENCE;CELLS ADHERENCE;CONTROL ANIMALS;DISRUPTED IMMUNOFLUORESCENCE;DISTRIBUTION PATTERNS;FREQUENTLY ALTERED;HO ΜM;HO-MEDIATED OCCLUDIN;ILEAL FRAGMENTS;ILEAL TJS","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2001,4,9.75,1.75,0.571428571428571,0,0.5,0,0,0,0,2,0,2,0,0.5,0,0.5,5.5,0.120370050743899,0.25,1,NA,0.334213197969543,0,0,0,"EDOARDO SESSA;PLACIDO BRAMANTI;LAURA NAPOLI;A. PRELLE;RITA DI LEO;STEFAN. DI DONATO;GIUSEPPE VITA;FRANCESCO FORTUNATO;LAURA ADOBBATI;PAOLO GIRLANDA;MONICA SCIACCO;GIACOMO P. COMI;P. DI BELLA;MARCHESE SS;GIANGAETANO D’ALEO;DI BELLA P;LUCA CHIVERI;ADREINA BORDONI;GIGLIOLA FAGIOLARI;COSTANZA LAMPERTI","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EDOARDO SESSA;PLACIDO BRAMANTI;STEFAN. DI DONATO;P. DI BELLA;MARCHESE SS;GIANGAETANO D’ALEO;DI BELLA P;CARMELA RIFICI;RITA DI LEO;GIUSEPPE VITA;PAOLO GIRLANDA;GIOVANNI DE LUCA;SERGIO BALDARI;CARMELO RODOLICO;ANNA MAZZEO;ANTONIO TOSCANO;LAURA NAPOLI;A. PRELLE;FRANCESCO FORTUNATO;LAURA ADOBBATI","0.4;0.4;0.2;0.2;0.2;0.2;0.2;0.2;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.05;0.05;0.05;0.05","EDOARDO SESSA;PLACIDO BRAMANTI;ANTÓNIO TOSCANO;CARMELA RIFICI;ANTONIO TOSCANO","2;2;1;1;1","EDOARDO SESSA;PLACIDO BRAMANTI;CARMELA RIFICI;ANTONIO TOSCANO;ANTÓNIO TOSCANO","0.4;0.4;0.2;0.12;0.05","EDOARDO SESSA;PLACIDO BRAMANTI;ANNA MAZZEO;ANTONIO TOSCANO;CARMELO RODOLICO;GIOVANNI DE LUCA;GIUSEPPE VITA;PAOLO GIRLANDA;RITA DI LEO;SERGIO BALDARI;CARMELA RIFICI;GIANGAETANO D’ALEO;P. DI BELLA;DI BELLA P;MARCHESE SS;STEFAN. DI DONATO;A. PAPADIMITRIOU;A. PRELLE;ADREINA BORDONI;ALESSANDRO BATTISTEL","12;12;10;10;10;10;10;10;10;10;7;7;7;5;5;5;0;0;0;0","EDOARDO SESSA;PLACIDO BRAMANTI;ANTONIO TOSCANO;CARMELA RIFICI;ANTÓNIO TOSCANO","12;12;10;7;0","EDOARDO SESSA;PLACIDO BRAMANTI;ANTONIO TOSCANO;CARMELA RIFICI;ANTÓNIO TOSCANO","2;2;1;1;0","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;PHYSICS","4;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;SURGERY;ANATOMY;ANESTHESIA;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GENETICS;MECHANICAL ENGINEERING;NEUROSCIENCE;PHYSICAL MEDICINE AND REHABILITATION;QUANTUM MECHANICS;SIMULATION;THERMODYNAMICS","3;3;3;3;2;1;1;1;1;1;1;1;1;1;1","NEUROLOGY;WEAKNESS;ABNORMALITY;ALTERNATIVE MEDICINE;ATROPHY;BIOMECHANICS;BLOOD PRESSURE;CENTRAL NERVOUS SYSTEM;DIABETES MELLITUS;DYSESTHESIA;ELBOW;EPILEPSY;GENE;LEVER;MULTIPLE SCLEROSIS;PERIPHERAL;POLYNEUROPATHY;POPULATION;POWER (PHYSICS);PTOSIS;RECEPTOR;REFLEX;SPASTICITY;TORQUE;TRIGEMINAL NEURALGIA;VISUAL ANALOGUE SCALE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARBAMAZEPINE;GABAPENTIN;GENOTYPE;HEART RATE;MITOCHONDRIAL DNA;NEURORADIOLOGY;NOCICEPTION;PERIPHERAL NERVOUS SYSTEM;PERIPHERAL NEUROPATHY;PHENOTYPE;RELIABILITY (SEMICONDUCTOR)","1;1;1;1;1;1;1;1;1;1;1","AUTONOMIC NERVOUS SYSTEM;GENETIC HETEROGENEITY;KEARNS–SAYRE SYNDROME;MITOCHONDRIAL DISEASE;MITOCHONDRIAL MYOPATHY","1;1;1;1;1","ACETATES;ANTICONVULSANTS;MULTIPLE SYSTEM ATROPHY;NEURALGIA;PERIPHERAL NERVOUS SYSTEM DISEASES;HUMANS;AUTONOMIC NERVOUS SYSTEM;BLINKING;MALE;MIDDLE AGED;MULTIPLE SCLEROSIS;MUSCLE SPASTICITY;NERVE FIBERS, MYELINATED;NOCICEPTORS;OCULOMOTOR NERVE;PAIN THRESHOLD;TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;;ADULT;AGED","4;4;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1","BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;EPILEPSY AND SEIZURES;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE","1;1;1;1","ABNORMALITY;BIOMECHANICS;DYSESTHESIA;KEARNS–SAYRE SYNDROME;LEVER;MITOCHONDRIA;MITOCHONDRIAL DISEASE;MITOCHONDRIAL DYSFUNCTION;MITOCHONDRIAL FUNCTION;MITOCHONDRIAL FUSION;NEURORADIOLOGY;NON-MOTOR SYMPTOMS;PERIPHERAL NERVOUS SYSTEM;SPASTICITY;TREATMENT","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL MORPHOLOGICAL;DISORDERS CLINICAL;EVALUATION TEST;GENETIC EVALUATION;MITOCHONDRIAL DISORDERS;MOLECULAR GENETIC;MULTIPLE SCLEROSIS;MULTIPLE SYSTEM;NOCICEPTIVE REFLEX;PAROXYSMAL SYMPTOMS;PATIENTS AFFECTED;PERIPHERAL NEUROPATHY;PILOT STUDY;RETROSPECTIVE STUDY;SCLEROSIS PATIENTS;SPASTICITY EVALUATION;SYMPTOMS TREATED;SYSTEM ATROPHY;TEST SET","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2002,7,7.85714285714286,1,1,0.142857142857143,0,0,0.428571428571429,0,5,0,0,1,0.71,0,0,0.14,46.29,0.838984885677911,0.428571428571429,0.857142857142857,NA,0.366242038216561,0,0,0,"EMANUELA MAZZON;SALVATORE CUZZOCREA;LAURA DUGO;ACHILLE P. CAPUTI;CHRISTOPH THIEMERMANN;IVANA SERRAINO;ANGELA DE SARRO;PRABAL K. CHATTERJEE;EMANUELA MASINI;WALTER FRIES;GIOVANNI TORTORELLA;GIUSEPPE VITA;COSIMO MARZOCCA;VINCENZA DI LEO;A CICCOLO;IGNAZIO BARBERI;MICHELA BAROLLO;FONS A. J. VAN DE LOO;ROSANNA DI PAOLA;FRANCESCO FULIA","6;5;4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","EMANUELA MAZZON;SALVATORE CUZZOCREA;LAURA DUGO;ACHILLE P. CAPUTI;ANGELA DE SARRO;CHRISTOPH THIEMERMANN;IVANA SERRAINO;PRABAL K. CHATTERJEE;EMANUELA MASINI;WALTER FRIES;COSIMO MARZOCCA;VINCENZA DI LEO;MICHELA BAROLLO;R. D’INCÀ;DANIELA SALVEMINI;GIACOMO CARLO STURNIOLO;PIER FRANCESCO MANNAIONI;JIE ZHANG;ANGELINA DE SARRO;JIA-HE LI","0.81;0.64;0.48;0.48;0.25;0.21;0.21;0.21;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14","EMANUELA MAZZON;ANTÓNIO TOSCANO","6;1","EMANUELA MAZZON;ANTÓNIO TOSCANO","0.81;0.12","EMANUELA MAZZON;ACHILLE P. CAPUTI;LAURA DUGO;SALVATORE CUZZOCREA;ANGELA DE SARRO;CHRISTOPH THIEMERMANN;PRABAL K. CHATTERJEE;FONS A. J. VAN DE LOO;GIACOMO CARLO STURNIOLO;MICHELA BAROLLO;R. D’INCÀ;VINCENZA DI LEO;WALTER FRIES;IVANA SERRAINO;ANGELINA DE SARRO;JIA-HE LI;JIE ZHANG;ROSANNA DI PAOLA;TIZIANA GENOVESE;A CICCOLO","323;204;204;204;146;139;139;120;119;119;119;119;119;45;39;39;39;26;26;19","EMANUELA MAZZON;ANTÓNIO TOSCANO","323;1","EMANUELA MAZZON;ANTÓNIO TOSCANO","6;1","MEDICINE;CHEMISTRY;BIOLOGY","6;4;2","ENDOCRINOLOGY;INTERNAL MEDICINE;BIOCHEMISTRY;CARDIOLOGY;IMMUNOLOGY;PATHOLOGY;PHARMACOLOGY;ANESTHESIA;BIOTECHNOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ORGANIC CHEMISTRY;PEDIATRICS","5;5;3;2;2;2;2;1;1;1;1;1;1","ISCHEMIA;NITRIC OXIDE;INFLAMMATION;OXIDATIVE STRESS;SUPERIOR MESENTERIC ARTERY;ANALYSIS OF VARIANCE;ARTERY;CARRAGEENAN;COLITIS;CYTOKINE;DIARRHEA;ENZYME;EXTRAVASATION;HEART FAILURE;HEMODYNAMICS;IN VITRO;IN VIVO;INTESTINAL PERMEABILITY;LARGE INTESTINE;MEMBRANE;SHOCK (CIRCULATORY);SMALL INTESTINE;STATISTICAL SIGNIFICANCE;TIGHT JUNCTION;TUMOR NECROSIS FACTOR ALPHA;ZINC","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITRIC OXIDE SYNTHASE;REPERFUSION INJURY;MALONDIALDEHYDE;CALPAIN;CARDIOMYOPATHY;INTERLEUKIN;MYELOPEROXIDASE;PERMEABILITY (ELECTROMAGNETISM);PROINFLAMMATORY CYTOKINE;SPLANCHNIC;ZYMOSAN","3;3;2;1;1;1;1;1;1;1;1","NITROTYROSINE;PARACELLULAR TRANSPORT;RESTRICTIVE CARDIOMYOPATHY","3;1;1","PEROXIDASE;MESENTERIC VASCULAR OCCLUSION;NITRIC OXIDE SYNTHASE;CYTOKINES;INTESTINAL MUCOSA;REPERFUSION INJURY;TYROSINE;ANIMALS;INTESTINES;NITRIC OXIDE;P-SELECTIN;COLITIS;ISCHEMIA;ISOENZYMES;MALE;MALONDIALDEHYDE;MULTIPLE ORGAN FAILURE;NEUTROPHILS;PLEURISY;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES","11;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4","PATHOPHYSIOLOGY OF MYOCARDIAL REPERFUSION INJURY;COPPER AND ZINC IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;ROLE OF CALPAIN IN CELLULAR PROCESSES AND DISEASES;ROLE OF NITRIC OXIDE IN HEALTH AND DISEASE;ROLE OF TREM-1 AND ENDOCAN IN INFLAMMATION","2;1;1;1;1;1","NITROTYROSINE;ISCHEMIA-REPERFUSION INJURY;MALONDIALDEHYDE;CALPAIN;CARDIAC FIBROSIS;CARDIAC IMAGING;CARDIOMYOPATHIES;CARDIOPROTECTION;CARRAGEENAN;DIABETIC CARDIOMYOPATHY;DILATED CARDIOMYOPATHY;EXTRAVASATION;INFLAMMATION;INTESTINAL PERMEABILITY;ISCHEMIC PRECONDITIONING;LARGE INTESTINE;MYOCARDIAL PERFUSION;PARACELLULAR TRANSPORT;PARP INHIBITORS;PROINFLAMMATORY CYTOKINE","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE LUNG;ARTERY OCCLUSION;BENEFICIAL EFFECTS;CALPAIN INHIBITOR;DISMUTASE MIMETIC;ENDOGENOUS INTERLEUKIN-;EXPERIMENTAL COLITIS;FAILURE INDUCED;IDIOPATHIC RESTRICTIVE;IIN VIVOI;INDUCED NITRIC;INFLAMMATORY RESPONSE;INJURY IIN;INTERLEUKIN- ENHANCES;INTESTINAL PERMEABILITY;LUNG INJURY;MULTIPLE ORGAN;MYOCARDIAL ISCHAEMIA;NITRIC OXIDE;ORGAN FAILURE;POLYADP-RIBOSE POLYMERASE;POSTISCHEMIC INJURY;PROTECTIVE EFFECTS;RAT MODEL;REPERFUSION INJURY;RESTRICTIVE CARDIOMYOPATHY;SELECTIVE SUPEROXIDE;SPLANCHNIC ARTERY;SUPEROXIDE DISMUTASE;ZINC SUPPLEMENTATION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VERSUS SHAM;WILD-TYPE MICE;INOS-KO MICE;MICE TREATED;VERSUS IRVEHICLE;DEPENDENT MANNER;DOSE DEPENDENT;FIGURE REPERFUSION;IRVEHICLE FIGURE;ISCHAEMIC MYOCARDIUM;KG VALUES;MESENTERIC ARTERY;MG KG;MG WET;MYOCARDIUM LEADS;SUPERIOR MESENTERIC;WET TISSUE;ARTERIAL BLOOD;BLOOD PRESSURE;BRITISH JOURNAL;CELIAC TRUNK;ENHANCED RELEASE;INFLAMMATORY RESPONSE;INTERCELLULAR ADHESION;LEFT VENTRICULAR;LIGHT TRANSMITTANCE;MESENTERIC INJURY;NEUTROPHIL RECRUITMENT;PHARMACOLOGY DOISJBJP;SAO SHOCK","5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2003,3,9.33333333333333,1,1,0,0.333333333333333,0,0.666666666666667,0,2,0,0,1,0.67,0,0,0.33,29.33,0.554213040450565,0.333333333333333,1,NA,0.222007722007722,0,0,0,"EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;CHRISTOPH THIEMERMAN;GIUSEPPINA AUTORE;CHRISTOPH THIEMERMANN;SALVATORE SCIORIO;AJITH K. SIRIWARDENA;LUCIA BARBARO MARTINO;GIOVANNA SPATARI;CARLO ABBATE;CONCETTINA FENGA;STEFANIA MARZOCCO;MARIO BARBARO;GIUSEPPINA CUTRONEO;IOANNIS VIRLOS;IVANA SERRAINO;ALDO PINTO;CHIARA COSTA;ANGELO FAVALORO","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;GIUSEPPINA AUTORE;CHRISTOPH THIEMERMANN;STEFANIA MARZOCCO;ALDO PINTO;ACHILLE P. CAPUTI;CHRISTOPH THIEMERMAN;AJITH K. SIRIWARDENA;IOANNIS VIRLOS;IVANA SERRAINO;TIZIANA GENOVESE;DOMENICO BRITTI;SALVATORE SCIORIO;LUCIA BARBARO MARTINO;GIOVANNA SPATARI;CARLO ABBATE;CONCETTINA FENGA;MARIO BARBARO","0.24;0.24;0.24;0.12;0.12;0.12;0.12;0.12;0.11;0.11;0.11;0.11;0.11;0.11;0.09;0.09;0.09;0.09;0.09;0.09","EMANUELA MAZZON;PLACIDO BRAMANTI","2;1","EMANUELA MAZZON;PLACIDO BRAMANTI","0.24;0.09","EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;AJITH K. SIRIWARDENA;CHRISTOPH THIEMERMAN;DOMENICO BRITTI;IOANNIS VIRLOS;IVANA SERRAINO;TIZIANA GENOVESE;ACHILLE P. CAPUTI;ALDO PINTO;CHRISTOPH THIEMERMANN;GIUSEPPINA AUTORE;STEFANIA MARZOCCO;ANGELO FAVALORO;CARLO ABBATE;CHIARA COSTA;CONCETTINA FENGA;FABIO TRIMARCHI;GIOVANNA SPATARI","82;82;82;62;62;62;62;62;62;20;20;20;20;20;6;6;6;6;6;6","EMANUELA MAZZON;PLACIDO BRAMANTI","82;6","EMANUELA MAZZON;PLACIDO BRAMANTI","2;1","CHEMISTRY;MEDICINE;ENGINEERING","3;3;1","INTERNAL MEDICINE;BIOCHEMISTRY;ENDOCRINOLOGY;PATHOLOGY;ANATOMY;CHEMICAL ENGINEERING;ORGANIC CHEMISTRY;PHARMACOLOGY","3;2;2;2;1;1;1;1","NITRIC OXIDE;OXIDATIVE STRESS;ACUTE PANCREATITIS;AMORPHOUS SILICA;ENZYME;INFLAMMATION;INHALATION;ISCHEMIA;LUNG;MEMBRANE;PANCREATITIS;PARENCHYMA;PULMONARY SURFACTANT;SALINE;SILICOSIS;SUPERIOR MESENTERIC ARTERY;TOXICITY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITRIC OXIDE SYNTHASE;CALPAIN;LIPID PEROXIDATION;MALONDIALDEHYDE;MYELOPEROXIDASE;NF-ΚB;PHOSPHOLIPID;REPERFUSION INJURY","2;1;1;1;1;1;1;1","NITROTYROSINE;PYRROLIDINE DITHIOCARBAMATE","2;1","TYROSINE;BRONCHI;I-KAPPA B PROTEINS;INTERCELLULAR ADHESION MOLECULE-1;LUNG;NEUTROPHILS;PEROXIDASE;PULMONARY ALVEOLI;PULMONARY FIBROSIS;RESPIRATORY MUCOSA;SILICOSIS;ANIMALS;ANTIOXIDANTS;IMMUNOHISTOCHEMISTRY;MALE;PANCREATITIS;PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;RATS;REACTION TIME;AMYLASES","6;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;2","DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;ROLE OF CALPAIN IN CELLULAR PROCESSES AND DISEASES","1;1;1","NITROTYROSINE;ACUTE PANCREATITIS;AMORPHOUS SILICA;CALPAIN;ISCHEMIA-REPERFUSION INJURY;MALONDIALDEHYDE;PARENCHYMA;PYRROLIDINE DITHIOCARBAMATE;SILICOSIS;SURFACTANT PROTEINS","2;1;1;1;1;1;1;1;1;1","ACUTE PANCREATITIS;CALPAIN INHIBITOR;CERULEIN-INDUCED MURINE;CRYSTALLINE SILICA;DITHIOCARBAMATE REDUCES;EXPERIMENTAL EXPOSURE;INTESTINAL ISCHEMIA-REPERFUSION;ISCHEMIA-REPERFUSION INJURY;MURINE ACUTE;PYRROLIDINE DITHIOCARBAMATE;RAT TIME;REDUCES INTESTINAL;SURFACTANT PROTEIN","1;1;1;1;1;1;1;1;1;1;1;1;1","MG WET;WET TISSUE;CALPAIN INHIBITOR;ACUTE PANCREATITIS;INTRACELLULAR ADHESION;MICROMOL MG;MICROMOL NA;ADHESION MOLECULE-;ARTERIAL BLOOD;BLOOD PRESSURE;IMMUNOHISTOCHEMICAL EXAMINATION;ISCHEMIA-REPERFUSION INJURY;LIPID PEROXIDATION;MALONDIALDEHYDE LEVELS;MARKED INCREASE;MARKEDLY REDUCED;MYELOPEROXIDASE ACTIVITY;NEUTROPHIL INFILTRATION;SHAM-OPERATED RATS;SPLANCHNIC ARTERY;STUDY DEMONSTRATES;ADHESION MOLECULE;ADP-RIBOSE SYNTHASE;ARTERY OCCLUSION;ARTERY OCCLUSION-REPERFUSION;ATTENUATES EXPERIMENTAL;BLOT ANALYSIS;CELIAC TRUNK;CERULEIN-TREATED MICE;DIPHOSPHATE ADP-RIBOSE","6;6;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2004,6,9,1.66666666666667,0.6,0,0.166666666666667,0,0.166666666666667,0,2,3,0,0,0.33,0.5,0,0,70.17,1.49120677697414,0.333333333333333,1,NA,0.443285179240235,0,0,0,"EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;TIZIANA GENOVESE;PLACIDO BRAMANTI;DOMENICO BRITTI;CHRISTOPH THIEMERMANN;NIMESH S. A. PATEL;ANGELINA DE SARRO;AGOSTINO PALMERI;CARMELO MUI;ROSARIO DI MAURO;STEFANIA MARZOCCO;M.R. DI PASQUALE;DANIELE BRUSCHETTA;P. DI BELLA;GIANGAETANO D’ALEO;FRANCESCO DATTOLA;P. BRUSCHETTA;MARIA TERESA DRAGO","4;4;4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;TIZIANA GENOVESE;DOMENICO BRITTI;CHRISTOPH THIEMERMANN;M.R. DI PASQUALE;P. BRUSCHETTA;NIMESH S. A. PATEL;E. ROTONDO;ANGELINA DE SARRO;CARMELO MUI;DANIELA SALVEMINI;DANIELE BRUSCHETTA;ANTONINA PISANI;GIUSEPPINA CUTRONEO;GIUSEPPE ANASTASI;GIUSEPPE SANTORO;ANGELO FAVALORO","0.5;0.5;0.5;0.45;0.38;0.38;0.25;0.25;0.25;0.25;0.25;0.25;0.14;0.14;0.12;0.12;0.12;0.12;0.12;0.12","EMANUELA MAZZON;PLACIDO BRAMANTI;GIANGAETANO D’ALEO;EDOARDO SESSA;NUNZIO MUSCARÀ;CARMELA RIFICI","4;3;1;1;1;1","EMANUELA MAZZON;PLACIDO BRAMANTI;GIANGAETANO D’ALEO;EDOARDO SESSA;NUNZIO MUSCARÀ;CARMELA RIFICI","0.5;0.45;0.07;0.07;0.07;0.07","EMANUELA MAZZON;ROSANNA DI PAOLA;SALVATORE CUZZOCREA;DOMENICO BRITTI;ANGELINA DE SARRO;CHRISTOPH THIEMERMANN;NIMESH S. A. PATEL;TIZIANA GENOVESE;PRABAL K. CHATTERJEE;FEDERICO ROTONDO;FRANCESCO DATTOLA;MASSIMO DE MAJO;STEFANIA MARZOCCO;CARMELO MUIÀ;CARMELO MUI;DANIELA SALVEMINI;PLACIDO BRAMANTI;ANGELO FAVALORO;ANTONINA PISANI;DANIELE BRUSCHETTA","382;382;382;321;229;229;229;214;168;108;108;108;108;61;45;45;39;20;20;20","EMANUELA MAZZON;PLACIDO BRAMANTI;CARMELA RIFICI;EDOARDO SESSA;GIANGAETANO D’ALEO;NUNZIO MUSCARÀ","382;39;19;19;19;19","EMANUELA MAZZON;PLACIDO BRAMANTI;CARMELA RIFICI;EDOARDO SESSA;GIANGAETANO D’ALEO;NUNZIO MUSCARÀ","4;3;1;1;1;1","MEDICINE;CHEMISTRY;PSYCHOLOGY;BIOLOGY","6;3;2;1","INTERNAL MEDICINE;ENDOCRINOLOGY;PATHOLOGY;BIOCHEMISTRY;ANATOMY;CARDIOLOGY;CELL BIOLOGY;DENTISTRY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;ORGANIC CHEMISTRY;PHARMACOLOGY","5;3;3;2;1;1;1;1;1;1;1;1;1;1;1","NITRIC OXIDE;INFLAMMATION;DISEASE;OXIDATIVE STRESS;ACUTE KIDNEY INJURY;ACUTE PANCREATITIS;ATAXIA;BASEMENT MEMBRANE;CELL;CEREBELLUM;COLITIS;CREATININE;DENTAL ALVEOLUS;ENZYME;ERYTHROPOIETIN;EXTRAVASATION;GENE;INHIBITORY POSTSYNAPTIC POTENTIAL;ISCHEMIA;KIDNEY;LIGATION;MOLAR;MUSCULAR DYSTROPHY;MYOCYTE;PANCREATITIS;PERIODONTITIS;REACTIVE OXYGEN SPECIES;SIGNAL TRANSDUCTION;SKELETAL MUSCLE;STIMULATION;TUMOR NECROSIS FACTOR ALPHA","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITRIC OXIDE SYNTHASE;LIPID PEROXIDATION;COGNITIVE IMPAIRMENT;DYSTROPHIN;FOCAL ADHESION;HEMIDESMOSOME;INFLAMMATORY BOWEL DISEASE;INTEGRIN;ITGA7;MALONDIALDEHYDE;MOTOR CORTEX;MUTATION;MYELOPEROXIDASE;MYOGENESIS;PROINFLAMMATORY CYTOKINE;REPERFUSION INJURY;SARCOLEMMA;SPINOCEREBELLAR ATAXIA;SUPEROXIDE;SUPEROXIDE DISMUTASE;TRANSCRANIAL MAGNETIC STIMULATION","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITROTYROSINE;LIMB-GIRDLE MUSCULAR DYSTROPHY;RENAL ISCHEMIA;SILENT PERIOD;VINCULIN","4;1;1;1;1","TYROSINE;MALE;ANIMALS;COLITIS;INFLAMMATORY BOWEL DISEASES;INTERCELLULAR ADHESION MOLECULE-1;INTERLEUKIN-1;KIDNEY;NEUTROPHIL INFILTRATION;PANCREATITIS;PEROXIDASE;POLY(ADP-RIBOSE) POLYMERASES;REPERFUSION INJURY;TUMOR NECROSIS FACTOR-ALPHA;GINGIVA;LIPID PEROXIDATION;MICE;MOUTH MUCOSA;MUSCLE, SKELETAL;MUSCULAR DYSTROPHIES, LIMB-GIRDLE","9;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY;MECHANOSENSITIVE ION CHANNELS IN PHYSIOLOGY AND DISEASE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;ROLE OF NITRIC OXIDE IN HEALTH AND DISEASE","1;1;1;1;1;1","NITROTYROSINE;INFLAMMATION;ACUTE KIDNEY INJURY;ACUTE PANCREATITIS;CORTICAL EXCITABILITY;ERYTHROCYTE;ERYTHROPOIESIS;ERYTHROPOIESIS-STIMULATING AGENTS;EXTRAVASATION;HEMIDESMOSOME;ITGA7;LIMB-GIRDLE MUSCULAR DYSTROPHY;MALONDIALDEHYDE;PROINFLAMMATORY CYTOKINE;RENAL ISCHEMIA;SARCOLEMMA;SILENT PERIOD;SKELETAL MUSCLE ATROPHY;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE PANCREATITIS;ATAXIA TYPE;BOWEL DISEASE;CERULEIN-INDUCED ACUTE;CORTICAL SILENT;DISMUTASE MIMETIC;ENDOGENOUS INTERLEUKIN-;ERYTHROPOIETIN REDUCES;EXPERIMENTAL INFLAMMATORY;IMMUNOHISTOCHEMICAL STUDY;INFLAMMATION CAUSED;INFLAMMATORY BOWEL;INJURY DYSFUNCTION;INTERLEUKIN- ENHANCES;LIGATURE-INDUCED PERIODONTITIS;PERIOD PROLONGATION;RENAL INJURY;SARCOGLYCANS VINCULIN-TALIN-INTEGRIN;SELECTIVE SUPEROXIDE;SILENT PERIOD;SPINOCEREBELLAR ATAXIA;SUPEROXIDE DISMUTASE;TYPE SCA;VINCULIN-TALIN-INTEGRIN SYSTEM","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE PANCREATITIS;ADHESION MOLECULE-;ADP-RIBOSE POLYMERASE;CERULEIN-TREATED MICE;INTERCELLULAR ADHESION;LIPID PEROXIDATION;PANCREATIC TISSUE;POLY ADP-RIBOSE;SUPEROXIDE DISMUTASE;AMYLASE ANDOR;ANDOR LIPASE;ANIONS PLAY;ATTENUATES EXPERIMENTAL;CELL NECROSIS;CERULEIN-MEDIATED ACUTE;DISMUTASE MIMETIC;DISMUTASE MIMETICS;EDEMA NEUTROPHIL;ENHANCED LIPID;EXAMINATION DEMONSTRATED;EXPERIMENTAL ACUTE;HISTOLOGICAL SCORE;IMMUNOHISTOCHEMICAL EXAMINATION;INCREASED TISSUE;INFILTRATION TISSUE;INJURY HISTOLOGICAL;INTRAPERITONEAL INJECTION;LOW-MOLECULAR-WEIGHT SYNTHETIC;MALONDIALDEHYDE IMMUNOHISTOCHEMICAL;MARKED INCREASE","4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2005,13,7.15384615384615,1.23076923076923,0.8125,0,0.0769230769230769,0,0.307692307692308,0,4,1,2,6,0.31,0.08,0.15,0.46,33.54,0.633473735284059,0.230769230769231,1,NA,0.336366430986781,0,0,0,"EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;CHRISTOPH THIEMERMANN;P. DI BELLA;NADIA MAMMONE;NIMESH S. A. PATEL;FABIO LA FORESTA;FRANCESCO CARLO MORABITO;ANTÓNIO TOSCANO;RITA DI LEO;ROSANNA DE PAOLA;EUGENIA CONTI;SANDRINE DELBOSC;CONCETTA CRISAFULLI;JEAN‐PAUL CRISTOL;SEIJI MIYOSHI;BRUNO DALLAPICCOLA;A. AMATO;GIUSEPPE VITA","4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","NADIA MAMMONE;FABIO LA FORESTA;FRANCESCO CARLO MORABITO;EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;ANTÓNIO TOSCANO;P. DI BELLA;B. AZZERBONI;CHRISTOPH THIEMERMANN;NIMESH S. A. PATEL;RITA DI LEO;ANTONIO DE VIVO;ALFREDO MANCUSO;GIUSY FANARA;ANTONGIULIO VITETTA;GIUSEPPE NAPPI;NUNZIO MUSCARÀ;ROSARIO GRUGNO;GIUSEPPE VITA","0.58;0.58;0.58;0.47;0.47;0.38;0.34;0.29;0.25;0.24;0.24;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.14","EMANUELA MAZZON;PLACIDO BRAMANTI;NADIA MAMMONE;ANTÓNIO TOSCANO;GIANGAETANO D’ALEO;EDOARDO SESSA;NUNZIO MUSCARÀ;ROSARIO GRUGNO;CARMELA RIFICI;A. TOSCANO","4;3;2;2;1;1;1;1;1;1","NADIA MAMMONE;EMANUELA MAZZON;PLACIDO BRAMANTI;ANTÓNIO TOSCANO;NUNZIO MUSCARÀ;ROSARIO GRUGNO;GIANGAETANO D’ALEO;EDOARDO SESSA;CARMELA RIFICI;A. TOSCANO","0.58;0.47;0.38;0.34;0.17;0.17;0.12;0.12;0.12;0.1","A. TOSCANO;ANNA SÁRKÖZY;ANTONIO PIZZUTI;BRUNO DALLAPICCOLA;BRUNO MARINO;CHRISTIAN NÉRI;EUGENIA CONTI;GRAZIANA ESPOSITO;M. CRISTINA DIGILIO;RICHARD S. D’AGOSTINO;EMANUELA MAZZON;SALVATORE CUZZOCREA;CHRISTOPH THIEMERMANN;NIMESH S. A. PATEL;INGE BAUER;JEAN‐PAUL CRISTOL;MAHA ABDELRAHMAN;MICHAEL BAUER;SANDRINE DELBOSC;PLACIDO BRAMANTI","159;159;159;159;159;159;159;159;159;159;144;144;118;118;71;71;71;71;71;63","A. TOSCANO;EMANUELA MAZZON;NADIA MAMMONE;NUNZIO MUSCARÀ;ROSARIO GRUGNO;PLACIDO BRAMANTI;ANTÓNIO TOSCANO;CARMELA RIFICI;EDOARDO SESSA;GIANGAETANO D’ALEO","159;144;59;29;29;24;11;10;10;10","EMANUELA MAZZON;ANTÓNIO TOSCANO;NADIA MAMMONE;A. TOSCANO;CARMELA RIFICI;EDOARDO SESSA;GIANGAETANO D’ALEO;NUNZIO MUSCARÀ;PLACIDO BRAMANTI;ROSARIO GRUGNO","4;2;2;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY","9;5;4;2;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;PHARMACOLOGY;ANESTHESIA;ARTIFICIAL INTELLIGENCE;ENDOCRINOLOGY;IMMUNOLOGY;SPEECH RECOGNITION;SURGERY;TELECOMMUNICATIONS;ANATOMY;AUDIOLOGY;CARDIOLOGY;CELL BIOLOGY;COMPUTER SECURITY;INTENSIVE CARE MEDICINE;MOLECULAR BIOLOGY;NEUROSCIENCE;NURSING;PATHOLOGY;PEDIATRICS;PROGRAMMING LANGUAGE;PSYCHIATRY;THERMODYNAMICS","7;4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INDEPENDENT COMPONENT ANALYSIS;KIDNEY;OXIDATIVE STRESS;PATTERN RECOGNITION (PSYCHOLOGY);PREGNANCY;WAVELET;ACUTE KIDNEY INJURY;ANTIBODY;ANTIOXIDANT;CARDIAC MUSCLE;CHANNEL (BROADCASTING);COMPLICATION;COMPONENT (THERMODYNAMICS);DELTOID CURVE;ELECTROENCEPHALOGRAPHY;ELECTROPHYSIOLOGY;ENZYME;ETIOLOGY;FEATURE EXTRACTION;FUNCTIONAL MAGNETIC RESONANCE IMAGING;GENE;HEART SEPTAL DEFECT;HEARTBEAT;HYPERICUM PERFORATUM;ILEUM;INFLAMMATION;INFUSION PUMP;INTRATHECAL;ISCHEMIA;LIVER INJURY;MIGRAINE;MUSCULAR DYSTROPHY;MYASTHENIA GRAVIS;MYOPATHY;NEPHRITIS;NEPHROSIS;NEUROIMAGING;NITRIC OXIDE;QUALITY OF LIFE (HEALTHCARE);RADAR;RECEPTOR;RESUSCITATION;SEPSIS;SHOCK (CIRCULATORY);SHOULDER GIRDLE;SIGNAL (PROGRAMMING LANGUAGE);SKELETAL MUSCLE;SPASTICITY;STIMULATION;SUPERIOR MESENTERIC ARTERY;THROMBOSIS","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","WAVELET TRANSFORM;AGONIST;AURA;BLIND SIGNAL SEPARATION;CORTICAL SPREADING DEPRESSION;FETUS;GLOMERULONEPHRITIS;IN VITRO FERTILISATION;ITGA7;MALONDIALDEHYDE;MULTIPLE ORGAN DYSFUNCTION SYNDROME;MYELOPEROXIDASE;NADPH OXIDASE;NITRIC OXIDE SYNTHASE;ORGAN DYSFUNCTION;REPERFUSION INJURY;SERUM SICKNESS;SUPEROXIDE;THROMBOPHILIA;TRANSCRANIAL MAGNETIC STIMULATION;TRANSCRIPTION FACTOR;VENOUS THROMBOSIS;WAVEFORM","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","APOCYNIN;BACLOFEN;GATA4;MIGRAINE WITH AURA;NITROTYROSINE;OVARIAN HYPERSTIMULATION SYNDROME;RENAL ISCHEMIA","1;1;1;1;1;1;1","HUMANS;MALE;ADULT;KIDNEY;REPERFUSION INJURY;FEMALE;MUSCULAR DYSTROPHIES, LIMB-GIRDLE;MYASTHENIA GRAVIS;NITRATES;;CREATININE;MUSCLE SPASTICITY;NADPH OXIDASES;NEPHRITIS;NITRITES;PEROXIDASE;ANIMALS;BACLOFEN;CECUM;DUODENUM","7;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3","BLIND SOURCE SEPARATION AND INDEPENDENT COMPONENT ANALYSIS;AMINO ACID TRANSPORT AND METABOLISM IN HEALTH AND DISEASE;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;HERBAL MEDICINE AND NATURAL COMPOUNDS RESEARCH;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;POLY(ADP-RIBOSE) POLYMERASE INHIBITION IN CANCER THERAPY;ROLE OF NITRIC OXIDE IN HEALTH AND DISEASE;THROMBOSIS AND COAGULATION DISORDERS","2;1;1;1;1;1;1;1;1;1;1;1","ARRHYTHMIA DETECTION;EEG ANALYSIS;APOCYNIN;BACLOFEN;CARDIAC MUSCLE;COMPONENT (THERMODYNAMICS);CONGENITAL HEART DEFECTS;CORTICAL SPREADING DEPRESSION;DEEP VEIN THROMBOSIS;DELTOID CURVE;ECG SIGNAL;EPILEPSY DETECTION;ETIOLOGY;GATA4;HEART SEPTAL DEFECT;HEARTBEAT;HEARTBEAT CLASSIFICATION;HYPERICUM PERFORATUM;INBORN ERRORS OF METABOLISM;INDEPENDENT COMPONENT ANALYSIS","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AI CENTRI;APPROACH BASED;ASSESSMENT SCALES;ATRIAL SEPTAL;AURA ELECTROPHYSIOLOGICAL;BACLOFEN INFUSION;BODY VENOUS;CENTRI SEMIOVALI;COMPARATIVO H-MRS;DI INDICI;DI N-ACETILASPARTATO;ELECTROCARDIOGRAM EXTRACTION;FECG EXTRACTION;FETAL ELECTROCARDIOGRAM;FUNCTIONAL NEUROIMAGING;GATA TRANSCRIPTION;H-MRS DI;HEMORRHAGIC SHOCK;HUMAN SMOOTH;HYPERICUM PERFORATUM;INDEPENDENT COMPONENT;INDICI DI;INFUSION DATA;INTRATHECAL BACLOFEN;ISCHEMIAREPERFUSION INJURY;JUVENILE LIMB-GIRDLE;KD ISOFORM;LIMB-GIRDLE MYASTHENIA;MICE LACKING;MOLECULAR STUDY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PERFORATUM EXTRACT;HEMORRHAGIC SHOCK;RENAL DYSFUNCTION;SAO-SHOCKED RATS;BLOOD PRESSURE;LIVER INJURY;NADPH OXIDASE;ARTERIAL BLOOD;REACTIVE OXYGEN;ADHESION MOLECULE-;ADP-RIBOSYLATED PROTEINS;ARTERY OCCLUSION;ATRIAL SEPTUM;CIRCULATORY FAILURE;DYSFUNCTION CAUSED;EXTRACT TREATMENT;INJURY CAUSED;INTERCELLULAR ADHESION;IR INJURY;MARKEDLY REDUCED;ORGAN DYSFUNCTION;OXIDATIVE STRESS;OXYGEN SPECIES;POLY ADP-RIBOSYLATED;POLYPHENOLIC COMPOUNDS;POSITIVE STAINING;SAO SHOCK;SEPTAL DEFECT;SIGNIFICANT FALL;SIGNIFICANTLY REDUCED","8;7;6;5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,90,11.11,0,0,22,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","1;1;1;1","AGING;BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;MENTAL HEALTH;NEURODEGENERATIVE;NEUROSCIENCES;PARKINSON'S DISEASE;SCHIZOPHRENIA;SERIOUS MENTAL ILLNESS","1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2006,38,8.5,2.86842105263158,0.348623853211009,0.394736842105263,0.473684210526316,0.947368421052632,0.473684210526316,0,27,6,1,2,0.71,0.16,0.03,0.05,40.84,0.799599428360709,0.342105263157895,1,NA,0.566874405678991,0.369565217391304,0.5,0.292152292152292,"SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;CONCETTA CRISAFULLI;TIZIANA GENOVESE;EMANUELA ESPOSITO;CARMELO MUIÀ;ROSARIA MELI;PLACIDO BRAMANTI;CHRISTOPH THIEMERMANN;CARMELO MUI;HISANORI SUZUKI;P. DI BELLA;MARTA MENEGAZZI;EDOARDO SPINA;ACHILLE P. CAPUTI;GIUSEPPE MALLEO;DOMENICO BRITTI;DANIELE ZITO;SIMONA RONCHETTI","28;27;20;19;16;16;14;7;7;6;6;5;5;5;4;4;3;3;2;2","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;CONCETTA CRISAFULLI;EMANUELA ESPOSITO;TIZIANA GENOVESE;CARMELO MUIÀ;PLACIDO BRAMANTI;ROSARIA MELI;CHRISTOPH THIEMERMANN;EDOARDO SPINA;ACHILLE P. CAPUTI;CARMELO MUI;P. DI BELLA;HISANORI SUZUKI;MARTA MENEGAZZI;CONCETTA D’ARRIGO;GAETANA MIGLIARDI;VINCENZA SANTORO;DOMENICO BRITTI","3.88;3.55;2.05;1.99;1.66;1.62;1.5;0.77;0.75;0.71;0.67;0.64;0.62;0.56;0.49;0.49;0.38;0.38;0.38;0.34","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;CONCETTA CRISAFULLI;TIZIANA GENOVESE;EMANUELA ESPOSITO;ROSARIA MELI;PLACIDO BRAMANTI;CHRISTOPH THIEMERMANN;CARMELO MUI;HISANORI SUZUKI;P. DI BELLA;MARTA MENEGAZZI;EDOARDO SPINA;ACHILLE P. CAPUTI;WOOKEE MIN;MARIKA COLLIN;EDOARDO SESSA;CARLO RICCARDI;JIE ZHANG","28;27;20;19;16;16;7;7;6;6;5;5;5;4;4;2;2;2;2;2","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;CONCETTA CRISAFULLI;EMANUELA ESPOSITO;TIZIANA GENOVESE;PLACIDO BRAMANTI;ROSARIA MELI;CHRISTOPH THIEMERMANN;EDOARDO SPINA;ACHILLE P. CAPUTI;CARMELO MUI;P. DI BELLA;HISANORI SUZUKI;MARTA MENEGAZZI;VINCENZA SANTORO;NADIA MAMMONE;EDOARDO SESSA;MARIKA COLLIN;CARLO RICCARDI","3.88;3.55;2.05;1.99;1.66;1.62;0.77;0.75;0.71;0.67;0.64;0.62;0.56;0.49;0.49;0.38;0.33;0.21;0.2;0.2","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;CONCETTA CRISAFULLI;CARMELO MUIÀ;EMANUELA ESPOSITO;TIZIANA GENOVESE;ROSARIA MELI;PLACIDO BRAMANTI;P. DI BELLA;ACHILLE P. CAPUTI;EDOARDO SPINA;CHRISTOPH THIEMERMANN;HISANORI SUZUKI;MARTA MENEGAZZI;DANIELA SALVEMINI;T. DOYLE;MAHA ABDELRAHMAN;GIUSEPPE MALLEO;CARLO RICCARDI","1094;925;651;644;601;562;506;275;233;229;223;216;212;211;211;169;169;145;123;104","EMANUELA MAZZON;SALVATORE CUZZOCREA;TIZIANA GENOVESE;PLACIDO BRAMANTI;EDOARDO SPINA;P. DI BELLA;ACHILLE P. CAPUTI;MICHELE TARI;ROSANNA DI PAOLA;VINCENZA SANTORO;ANTÓNIO TOSCANO;CARLO RICCARDI;CARMELO MUI;CONCETTA CRISAFULLI;PAOLODI BELLA;NADIA MAMMONE;ROSARIO GRUGNO;SILVIA MARINO;ANTONIO TOSCANO;EMANUELA ESPOSITO","925;822;277;219;216;215;144;73;69;47;43;40;29;29;19;15;14;14;4;4","EMANUELA MAZZON;SALVATORE CUZZOCREA;TIZIANA GENOVESE;PLACIDO BRAMANTI;ROSANNA DI PAOLA;CARMELO MUI;CONCETTA CRISAFULLI;EDOARDO SPINA;P. DI BELLA;EMANUELA ESPOSITO;ACHILLE P. CAPUTI;ANTONIO TOSCANO;ANTÓNIO TOSCANO;CARLO RICCARDI;CHRISTOPH THIEMERMANN;EDOARDO SESSA;JIE ZHANG;MARIKA COLLIN;MICHELE TARI;NADIA MAMMONE","27;22;10;6;5;4;4;4;4;3;2;1;1;1;1;1;1;1;1;1","MEDICINE;CHEMISTRY;BIOLOGY;PHYSICS;PSYCHOLOGY;MATERIALS SCIENCE;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE","35;24;13;6;4;2;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;PHARMACOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;PSYCHIATRY;PATHOLOGY;ANESTHESIA;CELL BIOLOGY;DENTISTRY;MOLECULAR BIOLOGY;SURGERY;THERMODYNAMICS;NEUROSCIENCE;ORGANIC CHEMISTRY;PEDIATRICS;QUANTUM MECHANICS;ARTIFICIAL INTELLIGENCE;BIOTECHNOLOGY;CANCER RESEARCH;CHROMATOGRAPHY;COMPOSITE MATERIAL;GENETICS;INTENSIVE CARE MEDICINE;LAW;MATHEMATICAL ECONOMICS;NURSING;OPTICS;OPTOELECTRONICS;RADIOLOGY;TRADITIONAL MEDICINE","26;23;20;16;15;11;5;4;3;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INFLAMMATION;NITRIC OXIDE;ENZYME;OXIDATIVE STRESS;IN VITRO;APOPTOSIS;DISEASE;GLYCOGEN;KINASE;SPINAL CORD;TUMOR NECROSIS FACTOR ALPHA;COLITIS;HYPERICUM PERFORATUM;INFILTRATION (HVAC);EDEMA;GENE;PERIODONTITIS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);SEPSIS;ACUTE PANCREATITIS;ANTIOXIDANT;CARRAGEENAN;CYTOKINE;ELECTROENCEPHALOGRAPHY;EPILEPSY;EXTRAVASATION;ILEUM;INTESTINAL PERMEABILITY;LUNG;MELATONIN;NECROSIS;PANCREATITIS;PLEURAL EFFUSION;REACTIVE OXYGEN SPECIES;RECEPTOR;SIGNAL TRANSDUCTION;SMALL INTESTINE;TIGHT JUNCTION","17;12;8;7;6;5;5;5;5;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NITRIC OXIDE SYNTHASE;ZYMOSAN;GLYCOGEN SYNTHASE;GSK-3;INFLAMMATORY BOWEL DISEASE;MYELOPEROXIDASE;SPINAL CORD INJURY;POLYMERASE;ICTAL;LAMINECTOMY;LIPID PEROXIDATION;NF-ΚB;OCCLUDIN;OLANZAPINE;PLEURISY;PROINFLAMMATORY CYTOKINE;SUPEROXIDE;TRANSCRIPTION FACTOR;ADVERSE DRUG REACTION;ANTIDEPRESSANT;ANTIPSYCHOTIC;ATP SYNTHASE;AURA;BIPOLAR DISORDER;BLEOMYCIN;CARBAMAZEPINE;CHRONIC HEPATITIS;CLOZAPINE;CONSTRUCT VALIDITY;COPPER DEFICIENCY;DEMENTIA;EPILEPTIC SEIZURE;EXON;HALOPERIDOL;INFLAMMATORY MYOPATHY;LAMOTRIGINE;LYAPUNOV EXPONENT;MALONDIALDEHYDE;MEMORY IMPAIRMENT;MICROGLIA;MULTIPLE ORGAN DYSFUNCTION SYNDROME;MUTATION;NAD+ KINASE;ORGAN DYSFUNCTION;PANCREATIC DISEASE;PERMEABILITY (ELECTROMAGNETISM);PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;PHARMACOEPIDEMIOLOGY;PHENOTYPE;PROGRAMMED CELL DEATH;PROTEIN KINASE A;REDUCTASE;REPERFUSION INJURY;RISPERIDONE;ROSIGLITAZONE;SEPTIC SHOCK;SPLANCHNIC;THERAPEUTIC DRUG MONITORING;TRANSCRANIAL MAGNETIC STIMULATION;TUNEL ASSAY","13;6;5;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITROTYROSINE;GSK3B;POLY ADP RIBOSE POLYMERASE;PEROXYNITRITE;ALPHA (FINANCE);ATYPICAL ANTIPSYCHOTIC;DOPAMINE ANTAGONIST;ELECTROPHORETIC MOBILITY SHIFT ASSAY;FAS LIGAND;GENETIC HETEROGENEITY;HEREDITARY SPASTIC PARAPLEGIA;HMG-COA REDUCTASE;MIGRAINE WITH AURA;MOOD STABILIZER;NFKB1;NICOTINAMIDE ADENINE DINUCLEOTIDE;NUCLEAR RECEPTOR;P50;PARACELLULAR TRANSPORT;PEROXISOME PROLIFERATOR;PYRROLIDINE DITHIOCARBAMATE;TRICYCLIC ANTIDEPRESSANT","12;4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MALE;ANIMALS;INFLAMMATION;LUNG;MICE;COLITIS;NEUTROPHIL INFILTRATION;PERIODONTITIS;PEROXIDASE;SPINAL CORD INJURIES;TUMOR NECROSIS FACTOR-ALPHA;TYROSINE;HUMANS;NITRIC OXIDE SYNTHASE TYPE II;ENZYME INHIBITORS;BENZODIAZEPINES;GLYCOGEN SYNTHASE KINASE 3;PANCREATITIS;PLANT EXTRACTS;PLEURISY","26;22;21;20;15;14;13;12;12;12;12;12;11;11;10;9;9;9;9;9","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;HERBAL MEDICINE AND NATURAL COMPOUNDS RESEARCH;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;MAMMALIAN CIRCADIAN RHYTHMS AND PHYSIOLOGY;POLY(ADP-RIBOSE) POLYMERASE INHIBITION IN CANCER THERAPY;SCHIZOPHRENIA RESEARCH AND TREATMENT;;BIOACTIVE COMPOUNDS IN SEAWEED;CHOLESTEROL-LOWERING TREATMENT;COPPER AND ZINC IN HEALTH AND DISEASE;DIABETES, OXIDATIVE STRESS, AND ANTIOXIDANTS;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;HEALTH EFFECTS OF TEA POLYPHENOLS;HEREDITARY ANGIOEDEMA: MOLECULAR MECHANISMS AND CLINICAL MANAGEMENT;IMPACT OF STIGMA ON MENTAL HEALTH CARE;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;MANAGEMENT AND PATHOPHYSIOLOGY OF TRAUMATIC BRAIN INJURY","4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NITROTYROSINE;ZYMOSAN;GSK3B;INFILTRATION (HVAC);SPINAL CORD INJURY;HYPERICUM PERFORATUM;INFLAMMATION;CARRAGEENAN;EXTRAVASATION;GSK-3;INNATE ANTIVIRAL RESPONSES;INTESTINAL PERMEABILITY;OBESITY-ASSOCIATED MICROBIOME;OCCLUDIN;PARP INHIBITOR;PARP INHIBITORS;PLEURISY;PROINFLAMMATORY CYTOKINE;ACUTE PANCREATITIS;ADAPTIVE IMMUNITY REGULATION","12;6;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1","GLYCOGEN SYNTHASE;EXPERIMENTAL SPINAL;SPINAL CORD;CORD TRAUMA;HYPERICUM PERFORATUM;INHIBITION REDUCES;EXPERIMENTAL COLITIS;EXPERIMENTAL PERIODONTITIS;LUNG INJURY;MULTIPLE ORGAN;ACTIVITY MEDIATES;ACUTE LUNG;ACUTE PANCREATITIS;BARRIER FUNCTION;DYSFUNCTION SYNDROME;INFLAMMATORY REACTION;KINASE- INHIBITION;MEDIATES POST-TRAUMATIC;MICE ILEUM;NON-SEPTIC SHOCK;ORGAN DYSFUNCTION;PARACELLULAR BARRIER;POLYADP-RIBOSE GLYCOHYDROLASE;POST-TRAUMATIC INFLAMMATORY;PROTECTIVE EFFECT;REDUCES SECONDARY;SECONDARY DAMAGE;SHOCK INDUCED;SYNTHASE KINASE-;SYNTHASE KINASE-Β","6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SPINAL CORD;TISSUE INJURY;PERFORATUM EXTRACT;HYPERICUM PERFORATUM;NEUTROPHIL INFILTRATION;WT MICE;GLYCOGEN SYNTHASE;MARKEDLY REDUCED;NITRIC OXIDE;OXIDE SYNTHASE;POLYPHENOLIC COMPOUNDS;RENAL DYSFUNCTION;IMMUNOHISTOCHEMICAL ANALYSIS;INDUCIBLE NITRIC;INFLAMMATORY RESPONSE;INOS NITROTYROSINE;MGKG IP;ORGAN FAILURE;POSITIVE STAINING;PROTEIN KINASE;SECTIONS OBTAINED;SIGNIFICANTLY REDUCED;TISSUE SECTIONS;ZYMOSAN-TREATED MICE;ASSESSED HOURS;CELLULAR PROCESSES;COLON INJURY;CORD TRAUMA;DYSFUNCTION SYNDROME;EXPERIMENTAL COLITIS","11;11;10;8;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2007,55,8.14545454545454,3.05454545454545,0.327380952380952,0.4,0.490909090909091,0.2,0.363636363636364,0,37,9,5,1,0.67,0.16,0.09,0.02,45.85,0.868852382264055,0.254545454545455,0.963636363636364,NA,0.619579417552743,0.50974025974026,0.508333333333333,0.272727272727273,"SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;PLACIDO BRAMANTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;CARMELO MUIÀ;ACHILLE P. CAPUTI;CONCETTA CRISAFULLI;GIOVANNI POLIMENI;P. DI BELLA;CHRISTOPH THIEMERMANN;GIUSEPPE MALLEO;EDOARDO SPINA;GIOACCHINO CALAPAI;GIANLUCA TRIFIRÓ;PAOLA MARIA CUTRONEO;ALESSANDRO OTERI;C MUIÀ;FRANCESCO SALVO","27;24;20;19;17;14;13;13;10;9;6;5;5;5;5;4;4;4;4;3","SALVATORE CUZZOCREA;EMANUELA MAZZON;ACHILLE P. CAPUTI;ROSANNA DI PAOLA;PLACIDO BRAMANTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;CARMELO MUIÀ;GIOVANNI POLIMENI;GIOACCHINO CALAPAI;CONCETTA CRISAFULLI;EDOARDO SPINA;GIANLUCA TRIFIRÓ;PAOLA MARIA CUTRONEO;P. DI BELLA;ALESSANDRO OTERI;GIUSEPPE MALLEO;CHRISTOPH THIEMERMANN;FRANCESCO SALVO;C MUIÀ","3.64;3.33;2.44;2.3;2.18;2.02;1.67;1.63;1.53;1.22;1.14;1.08;0.78;0.77;0.68;0.65;0.6;0.57;0.56;0.41","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;PLACIDO BRAMANTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;CARMELO MUIÀ;ACHILLE P. CAPUTI;GIOVANNI POLIMENI;P. DI BELLA;CHRISTOPH THIEMERMANN;GIUSEPPE MALLEO;EDOARDO SPINA;GIOACCHINO CALAPAI;GIANLUCA TRIFIRÓ;ALESSANDRO OTERI;FRANCESCO SALVO;LIDIA SAUTEBIN;EDOARDO SESSA;ALESSIA MELANI","27;24;20;19;17;14;13;13;9;6;5;5;5;5;4;4;3;3;3;2","SALVATORE CUZZOCREA;EMANUELA MAZZON;ACHILLE P. CAPUTI;ROSANNA DI PAOLA;PLACIDO BRAMANTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;CARMELO MUIÀ;GIOVANNI POLIMENI;GIOACCHINO CALAPAI;EDOARDO SPINA;GIANLUCA TRIFIRÓ;P. DI BELLA;ALESSANDRO OTERI;GIUSEPPE MALLEO;CHRISTOPH THIEMERMANN;FRANCESCO SALVO;EDOARDO SESSA;EDOARDO FERLAZZO;LIDIA SAUTEBIN","3.64;3.33;2.44;2.3;2.18;2.02;1.67;1.63;1.53;1.22;1.08;0.78;0.68;0.65;0.6;0.57;0.56;0.41;0.33;0.3","SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;EMANUELA ESPOSITO;PLACIDO BRAMANTI;ACHILLE P. CAPUTI;CONCETTA CRISAFULLI;CARMELO MUIÀ;TIZIANA GENOVESE;EDOARDO SPINA;FRANCESCO SALVO;GIOACCHINO CALAPAI;EMANUELA MASINI;DANIELA SALVEMINI;GEORGE M. MATUSCHAK;C MUIÀ;P. DI BELLA;GIANLUCA TRIFIRÓ;GIOVANNI POLIMENI;CLAUDIO CRICELLI","1244;1025;810;781;688;588;526;507;471;296;280;252;228;207;207;203;200;189;189;188","EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;ROSANNA DI PAOLA;ACHILLE P. CAPUTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;EDOARDO SPINA;GIOACCHINO CALAPAI;GIOVANNI POLIMENI;GIANLUCA TRIFIRÓ;ALESSANDRO OTERI;FRANCESCO SALVO;P. DI BELLA;ALESSIA MELANI;ANTÓNIO TOSCANO;ANTONIETTA ROSSI;EDOARDO SESSA;EDOARDO FERLAZZO;FRANCESCA ANTONIA ARCADI","922;808;688;595;588;544;322;296;194;189;188;159;159;144;136;125;95;88;80;56","EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;ROSANNA DI PAOLA;ACHILLE P. CAPUTI;EMANUELA ESPOSITO;TIZIANA GENOVESE;EDOARDO SPINA;GIOVANNI POLIMENI;P. DI BELLA;EDOARDO SESSA;ALESSIA MELANI;ANTONIETTA ROSSI;CARMELO MUIÀ;CHRISTOPH THIEMERMANN;GIANLUCA TRIFIRÓ;GIOACCHINO CALAPAI;GIUSEPPE MALLEO;MAHA ABDELRAHMAN;ADRIANA BASILE","20;19;19;15;13;12;10;5;4;4;3;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ECONOMICS;POLITICAL SCIENCE;ENGINEERING;MATERIALS SCIENCE","50;21;14;4;4;4;2;2;1;1","INTERNAL MEDICINE;PHARMACOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PSYCHIATRY;IMMUNOLOGY;PATHOLOGY;ANESTHESIA;CELL BIOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;ENVIRONMENTAL HEALTH;GENETICS;NEUROSCIENCE;PEDIATRICS;THERMODYNAMICS;TRADITIONAL MEDICINE;ANATOMY;BIOPHYSICS;DATABASE;DERMATOLOGY;LAW;MACROECONOMICS;MICROBIOLOGY;ORGANIC CHEMISTRY","38;31;20;20;15;14;9;7;6;6;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","INFLAMMATION;NITRIC OXIDE;RECEPTOR;TUMOR NECROSIS FACTOR ALPHA;SPINAL CORD;APOPTOSIS;ADVERSE EFFECT;ENZYME;DISEASE;ISCHEMIA;KINASE;OXIDATIVE STRESS;ACUTE PANCREATITIS;DRUG;EDEMA;EPILEPSY;GENE;GLYCOGEN;PANCREATITIS;SIGNAL TRANSDUCTION","17;13;9;9;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4","NITRIC OXIDE SYNTHASE;MYELOPEROXIDASE;SPINAL CORD INJURY;REPERFUSION INJURY;ETANERCEPT;GLYCOGEN SYNTHASE;GSK-3;PHARMACOVIGILANCE;TUNEL ASSAY;AGONIST;LAMINECTOMY;LIPID PEROXIDATION;PROINFLAMMATORY CYTOKINE;ADVERSE DRUG REACTION;ANTIDEPRESSANT;DRUG REACTION;PARKINSON'S DISEASE;PURINERGIC RECEPTOR;SEROTONIN;SUPEROXIDE","12;9;7;5;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2","NITROTYROSINE;GSK3B;P2 RECEPTOR;PEROXYNITRITE;ADENOSINE RECEPTOR;ARACHIDONATE 5-LIPOXYGENASE;BACLOFEN;BUTHIONINE SULFOXIMINE;CERAMIDE SYNTHASE;CLAVULANIC ACID;CORTICOSPINAL TRACT;DOPAMINE RECEPTOR D3;DOPAMINE TRANSPORTER;DYSKINESIA;ENOS;EXTRAPYRAMIDAL SYMPTOMS;FELBAMATE;FRAMESHIFT MUTATION;GENE POLYMORPHISM;HAPLOINSUFFICIENCY;HYPERALGESIA;LEUKOTRIENE C4;LMNA;MISSENSE MUTATION;NUCLEAR RECEPTOR;P2Y RECEPTOR;PPADS;PPAR AGONIST;RENAL ISCHEMIA;SEROTONIN TRANSPORTER;VINCULIN;WORTMANNIN","7;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SPINAL CORD INJURIES;TUMOR NECROSIS FACTOR-ALPHA;MALE;ANIMALS;MICE;HUMANS;PEROXIDASE;INFLAMMATION;APOPTOSIS;ENZYME INHIBITORS;TYROSINE;BCL-2-ASSOCIATED X PROTEIN;PROTO-ONCOGENE PROTEINS C-BCL-2;IMMUNOGLOBULIN G;NEUTROPHIL INFILTRATION;NEUTROPHILS;PLEURISY;;ADULT;DISEASE MODELS, ANIMAL","32;32;31;29;23;19;18;17;15;15;15;14;14;13;12;12;11;10;10;10","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;EPILEPSY AND SEIZURES;HERBAL MEDICINE AND NATURAL COMPOUNDS RESEARCH;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;MOLECULAR PHYSIOLOGY OF PURINERGIC SIGNALLING;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;SCHIZOPHRENIA RESEARCH AND TREATMENT;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;ARISTOLOCHIC ACID NEPHROPATHY AND UROTHELIAL CANCER;BIOACTIVE PROPERTIES OF LATEX COMPOUNDS;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;EFFECTS OF CAFFEINE ON HUMAN HEALTH;GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER","8;4;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","SPINAL CORD INJURY;NITROTYROSINE;GSK3B;ACUTE PANCREATITIS;INFILTRATION (HVAC);INFLAMMATION;INTRAPERITONEAL INJECTION;ISCHEMIA-REPERFUSION INJURY;PROINFLAMMATORY CYTOKINE;ADVERSE DRUG REACTION;ADVERSE DRUG REACTIONS;DEPRESSION (ECONOMICS);DRUG REACTION;DRUG SAFETY SURVEILLANCE;EXTRACELLULAR ATP;P2 RECEPTOR;PANCREATIC DISEASE;PATIENT REPORTING;SPONTANEOUS REPORTING SYSTEMS;3D RECONSTRUCTION","8;7;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1","SPINAL CORD;EXPERIMENTAL SPINAL;ACUTE PANCREATITIS;CERULEIN-INDUCED ACUTE;CORD INJURY;GLYCOGEN SYNTHASE;MOUSE MODEL;BENEFICIAL EFFECTS;CORD TRAUMA;KINASE-Β INHIBITION;SECONDARY DAMAGE;SPONTANEOUS REPORTING;SYNTHASE KINASE-Β;ADVERSE DRUG;ARTERY OCCLUSION;DRUG REACTIONS;INHIBITION ATTENUATES;ISCHAEMIAREPERFUSION INJURY;LUNG INFLAMMATION;ORGAN DYSFUNCTION;SPLANCHNIC ARTERY;ABRUPT WITHDRAWAL;ABSENCE STATUS;AC MUTATIONS;ACETONIC EXTRACT;ACID DATA;ACUTE HEPATITIS;ACUTE LUNG;ADVERSE REACTIONS;AG MODULATES","7;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ACUTE PANCREATITIS;SPINAL CORD;TISSUE INJURY;AMOXICILLINCLAVULANIC ACID;NEUTROPHIL INFILTRATION;AIRWAY INFLAMMATION;SIGNIFICANTLY REDUCED;CORD INJURY;MYELOPEROXIDASE ACTIVITY;CELL APOPTOSIS;CORD INFLAMMATION;CORD TRAUMA;INHIBITION SIGNIFICANTLY;LUNG INJURY;LUNG TISSUES;NECROTIZING ACUTE;ANTINOCICEPTIVE TOLERANCE;EPITHELIAL CELL;HERBAL MEDICINE;HISTOLOGICAL SCORE;INFLAMMATORY MEDIATORS;INFLAMMATORY RESPONSE;INJURY HISTOLOGICAL;LIMB FUNCTION;NITROTYROSINE FORMATION;OXIDATIVENITROSATIVE STRESS;SIGNIFICANTLY AMELIORATED;STRESS EPITHELIAL;TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE-MEDIATED;TISSUE DAMAGE","13;13;10;9;8;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2008,55,9.45454545454546,2.67272727272727,0.374149659863946,0.309090909090909,0.309090909090909,0.472727272727273,0.327272727272727,0,34,16,1,2,0.62,0.29,0.02,0.04,53.65,0.977815131539193,0.327272727272727,0.981818181818182,NA,0.657275129928225,0.467857142857143,0.498333333333333,0.340388007054674,"SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;PLACIDO BRAMANTI;ROSANNA DI PAOLA;TIZIANA GENOVESE;ROSARIA MELI;ROCCO CAMINITI;ACHILLE P. CAPUTI;CONCETTA CRISAFULLI;CARMELO MUIÀ;GIOVANNI POLIMENI;ANTONIO MASTINO;DANIELA SALVEMINI;SANDRO GRELLI;GIUSEPPINA MATTACE RASO;FRANCESCO SALVO;ANTONIETTA ROSSI;ANTONIO CALIGNANO;P. DI BELLA","28;24;18;16;15;15;11;7;7;6;5;4;4;4;3;3;3;3;3;3","SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;PLACIDO BRAMANTI;TIZIANA GENOVESE;ROSANNA DI PAOLA;ROSARIA MELI;ROCCO CAMINITI;ACHILLE P. CAPUTI;CONCETTA CRISAFULLI;CARMELO MUIÀ;ANTONIO MASTINO;DANIELA SALVEMINI;GIOVANNI POLIMENI;P. DI BELLA;GIUSEPPINA MATTACE RASO;MICHAEL M. NDENGELE;SANDRO GRELLI;EDOARDO SPINA;ANTONIO CALIGNANO","3.69;3.04;2.23;2.01;1.75;1.7;1.48;0.93;0.76;0.67;0.56;0.52;0.51;0.44;0.42;0.39;0.39;0.38;0.37;0.34","SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;PLACIDO BRAMANTI;ROSANNA DI PAOLA;TIZIANA GENOVESE;ACHILLE P. CAPUTI;GIOVANNI POLIMENI;ANTONIO MASTINO;ANTONIETTA ROSSI;P. DI BELLA;EDOARDO SPINA;GIANLUCA TRIFIRÓ;LIDIA SAUTEBIN;CARLO PERGOLA;MAURIZIO ANZINI;PAOLA ANZELLOTTI;CARLA GHELARDINI;ANTONIO GIORDANI;FABRIZIO MANETTI","28;24;18;16;15;15;7;4;4;3;3;3;3;3;3;2;2;2;2;2","SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;PLACIDO BRAMANTI;TIZIANA GENOVESE;ROSANNA DI PAOLA;ACHILLE P. CAPUTI;ANTONIO MASTINO;GIOVANNI POLIMENI;P. DI BELLA;EDOARDO SPINA;GIANLUCA TRIFIRÓ;VINCENZA SANTORO;EDOARDO SESSA;EDOARDO FERLAZZO;ANTONIETTA ROSSI;LIDIA SAUTEBIN;CARLO PERGOLA;ALESSIA MELANI;CONCETTA D’ARRIGO","3.69;3.04;2.23;2.01;1.75;1.7;0.76;0.52;0.44;0.42;0.37;0.34;0.27;0.25;0.21;0.2;0.2;0.2;0.17;0.14","EMANUELA MAZZON;SALVATORE CUZZOCREA;ROSANNA DI PAOLA;EMANUELA ESPOSITO;TIZIANA GENOVESE;PLACIDO BRAMANTI;ANDREA SBARBATI;ANTONIO MARCO MARIA OSCULATI;ASMAA CHAKIR;BARBARA ROSSI;DONATELLA BENATI;ELENA NICOLATO;EUGENE C. BUTCHER;FEDERICA SCHIO;FLAVIA MERIGO;FRANCESCO OSCULATI;GABRIELA CONSTANTIN;GRACIELA NAVARRO MORA;JOHN B. LOWE;JONATHON W. HOMEISTER","1511;1487;907;867;740;674;481;481;481;481;481;481;481;481;481;481;481;481;481;481","EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;ROSANNA DI PAOLA;EMANUELA ESPOSITO;TIZIANA GENOVESE;FRANCESCO OSCULATI;GIOVANNI CARLO FEDERICO VILLA;ANTONIETTA ROSSI;ANTONIO MASTINO;EDOARDO SPINA;ACHILLE P. CAPUTI;EMANUELA MASINI;GIANLUCA TRIFIRÓ;GIOVANNI POLIMENI;VINCENZA SANTORO;ANDREA CAPPELLI;ANTONIO GIORDANI;CARLA GHELARDINI;CARLO PERGOLA","1449;948;645;640;587;551;481;213;159;112;93;90;71;67;63;60;52;52;52;52","EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;TIZIANA GENOVESE;ACHILLE P. CAPUTI;ANTONIO MASTINO;GIOVANNI POLIMENI;ANTONIETTA ROSSI;EDOARDO SPINA;P. DI BELLA;GIANLUCA TRIFIRÓ;EDOARDO FERLAZZO;EDOARDO SESSA;VINCENZA SANTORO;ALESSIA MELANI;ANDREA CAPPELLI;ANTONELLA ALAGNA;ANTONIO GIORDANI","23;17;15;13;11;11;5;4;4;3;3;3;2.91;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;PSYCHOLOGY;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY","46;26;22;3;3;3;2;2;1","INTERNAL MEDICINE;BIOCHEMISTRY;IMMUNOLOGY;PHARMACOLOGY;ENDOCRINOLOGY;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;CANCER RESEARCH;CELL BIOLOGY;ANESTHESIA;BIOTECHNOLOGY;MOLECULAR BIOLOGY;ORGANIC CHEMISTRY;VIROLOGY;DATABASE;ECONOMIC GROWTH;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;LAW;NURSING;OPTICS;STEREOCHEMISTRY;SURGERY;UROLOGY","27;22;22;21;13;9;8;8;8;7;6;5;5;5;4;4;3;2;2;2;2;2;2;2;2;2","INFLAMMATION;GENE;RECEPTOR;ENZYME;TUMOR NECROSIS FACTOR ALPHA;APOPTOSIS;DISEASE;SPINAL CORD;EPILEPSY;IN VITRO;IN VIVO;VIRUS;CANCER;CARRAGEENAN;CELL CULTURE;COLITIS;DOPAMINE;DRUG;MATRIX METALLOPROTEINASE;MELATONIN;NECROSIS;NEUROPROTECTION;NITRIC OXIDE;SIGNAL TRANSDUCTION","16;9;9;7;7;6;6;6;5;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3","NITRIC OXIDE SYNTHASE;PROINFLAMMATORY CYTOKINE;SPINAL CORD INJURY;SUPEROXIDE;ETANERCEPT;MUTATION;MYELOPEROXIDASE;NOCICEPTION;AGONIST;CERAMIDE;CYCLOOXYGENASE;FATTY LIVER;HERPES SIMPLEX VIRUS;INFLAMMATORY BOWEL DISEASE;LIPID PEROXIDATION;METFORMIN;MITOGEN-ACTIVATED PROTEIN KINASE;PARKINSON'S DISEASE;PERIPHERAL BLOOD MONONUCLEAR CELL;PROGRAMMED CELL DEATH;PROTEIN KINASE A;RECOMBINANT DNA;REPERFUSION INJURY;TRANSFECTION;TUNEL ASSAY","6;6;6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PEROXYNITRITE;NITROTYROSINE;CERAMIDE SYNTHASE;HYPERALGESIA;STEATOHEPATITIS;(+)-NALOXONE;ACID SPHINGOMYELINASE;ADENOSINE RECEPTOR;ATYPICAL ANTIPSYCHOTIC;AUTODOCK;BIGUANIDE;CANNABINOID RECEPTOR;CASPASE;CASPASE 3;CLINICAL GLOBAL IMPRESSION;DOPAMINE ANTAGONIST;ESTROGEN RECEPTOR;GENE MUTATION;GENETICALLY MODIFIED MOUSE;HYDROXYDOPAMINE;INTERFERON ALFA;LEUCINE ZIPPER;LUNG FIBROSIS;MEDIUM SPINY NEURON;MISSENSE MUTATION;NONALCOHOLIC FATTY LIVER DISEASE;OLIGODENDROCYTE;OXCARBAZEPINE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PAPILLARY THYROID CANCER;PLACENTA;POLY ADP RIBOSE POLYMERASE;RNA SPLICING;ROFECOXIB;SERTRALINE;STAUROSPORINE;STREPTOCOCCUS THERMOPHILUS;SUBSTANTIA NIGRA;V600E;ZIPRASIDONE","4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANIMALS;MALE;TUMOR NECROSIS FACTOR-ALPHA;SPINAL CORD INJURIES;MICE;HUMANS;APOPTOSIS;PLEURISY;EDEMA;LUNG;ANTI-INFLAMMATORY AGENTS;CYCLOOXYGENASE 2;INTERCELLULAR ADHESION MOLECULE-1;INTERLEUKIN-1BETA;NF-KAPPA B;PEROXIDASE;PEROXYNITROUS ACID;TYROSINE;ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;COLITIS","36;33;30;29;25;20;17;15;14;14;12;12;12;12;12;12;12;12;11;11","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPILEPSY AND SEIZURES;HERPESVIRUSES: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;PHARMACOLOGICAL EFFECTS OF LICORICE ROOTS;ROLE OF NITRIC OXIDE IN HEALTH AND DISEASE;SPHINGOLIPID SIGNALLING AND METABOLISM IN HEALTH AND DISEASE;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;BIOACTIVE COMPOUNDS IN SEAWEED;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CHOLESTEROL-LOWERING TREATMENT;CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS AND CRISPR-ASSOCIATED PROTEINS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","PROINFLAMMATORY CYTOKINE;SPINAL CORD INJURY;INFLAMMATION;CARRAGEENAN;NITROTYROSINE;ADVERSE DRUG REACTIONS;CERAMIDE SYNTHASE;DOCKING (ANIMAL);DRUG HYPERSENSITIVITY;ENDOTOXIN HYPORESPONSIVENESS;GLYCYRRHIZIN;HIV INTERACTION;MELATONIN;NEURODEGENERATION;NEUROINFLAMMATION;PAIN MODULATION;PEROXYNITROUS ACID;STEATOHEPATITIS;TREATMENT;ACID SPHINGOMYELINASE","6;6;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","SPINAL CORD;CORD INJURY;EXPERIMENTAL SPINAL;ALLERGIC REACTIONS;ANTINOCICEPTIVE TOLERANCE;BIOLOGICAL EVALUATION;CORD TRAUMA;DATABASE GIF;DOCKING SIMULATIONS;EXPERIMENTAL COLITIS;INFLAMMATORY RESPONSE;ITALIAN SPONTANEOUS;LUNG INJURY;MORPHINE ANTINOCICEPTIVE;ORAL DRUGS;PARKINSONS DISEASE;PRIMARY CARE;SECONDARY DAMAGE;SIGNAL TRANSDUCTION;SIGNALING PATHWAYS;TRANSDUCTION PATHWAYS;AA RECEPTOR;ACUTE INFLAMMATION;ACUTE TISSUE;ADENOSINE AA;ADHESION MECHANISMS;ADP-RIBOSE POLYMERASE-;ADVERSE REACTIONS;ALPHA B-BASED;ANALGESIC AGENTS","8;6;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","SPINAL CORD;TISSUE INJURY;NEUTROPHIL INFILTRATION;CORD TRAUMA;CORD INJURY;TISSUE DAMAGE;ANTINOCICEPTIVE TOLERANCE;NECROSIS FACTOR-Α;BOWEL DISEASES;CORD INFLAMMATION;DINITROBENZENE SULFONIC;GILZ-TG MICE;INFLAMMATORY PROCESS;LIMB FUNCTION;MORPHINE ANTINOCICEPTIVE;MORPHINE TOLERANCE;MURINE MODEL;PLASMA CONCENTRATIONS;PROTECTIVE EFFECTS;PURE MNTBAP;VALPROIC ACID;VASCULAR CLIPS;ANTI-INFLAMMATORY EFFECTS;APOPTOSIS TERMINAL;BRAIN INJURY;CARBONATE RADICAL;CARRAGEENAN-INDUCED PLEURISY;CERAMIDE BIOSYNTHESIS;CLIPS FORCE;EDEMA NEUTROPHIL","19;10;8;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4500000,346153.85,5,13,8,1,26,69230.7692307692,0.794444444444445,"AARHUS UNIVERSITY HOSPITAL;AGENZIA REGIONALE DI SANITÀ DELLA TOSCANA;ASTRAZENECA (SWEDEN);CENTRO NEUROLESI BONINO PULEJO;ERASMUS MC;HOSPITAL DEL MAR MEDICAL RESEARCH INSTITUTE;LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE;POMPEU FABRA UNIVERSITY;UNIVERSITY OF AVEIRO;UNIVERSITY OF BORDEAUX;UNIVERSITY OF MILANO-BICOCCA;UNIVERSITY OF NOTTINGHAM;UNIVERSITY OF SANTIAGO DE COMPOSTELA","1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2007-1 (CALL FOR PROPOSAL)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES","1;1;1","CLINICAL RESEARCH;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);PATIENT SAFETY","1;1;1","GENERIC HEALTH RELEVANCE","1",NA,NA,"NOT SITE-SPECIFIC CANCER","1",NA,NA,"B11 COMPUTER SCIENCE AND INFORMATICS","1",NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES","1;1;1","BRAIN DISORDERS;MULTIPLE SCLEROSIS;NEURODEGENERATIVE;NEUROSCIENCES;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1;1;1;1;1","NEUROLOGICAL","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2009,76,9,2.80263157894737,0.356807511737089,0.460526315789474,0.276315789473684,0.223684210526316,0.368421052631579,0,39,22,10,3,0.51,0.29,0.13,0.04,47.14,1.01918650920324,0.328947368421053,0.93421052631579,NA,0.640494446782384,0.561038961038961,0.577922077922078,0.426179604261796,"PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;TIZIANA GENOVESE;CONCETTA CRISAFULLI;EMANUELA ESPOSITO;MARIA GALUPPO;IRENE PATERNITI;ROSARIA MELI;ROCCO CAMINITI;LIDIA SAUTEBIN;ACHILLE P. CAPUTI;BARBARA SPANÒ;ANTONIETTA ROSSI;PIETRO LANZAFAME;PIERRE GENTON;GIANLUCA TRIFIRÓ;CARLO PERGOLA;ROCCO SALVATORE CALABRÒ","35;33;25;19;15;14;13;8;7;5;5;5;5;4;4;4;4;4;4;4","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;CONCETTA CRISAFULLI;ROSANNA DI PAOLA;TIZIANA GENOVESE;EMANUELA ESPOSITO;MARIA GALUPPO;IRENE PATERNITI;ANDREA SBARBATI;FRANCESCO OSCULATI;FLAVIA MERIGO;PIETRO LANZAFAME;SILVIA MARINO;ROCCO CAMINITI;ROCCO SALVATORE CALABRÒ;ROSARIA MELI;GIUSEPPE NOVELLI;ACHILLE P. CAPUTI;BARBARA SPANÒ","4.77;4.53;3.14;2.37;2.33;1.68;1.55;1.32;0.88;0.82;0.82;0.7;0.63;0.63;0.62;0.62;0.54;0.53;0.52;0.49","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;TIZIANA GENOVESE;EMANUELA ESPOSITO;MARIA GALUPPO;LIDIA SAUTEBIN;ACHILLE P. CAPUTI;BARBARA SPANÒ;ANTONIETTA ROSSI;PIETRO LANZAFAME;GIANLUCA TRIFIRÓ;CARLO PERGOLA;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;GIUSEPPE NOVELLI;FRANCESCO OSCULATI;OLIVER WERZ;DOMENICO ITALIANO","35;33;25;19;15;13;8;5;5;4;4;4;4;4;4;4;4;4;3;3","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;ROSANNA DI PAOLA;TIZIANA GENOVESE;EMANUELA ESPOSITO;MARIA GALUPPO;FRANCESCO OSCULATI;PIETRO LANZAFAME;SILVIA MARINO;ROCCO SALVATORE CALABRÒ;GIUSEPPE NOVELLI;ACHILLE P. CAPUTI;BARBARA SPANÒ;GIANGAETANO D’ALEO;LIDIA SAUTEBIN;DOMENICO ITALIANO;GIANLUCA TRIFIRÓ;EDOARDO SESSA;ANTONIETTA ROSSI","4.77;4.53;3.14;2.33;1.68;1.55;1.32;0.82;0.63;0.63;0.62;0.53;0.52;0.49;0.45;0.45;0.44;0.39;0.39;0.35","SALVATORE CUZZOCREA;EMANUELA MAZZON;PLACIDO BRAMANTI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;TIZIANA GENOVESE;CONCETTA CRISAFULLI;ROSARIA MELI;ANNA IACONO;ANTONIO CALIGNANO;ROBERTO RUSSO;CHRISTOPH THIEMERMANN;GIUSEPPINA MATTACE RASO;DANIELE PIOMELLI;ACHILLE P. CAPUTI;MARIA GALUPPO;AHILA SIVARAJAH;ELISA BENETTI;IRENE PATERNITI;MARGHERITA GALLICCHIO","2070;1232;1183;761;667;581;476;473;401;401;383;372;364;346;268;264;256;256;256;256","SALVATORE CUZZOCREA;EMANUELA MAZZON;PLACIDO BRAMANTI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;TIZIANA GENOVESE;ACHILLE P. CAPUTI;ANTONIETTA ROSSI;ANTÓNIO TOSCANO;GIANLUCA TRIFIRÓ;MARIA ANTONIETTA CATANIA;EDOARDO FERLAZZO;GIOVANNI CARLO FEDERICO VILLA;STEFANIA CERUTI;ALESSIA MELANI;EDOARDO SPINA;FRANCESCO OSCULATI;DOMENICO ITALIANO;CINZIA CICCACCI;CARLO PERGOLA","1471;1232;1174;623;580;512;251;238;226;218;173;125;118;118;87;85;85;79;72;69","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;ROSANNA DI PAOLA;TIZIANA GENOVESE;EMANUELA ESPOSITO;EDOARDO FERLAZZO;ANTONIETTA ROSSI;BARBARA SPANÒ;FRANCESCO OSCULATI;ROCCO SALVATORE CALABRÒ;PIETRO LANZAFAME;SILVIA MARINO;ACHILLE P. CAPUTI;DOMENICO ITALIANO;EDOARDO SESSA;GIANLUCA TRIFIRÓ;ALESSANDRO CELONA;ANTÓNIO TOSCANO;EDOARDO SPINA","34;25;23;17;13;10;5;4;4;4;4;4;4;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE","63;34;32;14;8;4;3;2;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;PHARMACOLOGY;PSYCHIATRY;ENDOCRINOLOGY;IMMUNOLOGY;NEUROSCIENCE;PATHOLOGY;ENVIRONMENTAL HEALTH;CELL BIOLOGY;GENETICS;ANESTHESIA;RADIOLOGY;SURGERY;ORGANIC CHEMISTRY;PEDIATRICS;AUDIOLOGY;GASTROENTEROLOGY;CARDIOLOGY;DEVELOPMENTAL PSYCHOLOGY;QUANTUM MECHANICS;STEREOCHEMISTRY","46;33;31;22;21;18;13;10;9;8;8;7;7;6;5;5;4;4;3;3;3;3","INFLAMMATION;NITRIC OXIDE;RECEPTOR;APOPTOSIS;ENZYME;GENE;SPINAL CORD;DISEASE;POPULATION;EPILEPSY;IN VITRO;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;CENTRAL NERVOUS SYSTEM;ISCHEMIA;OXIDATIVE STRESS;TUMOR NECROSIS FACTOR ALPHA;COGNITION;CYTOKINE;ENDOGENY;MULTIPLE SCLEROSIS;NEUROLOGY;STIMULATION","23;17;16;11;11;11;11;10;8;7;6;5;5;4;4;4;4;3;3;3;3;3;3","NITRIC OXIDE SYNTHASE;SPINAL CORD INJURY;AGONIST;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;ALLELE;LAMINECTOMY;LIPID PEROXIDATION;MICROGLIA;CYCLOOXYGENASE;INFLAMMATORY BOWEL DISEASE;MUTATION;MYELOPEROXIDASE;PROINFLAMMATORY CYTOKINE;SUPEROXIDE;WHITE MATTER;ARACHIDONIC ACID;CERAMIDE;CHROMOSOME;DUCTAL CELLS;ENDOCANNABINOID SYSTEM;ENZYME INHIBITOR;EX VIVO;GENOTYPE;IMMUNOSTAINING;LEUKOTRIENE;LIPOXYGENASE;MAGNETIZATION TRANSFER;MAPK/ERK PATHWAY;NEURORADIOLOGY;NOCICEPTION;OCCLUDIN;PARKINSON'S DISEASE;PROGRESSIVE MYOCLONUS EPILEPSY;REPERFUSION INJURY;TOPIRAMATE;TRANSCRIPTION FACTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR;VERBASCOSIDE;ZYMOSAN","18;11;7;7;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NITROTYROSINE;CANNABINOID RECEPTOR;PEROXYNITRITE;ADENOSINE RECEPTOR;ARACHIDONATE 5-LIPOXYGENASE;KARYOTYPE;MISSENSE MUTATION;NUCLEAR RECEPTOR;ABSOLUTE NEUTROPHIL COUNT;ALPHA (FINANCE);ANTIRETROVIRAL THERAPY;BACLOFEN;BLOOD–RETINAL BARRIER;BRAIN METASTASIS;CERAMIDE SYNTHASE;CNIDOCYTE;CYP2C9;CYSTATHIONINE BETA SYNTHASE;DEEP BRAIN STIMULATION;EICOSANOID;ENOS;FACTOR V LEIDEN;FRACTIONAL ANISOTROPY;GREY MATTER;HYPERALGESIA;KAINIC ACID;LEUKOTRIENE C4;LEVODOPA;METHYLENETETRAHYDROFOLATE REDUCTASE;MICROSATELLITE;MULTIPLEX POLYMERASE CHAIN REACTION;NEUROACTIVE STEROID;NONALCOHOLIC FATTY LIVER DISEASE;OLIGODENDROCYTE;OMEGA-N-METHYLARGININE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PHARMACOGENETICS;POLYMORPHISM (COMPUTER SCIENCE);POSTERIOR CEREBRAL ARTERY;PROBAND;PROSTAGLANDIN H2;RENAL ISCHEMIA;ROFECOXIB;SEROTONIN TRANSPORTER;SODIUM HYDROSULFIDE;THIOBARBITURIC ACID;TRACTOGRAPHY;VOXEL-BASED MORPHOMETRY","11;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MALE;ANIMALS;SPINAL CORD INJURIES;HUMANS;TYROSINE;INFLAMMATION;MICE;NITRIC OXIDE SYNTHASE TYPE II;APOPTOSIS;ANTI-INFLAMMATORY AGENTS;FEMALE;PEROXIDASE;PPAR ALPHA;BCL-2-ASSOCIATED X PROTEIN;NF-KAPPA B;TUMOR NECROSIS FACTOR-ALPHA;PROTO-ONCOGENE PROTEINS C-BCL-2;RATS;MACROPHAGES;NEUTROPHILS","51;41;40;37;33;27;27;27;26;24;23;22;22;21;21;19;16;16;15;15","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;EPILEPSY AND SEIZURES;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;PHARMACOLOGICAL EFFECTS OF LICORICE ROOTS;ROLE OF MICROGLIA IN NEUROLOGICAL DISORDERS;SCHIZOPHRENIA RESEARCH AND TREATMENT;SPHINGOLIPID SIGNALLING AND METABOLISM IN HEALTH AND DISEASE;SWEETENERS' TASTE AND IMPACT ON HEALTH;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;AGE-RELATED MACULAR DEGENERATION RESEARCH;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DEVELOPMENT OF NUMERICAL COGNITION AND MATHEMATICS ABILITIES;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME","6;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","NITROTYROSINE;SPINAL CORD INJURY;INFLAMMATION;LIPID;PALMITOYLETHANOLAMIDE;PROINFLAMMATORY CYTOKINE;ADENOSINE A2A RECEPTOR;ADENOSINE RECEPTORS;AROMATASE INHIBITORS;CERAMIDE;DUCTAL CELLS;EPILEPSY;EX VIVO;IMMUNOSTAINING;INFILTRATION (HVAC);MAGNETIZATION TRANSFER;NEUROINFLAMMATION;NEURORADIOLOGY;OBESITY-ASSOCIATED MICROBIOME;OCCLUDIN","11;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SPINAL CORD;CORD INJURY;INFLAMMATORY RESPONSE;MULTIPLE SCLEROSIS;CORD TRAUMA;EXPERIMENTAL MODEL;MOUSE MODEL;PEROXISOME PROLIFERATOR-ACTIVATED;RECEPTOR AGONIST;SECONDARY INFLAMMATORY;AA RECEPTOR;ADENOSINE AA;AGONIST TREATMENT;ANTI-INFLAMMATORY EFFECT;ANTI-INFLAMMATORY EFFECTS;BIOLOGICAL EVALUATION;BOWEL DISEASE;COMPRESSION INJURY;CORD COMPRESSION;INFLAMMATORY BOWEL;INFLAMMATORY PROCESS;MULTIPLE ORGAN;NITRIC OXIDE;PARKINSONS DISEASE;POTENT INHIBITORS;PROLIFERATOR-ACTIVATED RECEPTOR-Α;PROTECTIVE EFFECT;REDUCES JNK;SELECTIVE ADENOSINE;ACID AMIDASE","11;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","SPINAL CORD;CORD INJURY;ISCHEMIC STROKE;TISSUE DAMAGE;MITOGEN-ACTIVATED PROTEIN;PROTEIN KINASE;AA RECEPTOR;TISSUE INJURY;ANTINOCICEPTIVE TOLERANCE;FOUR-LEVEL T-T;MARKEDLY REDUCED;PROTECTIVE EFFECT;SIGNIFICANTLY REDUCED;T-T LAMINECTOMY;ADENOSINE AA;BCL- EXPRESSION;CORD TRAUMA;CRYPTOGENIC ISCHEMIC;GREEN TEA;INJURY SCI;INOS EXPRESSION;ISCHAEMIC STRIATUM;JNK MAPK;MGKG IP;MICE RESULTED;MYELOPEROXIDASE ACTIVITY;NUCLEAR FACTOR-KAPPAB;OXIDATIVE STRESS;PERITONEAL FIBROSIS;REGIONAL MYOCARDIAL","28;15;8;8;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,200,1.72,0,0,20,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Japan","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES","1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2010,73,8.04109589041096,2.86301369863014,0.349282296650718,0.356164383561644,0.493150684931507,0.47945205479452,0.342465753424658,2,32,24,4,8,0.44,0.33,0.05,0.11,31.68,0.701139971094509,0.26027397260274,0.904109589041096,NA,0.652839496383536,0.554320987654321,0.609042553191489,0.470731707317073,"PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;MARIA GALUPPO;TIZIANA GENOVESE;SILVIA MARINO;DANIELA IMPELLIZZERI;CHRISTOPH THIEMERMANN;DOMENICO ITALIANO;EDOARDO FERLAZZO;CONCETTA CRISAFULLI;PIETRO LANZAFAME;EDOARDO SPINA;ALESSIA MELANI;FELICITA PEDATA;FRANCESCO CORDICI;PIERRE GENTON","45;31;30;23;19;17;15;9;7;6;5;5;5;4;4;4;3;3;3;3","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;MARIA GALUPPO;EDOARDO FERLAZZO;SILVIA MARINO;TIZIANA GENOVESE;IRCCS CENTRO;DANIELA IMPELLIZZERI;DOMENICO ITALIANO;PIETRO LANZAFAME;PIERRE GENTON;GIOVANNI POLIMENI;CHRISTOPH THIEMERMANN;CONCETTA CRISAFULLI;ROCCO SALVATORE CALABRÒ;EDOARDO SPINA","6.41;4.25;4.15;3.21;2.59;2.18;1.97;1.7;1.37;1.03;1;0.95;0.64;0.61;0.59;0.58;0.54;0.54;0.53;0.5","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;MARIA GALUPPO;TIZIANA GENOVESE;SILVIA MARINO;DANIELA IMPELLIZZERI;DOMENICO ITALIANO;EDOARDO FERLAZZO;PIETRO LANZAFAME;EDOARDO SPINA;FRANCESCO CORDICI;ALESSIA BRAMANTI;ROCCO SALVATORE CALABRÒ;SOW‐HSIN CHEN;CARMELO CORSARO;LILLA BONANNO","45;31;30;23;19;17;15;9;7;6;5;5;4;4;3;3;3;2;2;2","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;MARIA GALUPPO;EDOARDO FERLAZZO;SILVIA MARINO;TIZIANA GENOVESE;IRCCS CENTRO;DANIELA IMPELLIZZERI;DOMENICO ITALIANO;PIETRO LANZAFAME;GIOVANNI POLIMENI;ROCCO SALVATORE CALABRÒ;EDOARDO SPINA;ALESSIA BRAMANTI;GIUSEPPE GERVASI;SOW‐HSIN CHEN","6.41;4.25;4.15;3.21;2.59;2.18;1.97;1.7;1.37;1.03;1;0.95;0.64;0.61;0.58;0.53;0.5;0.41;0.37;0.31","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;IRENE PATERNITI;EMANUELA ESPOSITO;MARIA GALUPPO;ROSANNA DI PAOLA;DANIELA IMPELLIZZERI;DOMENICO ITALIANO;TIZIANA GENOVESE;EDOARDO SPINA;EDOARDO FERLAZZO;CHRISTOPH THIEMERMANN;ANDREAS KOEBERLE;ANTONIETTA ROSSI;CARLO PERGOLA;FRIEDERIKE DEHM;LIDIA SAUTEBIN;MARIKA HOFFMANN;OLIVER WERZ","1363;1082;981;750;601;415;397;209;206;185;153;135;126;125;125;125;125;125;125;125","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;EMANUELA ESPOSITO;ROSANNA DI PAOLA;DOMENICO ITALIANO;EDOARDO SPINA;EDOARDO FERLAZZO;ANTONIETTA ROSSI;FRANCESCO OSCULATI;SILVIA MARINO;BARBARA SPANÒ;C. BRANCA;CARMELO CORSARO;FRANCESCO MALLAMACE;JEROEN SPOOREN;H. EUGENE STANLEY;NANCY LEONE;SOW‐HSIN CHEN;LORENZO DE SANTI","1353;925;886;499;260;206;153;135;125;124;123;122;93;93;93;93;88;88;88;87","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;EMANUELA ESPOSITO;ROSANNA DI PAOLA;SILVIA MARINO;EDOARDO FERLAZZO;DOMENICO ITALIANO;EDOARDO SPINA;ROCCO SALVATORE CALABRÒ;TIZIANA GENOVESE;ALESSIA BRAMANTI;ANTONIO MASTINO;BARBARA SPANÒ;C. BRANCA;CARMELO CORSARO;FRANCESCO CORDICI;FRANCESCO MALLAMACE;FRANCESCO OSCULATI;GIANGAETANO D’ALEO","44;27;23;14;12;7;5;5;4;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;ECONOMICS;GEOGRAPHY;MATHEMATICS;SOCIOLOGY","63;25;24;14;8;5;2;2;2;1;1;1;1;1","INTERNAL MEDICINE;PHARMACOLOGY;BIOCHEMISTRY;PSYCHIATRY;ANESTHESIA;IMMUNOLOGY;ENDOCRINOLOGY;NEUROSCIENCE;PATHOLOGY;GENETICS;CELL BIOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;RADIOLOGY;AUDIOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;THERMODYNAMICS;ANATOMY;ARTIFICIAL INTELLIGENCE;CARDIOLOGY;PHYSICAL THERAPY;SURGERY","49;26;25;22;19;19;18;13;10;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3","INFLAMMATION;RECEPTOR;NITRIC OXIDE;APOPTOSIS;DISEASE;SPINAL CORD;EPILEPSY;GENE;ISCHEMIA;ELECTROENCEPHALOGRAPHY;ENZYME;IN VITRO;NEUROLOGY;COGNITION;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;MULTIPLE SCLEROSIS;NEUROPROTECTION;OXIDATIVE STRESS;POPULATION","23;17;13;12;10;10;9;7;7;5;5;5;5;4;4;4;4;4;4;4","NITRIC OXIDE SYNTHASE;AGONIST;SPINAL CORD INJURY;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;TUNEL ASSAY;PROINFLAMMATORY CYTOKINE;REPERFUSION INJURY;ALZHEIMER'S DISEASE;LAMINECTOMY;NADPH OXIDASE;PARKINSON'S DISEASE;DOPAMINERGIC;SMOOTH PURSUIT;TRANSCRIPTION FACTOR;BRAIN SIZE;DEMENTIA;EXPANDED DISABILITY STATUS SCALE;FOCAL ADHESION;GABAPENTIN;GLUTAMINE;LAMININ;MUTATION;NEUROINFLAMMATION;NEUROPSYCHOLOGY;NEURORADIOLOGY;NOCICEPTION;PROGRAMMED CELL DEATH;SEROTONIN;SPLANCHNIC;TEMPORAL LOBE;TOPIRAMATE;WAKEFULNESS;WHITE MATTER;ZYMOSAN","13;12;9;7;6;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NITROTYROSINE;APOCYNIN;ADENOSINE RECEPTOR;NUCLEAR RECEPTOR;SEROTONERGIC;ANTIRETROVIRAL THERAPY;ARACHIDONATE 5-LIPOXYGENASE;BACLOFEN;CANNABINOID RECEPTOR;CASPASE;CELL CYCLE CHECKPOINT;CLINICAL DEMENTIA RATING;COMPOUND HETEROZYGOSITY;CYCLIN D1;DOPAMINE TRANSPORTER;DYSTROGLYCAN;FRONTOTEMPORAL DEMENTIA;GREY MATTER;HIPPOCAMPAL SCLEROSIS;HYPERALGESIA;INFLAMMATORY BOWEL DISEASES;LMNA;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;MODIFIED RANKIN SCALE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NFKB1;OLIGODENDROCYTE;ORAL ALLERGY SYNDROME;ORAL FOOD CHALLENGE;OXCARBAZEPINE;PEROXISOME PROLIFERATOR;PEROXYNITRITE;PERSISTENT VEGETATIVE STATE;PHOSPHODIESTERASE 3;PROSTATITIS;SEROTONIN TRANSPORTER;SUBSTANTIA NIGRA;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;VERBAL FLUENCY TEST;VINCULIN;WHEAT ALLERGY;ZONISAMIDE","11;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MALE;APOPTOSIS;HUMANS;SPINAL CORD INJURIES;TYROSINE;ANIMALS;TUMOR NECROSIS FACTOR-ALPHA;FEMALE;REPERFUSION INJURY;MICE;INFLAMMATION;INTERLEUKIN-1BETA;NEUTROPHIL INFILTRATION;NF-KAPPA B;ADULT;PLEURISY;COGNITION DISORDERS;CYTOKINES;NITRIC OXIDE SYNTHASE TYPE II;","47;37;36;32;32;29;23;21;21;19;17;17;17;16;15;15;14;14;14;13","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;EPILEPSY AND SEIZURES;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MECHANISMS OF ALZHEIMER'S DISEASE;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;DYNAMICS AND TRANSITIONS IN GLASSY MATERIALS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;MOLECULAR PHYSIOLOGY OF PURINERGIC SIGNALLING;PATHOPHYSIOLOGY OF MYOCARDIAL REPERFUSION INJURY;ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS IN IMMUNITY;SCHIZOPHRENIA RESEARCH AND TREATMENT;BIOACTIVE PROPERTIES OF LATEX COMPOUNDS;CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIFFUSION MAGNETIC RESONANCE IMAGING","6;5;5;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","NITROTYROSINE;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;SPINAL CORD INJURY;INFLAMMATION;PROINFLAMMATORY CYTOKINE;APOCYNIN;NEUROINFLAMMATION;ISCHEMIA-REPERFUSION INJURY;NADPH OXIDASES;SMOOTH PURSUIT;STATUS EPILEPTICUS;ADENOSINE A2A RECEPTOR;ADENOSINE RECEPTORS;ALZHEIMER'S DISEASE;EPILEPSY;GLASS TRANSITION;GLUTAMINE;INFILTRATION (HVAC);MELATONIN;NEURODEGENERATION","11;7;7;5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","SPINAL CORD;ALZHEIMERS DISEASE;CORD INJURY;CORD TRAUMA;ISCHEMIAREPERFUSION INJURY;NADPH OXIDASE;ACUTE LUNG;ADENOSINE AA;EXPERIMENTAL MODEL;LUNG INFLAMMATION;MULTIPLE SCLEROSIS;OCULAR MOVEMENTS;PARKINSONS DISEASE;PURSUIT OCULAR;AA RECEPTOR;AGONISTS REDUCE;INFLAMMATORY PROCESS;INFLAMMATORY RESPONSE;LENNOXGASTAUT SYNDROME;MULTIPLE ORGAN;OLPRINONE ATTENUATES;PPAR-ΒΔ AGONIST;RECEPTOR AGONISTS;RODENT MODEL;AA RECEPTOR-SELECTIVE;ACID RELEASE;ACTIVATION SENSITIZES;ACTIVATOR RECEPTOR-Α;ACUTE INFLAMMATORY;ACUTE PANCREATITIS","10;5;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","NEUTROPHIL INFILTRATION;SPINAL CORD;STATUS EPILEPTICUS;TISSUE DAMAGE;CTX PATIENTS;DIP PATIENTS;GITR MICE;PEROXISOME PROLIFERATOR-ACTIVATED;ABSENCE STATUS;ACUTE PANCREATITIS;ANTI-INFLAMMATORY ACTIVITY;CLASSIC HIPPOCAMPAL;HIPPOCAMPAL SCLEROSIS;HYPERICUM PERFORATUM;IMMUNOHISTOCHEMICAL ANALYSIS;INFLAMMATORY RESPONSE;LUNG TISSUES;MGKG IP;MYELOPEROXIDASE ACTIVITY;NF-ΚB ACTIVATION;PLEURAL CAVITY;PPAR ΒΔ;PUTAMEN UPTAKE;REPERFUSION INJURY;SIGNIFICANTLY REDUCED;TISSUE INJURY;AA RELEASE;ADENOSINE AA;ADHESION MOLECULE;ANTI-INFLAMMATORY EFFECTS","8;7;7;7;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,4,1.91,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BRAMANTI PLACIDO;GALLI GIOVANNI;LANZAFAME PIETRO;ZONA PAOLO","1;1;1;1","IRCCS CENTRO NEUROLESI ""BONINO-PULEJO""","1","40 ENGINEERING;4015 MARITIME ENGINEERING","2;1",NA,NA,NA,NA,"A61B5/308;H04B14/04","1;1","A61B5/30;H04B14/046","1;1",1,2,200,1.96,1,1,41,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","1;1;1","AUTOIMMUNE DISEASE;BRAIN DISORDERS;CLINICAL RESEARCH;MULTIPLE SCLEROSIS;NEURODEGENERATIVE;NEUROSCIENCES","1;1;1;1;1;1","NEUROLOGICAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2011,62,8.33870967741935,2.51612903225806,0.397435897435897,0.370967741935484,0.419354838709677,0.32258064516129,0.306451612903226,1,27,18,7,6,0.44,0.29,0.11,0.1,32.76,0.770156662854713,0.225806451612903,0.854838709677419,NA,0.60420549797222,0.51984126984127,0.5175983436853,0.401154401154401,"SALVATORE CUZZOCREA;PLACIDO BRAMANTI;EMANUELA MAZZON;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;ROCCO SALVATORE CALABRÒ;MARIA GALUPPO;SILVIA MARINO;DANIELA IMPELLIZZERI;GIUSEPPE GERVASI;EDOARDO SPINA;ANNALISA BAGLIERI;TIZIANA GENOVESE;ROSALIA CRUPI;ROSARIA MELI;DOMENICO ITALIANO;PATRIZIA MONDELLO;CARMELA ALOISI;STEFANIA MONDELLO","26;25;24;15;14;13;8;7;7;6;5;5;4;4;3;3;3;3;3;3","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;IRENE PATERNITI;ROCCO SALVATORE CALABRÒ;EMANUELA ESPOSITO;ROSANNA DI PAOLA;GIUSEPPE GERVASI;SILVIA MARINO;IRCCS CENTRO;L. ZAMPIERI;M. L. PUMO;EDOARDO SPINA;MARIA GALUPPO;ROSALIA CRUPI;DANIELA IMPELLIZZERI;TIZIANA GENOVESE;GIOVANNI POLIMENI;MARIA ROSARIA CATANIA;SALVATOR CUZZOCREA","4.03;3.31;3.02;2.07;1.9;1.83;1.54;1.32;1;1;1;1;0.99;0.91;0.77;0.71;0.61;0.58;0.5;0.5","SALVATORE CUZZOCREA;PLACIDO BRAMANTI;EMANUELA MAZZON;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;GIUSEPPE GERVASI;EDOARDO SPINA;ANNALISA BAGLIERI;ROSALIA CRUPI;DOMENICO ITALIANO;PATRIZIA MONDELLO;CARMELA ALOISI;FRANCESCO CORALLO;LILLA BONANNO;EDOARDO FERLAZZO;EDOARDO SESSA;GIOVANNI POLIMENI","26;25;24;15;14;13;8;7;5;5;4;3;3;3;3;2;2;2;2;2","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;IRENE PATERNITI;ROCCO SALVATORE CALABRÒ;EMANUELA ESPOSITO;ROSANNA DI PAOLA;GIUSEPPE GERVASI;SILVIA MARINO;IRCCS CENTRO;M. L. PUMO;EDOARDO SPINA;ROSALIA CRUPI;GIOVANNI POLIMENI;SALVATOR CUZZOCREA;ANNALISA BAGLIERI;DOMENICO ITALIANO;LILLA BONANNO;PATRIZIA MONDELLO;CARMELA ALOISI","4.03;3.31;3.02;2.07;1.9;1.83;1.54;1.32;1;1;1;0.99;0.77;0.58;0.5;0.45;0.42;0.37;0.35;0.35","SALVATORE CUZZOCREA;EMANUELA MAZZON;PLACIDO BRAMANTI;IRENE PATERNITI;EMANUELA ESPOSITO;ROSANNA DI PAOLA;DANIELA IMPELLIZZERI;MARIA GALUPPO;EDOARDO SPINA;TIZIANA GENOVESE;CHIARA PARRAVICINI;CLAUDIA MARTINI;CLAUDIA VERDERIO;DAVIDE LECCA;FLAVIA ANTONUCCI;MARIA LETIZIA TRINCAVELLI;MARIA P. ABBRACCHIO;MARTA FUMAGALLI;PATRIZIA ROSA;PHILIP R. LEE","1047;963;702;644;614;552;319;255;222;193;168;168;168;168;168;168;168;168;168;168","EMANUELA MAZZON;SALVATORE CUZZOCREA;PLACIDO BRAMANTI;ROSANNA DI PAOLA;EMANUELA ESPOSITO;EDOARDO SPINA;ANTONIO MASTINO;ANTONIO TOSCANO;ANNA FURNARI;SILVIA MARINO;DOMENICO ITALIANO;ROCCO SALVATORE CALABRÒ;BARBARA SPANÒ;GIANLUCA TRIFIRÓ;CARMELA ALOISI;PATRIZIA MONDELLO;ANNALISA BAGLIERI;M. L. PUMO;SALVATOR CUZZOCREA;EDOARDO SESSA","903;840;688;411;387;208;109;85;82;75;74;67;65;55;48;48;42;42;34;28","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;ROSANNA DI PAOLA;EMANUELA ESPOSITO;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;EDOARDO SPINA;GIUSEPPE GERVASI;DOMENICO ITALIANO;ANNALISA BAGLIERI;ANTONIO MASTINO;EDOARDO SESSA;FRANCESCO CORALLO;GIOVANNI POLIMENI;LILLA BONANNO;M. L. PUMO;ACHILLE P. CAPUTI;ALESSIA BRAMANTI;ANNA FURNARI","24;23;21;11;10;8;7;4;4;3;2;2;2;2;2;2;2;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;GEOLOGY;MATERIALS SCIENCE;MATHEMATICS","57;22;16;10;5;4;4;1;1;1","INTERNAL MEDICINE;PHARMACOLOGY;PSYCHIATRY;BIOCHEMISTRY;ANESTHESIA;ENDOCRINOLOGY;NEUROSCIENCE;IMMUNOLOGY;PATHOLOGY;CARDIOLOGY;CELL BIOLOGY;RADIOLOGY;SURGERY;MECHANICAL ENGINEERING;AUDIOLOGY;BIOTECHNOLOGY;GENETICS;PROGRAMMING LANGUAGE;TRADITIONAL MEDICINE;VIROLOGY","46;25;20;17;13;12;12;11;10;6;6;6;6;4;3;3;3;3;3;3","INFLAMMATION;DISEASE;RECEPTOR;SPINAL CORD;NITRIC OXIDE;IN VITRO;MAGNETIC RESONANCE IMAGING;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);COGNITION;ISCHEMIA;ADVERSE EFFECT;ALTERNATIVE MEDICINE;NEUROPROTECTION;OXIDATIVE STRESS;STROKE (ENGINE);AMINO ACID;APOPTOSIS;ATROPHY;CENTRAL NERVOUS SYSTEM;ENZYME;FIBROSIS;GENE;HIPPOCAMPAL FORMATION;HIPPOCAMPUS;IN VIVO;KIDNEY;MIGRAINE;NEUROLOGY;PATHOGENESIS;THROMBOSIS","15;12;10;10;9;6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","NITRIC OXIDE SYNTHASE;SPINAL CORD INJURY;AGONIST;TOLERABILITY;ZYMOSAN;ANTIPSYCHOTIC;MYELOPEROXIDASE;PARKINSON'S DISEASE;PLACEBO;PROINFLAMMATORY CYTOKINE;PULMONARY FIBROSIS;REPERFUSION INJURY;WHITE MATTER;ALZHEIMER'S DISEASE;ANTAGONIST;ANTIDEPRESSANT;BLEOMYCIN;CEREBRAL INFARCTION;CLOZAPINE;COGNITIVE IMPAIRMENT;DEMENTIA;DENTATE GYRUS;DIFFUSION MRI;FLUID-ATTENUATED INVERSION RECOVERY;GLUTAMINE;HYPERINTENSITY;LAMINECTOMY;NADPH OXIDASE;NEUROCOGNITIVE;NEUROPSYCHOLOGY;NEUROTROPHIC FACTORS;PATENT FORAMEN OVALE;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR","8;7;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NITROTYROSINE;CANNABINOID RECEPTOR;APOCYNIN;ATYPICAL ANTIPSYCHOTIC;BEHAVIOURAL DESPAIR TEST;DOUBLECORTIN;EXTRAPYRAMIDAL SYMPTOMS;PARADOXICAL EMBOLISM;VOXEL-BASED MORPHOMETRY;ADENOSINE RECEPTOR;ALLELE FREQUENCY;ALPHA (FINANCE);ATHETOSIS;BACLOFEN;BRADYCARDIA;BRAIN METASTASIS;COAGULATION CASCADE;COGNITIVE RESERVE;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;DIZOCILPINE;DOPAMINE AGONIST;DYSKINESIA;ENOS;EXCITOTOXICITY;EXECUTIVE DYSFUNCTION;FRONTOTEMPORAL DEMENTIA;GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;GREY MATTER;HAPLOTYPE;INTERFERON BETA-1B;INTRATRACHEAL INSTILLATION;KETOROLAC TROMETHAMINE;LAMIVUDINE;LEUKOARAIOSIS;LEVODOPA;LYMPHEDEMA;MIGRAINE WITH AURA;MYELOPOIESIS;NEUROACTIVE STEROID;NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;OLIGODENDROCYTE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PALIPERIDONE;PALIPERIDONE PALMITATE;POLY ADP RIBOSE POLYMERASE;PRAMIPEXOLE;REMYELINATION;RENAL ISCHEMIA;REVERSE TRANSCRIPTASE;SEROTONERGIC;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL INTERFERING RNA;SOD1;TLR2;TOLL-LIKE RECEPTOR;WISCONSIN CARD SORTING TEST;ZIDOVUDINE","5;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MALE;ANIMALS;HUMANS;TYROSINE;MICE;FEMALE;INFLAMMATION;SPINAL CORD;SPINAL CORD INJURIES;BCL-2-ASSOCIATED X PROTEIN;MULTIPLE ORGAN FAILURE;PROTO-ONCOGENE PROTEINS C-BCL-2;LUNG;NITRIC OXIDE SYNTHASE TYPE II;POLY(ADP-RIBOSE) POLYMERASES;TUMOR NECROSIS FACTOR-ALPHA;;ADULT;ANTIPSYCHOTIC AGENTS;FAS LIGAND PROTEIN","39;27;27;27;20;18;17;17;17;15;15;15;14;13;12;12;11;11;11;11","PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;SCHIZOPHRENIA RESEARCH AND TREATMENT;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;GAMMA-RAY BURSTS AND SUPERNOVAE CONNECTIONS;HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 INFECTION;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;PATENT FORAMEN OVALE AND CEREBROVASCULAR EVENTS;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS IN IMMUNITY;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;CHEMISTRY AND HEALTH EFFECTS OF OLIVE OIL;CHRONIC CEREBRAL HYPOPERFUSION-RELATED NEURODEGENERATIVE DISEASES;CLINICAL SIGNIFICANCE OF POLICOSANOL IN LIPID MANAGEMENT;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","NITROTYROSINE;SPINAL CORD INJURY;STROKE (ENGINE);TOLERABILITY;ZYMOSAN;NEUROIMAGING DATA ANALYSIS;PATHOGENESIS;PROINFLAMMATORY CYTOKINE;TREATMENT;ADENOSINE RECEPTORS;APOCYNIN;CRYPTOGENIC STROKE;DOPAMINE DYSFUNCTION;DOUBLECORTIN;EXTRAPYRAMIDAL SYMPTOMS;FLUID-ATTENUATED INVERSION RECOVERY;HIPPOCAMPAL NEUROGENESIS;HTLV-1;INFILTRATION (HVAC);INFLAMMATION","5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","SPINAL CORD;CORD INJURY;INFLAMMATORY PROCESS;MULTIPLE ORGAN;ALZHEIMERS DISEASE;CORE-COLLAPSE SUPERNOVAE;CREUTZFELDT-JAKOB DISEASE;DIFFUSION-WEIGHTED IMAGING;EXPERIMENTAL MODEL;FLUID-ATTENUATED INVERSION;INVERSION RECOVERY;ISCHEMIAREPERFUSION INJURY;ISCHEMIC STROKE;LUNG FIBROSIS;MOUSE MODEL;ORGAN FAILURE;PARKINSONS DISEASE;RECOVERY SEQUENCE;SIGNALING PATHWAY;SPORADIC CREUTZFELDT-JAKOB;-NITRO--BENZOXADIAZOL--YLTHIOHEXANOL NBDHEX;AA RECEPTOR;AARECEPTOR AGONISTS;ACUTE LUNG;ACUTE SPINAL;ADENOSINE AA;ADENOSINE AARECEPTOR;ADJUNCTIVE TREATMENT;ADMINISTRATION INHIBIT;ADULT HIPPOCAMPAL","7;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","SPINAL CORD;URACIL NUCLEOTIDES;HYPERICUM PERFORATUM;KYNTRP RATIO;PALIPERIDONE ER;PRIMARY ISOLATES;PDE INHIBITORS;SIGNIFICANTLY REDUCED;ADHESION MOLECULES;CELLS EXPRESSING;CORD INJURY;GPR ACTIVATION;NG OPCS;OPC DIFFERENTIATION;PRECURSOR CELLS;TISSUE DAMAGE;CELL LINES;CENTRAL NERVOUS;CHRONIC CORTICOSTERONE;GITR-WT MICE;HTLV- PRIMARY;HTLV- RT;LUNG INJURY;MINI-OSMOTIC PUMP;MOLECULES EXPRESSION;NERVOUS SYSTEM;NEUTROPHIL INFILTRATION;NITRIC OXIDE;NONSEPTIC SHOCK;OXIDE SYNTHASE","11;8;7;6;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2012,40,8.55,2.2,0.454545454545455,0.375,0.375,0.125,0.275,2,15,11,6,6,0.38,0.28,0.15,0.15,27.95,0.669167208030985,0.3,0.875,4.59870550161812,0.532393706098455,0.436170212765957,0.409313725490196,0.4,"PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;DANIELA IMPELLIZZERI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;DOMENICO ITALIANO;ROSANNA DI PAOLA;IRENE PATERNITI;ALESSANDRO CAPPELLANI;ROSALIA D’ANGELO;GIUSEPPE GERVASI;ANTONINA SIDOTI;ANNALISA BAGLIERI;ANTÓNIO TOSCANO;SANDRO GRELLI;BEATRICE MACCHI;PATRIZIA MONTELLA;ROBERTA LIZIO","15;12;11;11;10;9;5;4;4;4;3;3;3;3;3;3;2;2;2;2","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;DANIELA IMPELLIZZERI;IRCCS CENTRO;ANTÓNIO TOSCANO;DOMENICO ITALIANO;GIUSEPPE GERVASI;IRENE PATERNITI;SILVIA MARINO;OLIMPIA MUSUMECI;ROSALIA D’ANGELO;ANTONINA SIDOTI;ROSANNA DI PAOLA;AKBAR AHMAD;ALESSANDRO PADOVANI;ALESSANDRO CAPPELLANI;MASSIMILIANO FILOSTO","2.38;2.11;1.69;1.61;1.6;1.44;1;0.9;0.84;0.58;0.53;0.51;0.5;0.43;0.43;0.42;0.4;0.37;0.35;0.33","PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;DANIELA IMPELLIZZERI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;DOMENICO ITALIANO;IRENE PATERNITI;ROSALIA D’ANGELO;GIUSEPPE GERVASI;ANTONINA SIDOTI;ANNALISA BAGLIERI;ANTÓNIO TOSCANO;CARMELA RINALDI;EDOARDO SPINA;ROSARIA DE LUCA;ANTONIO MASTINO;FRANCESCO CORALLO;DOMENICO ITALIANO","15;12;11;11;10;9;5;4;4;3;3;3;3;3;2;2;2;2;1;1","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;SALVATORE CUZZOCREA;EMANUELA MAZZON;EMANUELA ESPOSITO;DANIELA IMPELLIZZERI;IRCCS CENTRO;ANTÓNIO TOSCANO;DOMENICO ITALIANO;GIUSEPPE GERVASI;IRENE PATERNITI;SILVIA MARINO;ROSALIA D’ANGELO;ANTONINA SIDOTI;ROSARIA DE LUCA;CARMELA RINALDI;EDOARDO SPINA;ANTONIO MASTINO;DAVID MILITI;ANNALISA BAGLIERI","2.38;2.11;1.69;1.61;1.6;1.44;1;0.9;0.84;0.58;0.53;0.51;0.43;0.43;0.33;0.27;0.27;0.25;0.25;0.24","SALVATORE CUZZOCREA;EMANUELA ESPOSITO;PLACIDO BRAMANTI;EMANUELA MAZZON;DANIELA IMPELLIZZERI;SILVIA MARINO;ANNALISA BAGLIERI;IRENE PATERNITI;ANDREW KAMADULSKI;CAROLINA MUSCOLI;CONCETTA DAGOSTINO;DANIELA SALVEMINI;JAN S. RYERSE;LEESA BRYANT;SMITA RAUSARIA;TIMOTHY M. DOYLE;WILLIAM L. NEUMANN;ZHOUMOU CHEN;ROSANNA DI PAOLA;A GUIZZARO","422;417;305;266;222;187;163;157;156;156;156;156;156;156;156;156;156;156;153;151","PLACIDO BRAMANTI;EMANUELA MAZZON;SALVATORE CUZZOCREA;EMANUELA ESPOSITO;SILVIA MARINO;ANNALISA BAGLIERI;EDOARDO SPINA;ROCCO SALVATORE CALABRÒ;DOMENICO ITALIANO;ANTONIO MASTINO;GAETANO GORGONE;FRANCESCO SALVO;DANIELA IMPELLIZZERI;IRENE PATERNITI;ANTÓNIO TOSCANO;GIUSEPPE GERVASI;ROSALIA D’ANGELO;DAVID MILITI;VINCENZA SANTORO;FRANCESCO OSCULATI","300;241;225;199;187;163;117;106;92;49;47;44;43;43;37;37;30;25;23;20","PLACIDO BRAMANTI;EMANUELA MAZZON;ROCCO SALVATORE CALABRÒ;SALVATORE CUZZOCREA;SILVIA MARINO;DOMENICO ITALIANO;ANNALISA BAGLIERI;ANTÓNIO TOSCANO;ANTONIO MASTINO;EDOARDO SPINA;EMANUELA ESPOSITO;GIUSEPPE GERVASI;ROSALIA D’ANGELO;ROSARIA DE LUCA;ANTONINA SIDOTI;CARMELA RINALDI;DANIELA IMPELLIZZERI;DAVID MILITI;EDOARDO FERLAZZO;FRANCESCO CORALLO","14;10;9;7;5;5;3;3;2;2;2;2;2;2;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;PHYSICS;SOCIOLOGY","34;18;10;8;5;2;1;1;1;1;1","INTERNAL MEDICINE;PSYCHIATRY;PHARMACOLOGY;BIOCHEMISTRY;GENETICS;IMMUNOLOGY;NEUROSCIENCE;ENDOCRINOLOGY;PATHOLOGY;CELL BIOLOGY;RADIOLOGY;MOLECULAR BIOLOGY;ALGORITHM;ANATOMY;ANESTHESIA;AUDIOLOGY;CANCER RESEARCH;CARDIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;MECHANICAL ENGINEERING;ORGANIC CHEMISTRY;PSYCHOTHERAPIST;STEREOCHEMISTRY","23;13;11;8;8;8;8;6;6;5;5;4;2;2;2;2;2;2;2;2;2;2;2;2","GENE;INFLAMMATION;RECEPTOR;COGNITION;DISEASE;ENZYME;EPILEPSY;MAGNETIC RESONANCE IMAGING;NITRIC OXIDE;CENTRAL NERVOUS SYSTEM;NEUROIMAGING;POPULATION;APOPTOSIS;ARTHRITIS;DOPAMINE;IMMUNOHISTOCHEMISTRY;KINASE;NEUROLOGY;NEUROPROTECTION;OPEN FIELD;PANCREATITIS;RHEUMATOID ARTHRITIS;SIGNAL TRANSDUCTION;SPINAL CORD;STROKE (ENGINE)","8;8;8;5;5;5;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","AGONIST;EXON;MICROGLIA;ALLELE;GENOTYPE;MUTATION;NITRIC OXIDE SYNTHASE;PHENOTYPE;PROINFLAMMATORY CYTOKINE;ANTIDEPRESSANT;DEMENTIA;PARKINSON'S DISEASE;TUNEL ASSAY;ACUTE DISSEMINATED ENCEPHALOMYELITIS;ADRENOMEDULLIN;AGLYCONE;ALZHEIMER'S DISEASE;ANHEDONIA;ANTAGONIST;ASTROCYTE;ASTROGLIOSIS;AUDITORY HALLUCINATION;AUTOIMMUNE DISEASE;CHOLECYSTOKININ;COGNITIVE IMPAIRMENT;CORTICOSTERONE;CYCLOADDITION;CYTOCHROME C;CYTOCHROME P450;DECREASED LIBIDO;DENTATE GYRUS;DIFFUSION MRI;DOPAMINERGIC;DOWNREGULATION AND UPREGULATION;ENANTIOSELECTIVE SYNTHESIS;ENCEPHALOMYELITIS;ETANERCEPT;FUNCTIONAL NEUROIMAGING;GAIT ATAXIA;GENE DUPLICATION;GENOME;GLIAL FIBRILLARY ACIDIC PROTEIN;GLUCOSE TRANSPORTER;GLUTAMATE RECEPTOR;HUMAN LEUKOCYTE ANTIGEN;HYPERHOMOCYSTEINEMIA;IMINOSUGAR;INDOLIZIDINE;LAMOTRIGINE;LEFT VENTRICLES;LEVETIRACETAM;LOCUS (GENETICS);MAJOR DEPRESSIVE DISORDER;MALONDIALDEHYDE;MITOGEN-ACTIVATED PROTEIN KINASE;MUTANT;MYELOPEROXIDASE;MYOTONIA;NAD+ KINASE;NEURAL SUBSTRATE;NEUROCOGNITIVE;NEUROINFLAMMATION;NEUROPSYCHOLOGY;OLEUROPEIN;OVERPRODUCTION;OXIDASE TEST;PACLITAXEL;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;PHARMACODYNAMICS;PLACEBO;PLEURISY;POLYPHENOL;POPULATION PHARMACOKINETICS;PREFRONTAL CORTEX;PROGRAMMED CELL DEATH;PROTEIN KINASE A;RANDOM EFFECTS MODEL;RESPIRATORY EPITHELIUM;RHO-ASSOCIATED PROTEIN KINASE;ROTAROD PERFORMANCE TEST;SPINAL CORD INJURY;SPINOCEREBELLAR ATAXIA;STOP CODON;SUPEROXIDE;SYNOVITIS;SYSTEMIC DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS;TLR4;TOPIRAMATE;TRANSFECTION;TYPE II COLLAGEN;WHITE MATTER","4;4;4;3;3;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANNABINOID RECEPTOR;ALLELE FREQUENCY;HAPLOTYPE;NITROTYROSINE;PENETRANCE;ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE;CASPASE;CERULETIDE;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;DORSOLATERAL PREFRONTAL CORTEX;DOUBLECORTIN;ENANTIOPURE DRUG;FASUDIL;GLUTAMATERGIC;HAMILTON RATING SCALE FOR DEPRESSION;HYDROXYTYROSOL;LEVODOPA;MEMORY CLINIC;METHYLENETETRAHYDROFOLATE REDUCTASE;MISSENSE MUTATION;MONOOXYGENASE;MYOTONIA CONGENITA;NEUROPSYCHOLOGICAL ASSESSMENT;NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;NITRONE;PEROXYNITRITE;POINT MUTATION;PROBAND;PRODROMAL STAGE;REUPTAKE INHIBITOR;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBSTANTIA NIGRA;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE","4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MALE;HUMANS;FEMALE;;ADULT;MIDDLE AGED;ANIMALS;BRAIN;ANTICONVULSANTS;STROKE;AGED;ITALY;MAGNETIC RESONANCE IMAGING;MICE;SEROTONIN UPTAKE INHIBITORS;SPINAL CORD INJURIES;TRIAZINES;YOUNG ADULT;BCL-2-ASSOCIATED X PROTEIN;BRAIN INFARCTION","23;20;14;12;11;11;8;8;7;7;6;6;6;6;6;6;6;6;5;5","CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ATOPIC DERMATITIS AND SKIN MICROBIOME;CYANOGENIC GLYCOSIDES IN PLANTS AND INDUSTRIAL WASTEWATERS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;DRUG METABOLISM AND PHARMACOGENOMICS;EFFECTS OF CAFFEINE ON HUMAN HEALTH;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;EPILEPSY AND SEIZURES;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","INFLAMMATION;PALMITOYLETHANOLAMIDE;NEUROIMAGING;PROINFLAMMATORY CYTOKINE;CEREBRAL CAVERNOUS MALFORMATIONS;GLYCOGEN;GLYCOGEN STORAGE DISEASES;GLYCOSYLATION MECHANISMS;NEURODEGENERATION;NITROTYROSINE;PENETRANCE;SPINAL CORD INJURY;STROKE (ENGINE);ACUTE DISSEMINATED ENCEPHALOMYELITIS;ADRENERGIC SIGNALING;ADRENOMEDULLIN;AGLYCONE;ALZHEIMER'S DISEASE;AMINO ACID TRANSPORTERS;ANHEDONIA","4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","SPINAL CORD;MOUSE MODEL;ACUTE PANCREATITIS;ALZHEIMERS DISEASE;CCM GENE;CEREBRAL CAVERNOUS;CORD INJURY;CORD TRAUMA;EXPERIMENTAL MODEL;ITALIAN FAMILY;PARKINSONS DISEASE;ACUTE DISSEMINATED;ACUTE LUNG;ADULT ACUTE;AGE- GENDER-RELATED;AGONIST GW;ALLELIC VARIANTS;AMELIORATES CERULEIN-;AMELIORATES COLLAGEN-INDUCED;ANTI-INFLAMMATORY EFFECTS;ANTIDEPRESSANT EFFECTS;APOPTOSIS INVOLVES;ATAXIA TYPE;BODY ODOR;BRAIN TRAUMA;CASE-CONTROL STUDY;CAUSATIVE MUTATION;CAVERNOUS MALFORMATION;CAVERNOUS MALFORMATIONS;CEREBRAL VENTRICLES","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GRAY MATTER;SAO SHOCK;AD SUBJECTS;ALPHA SOURCES;CORTICAL GRAY;MATTER VOLUME;PROATHEROSCLEROTIC FACTORS;AMNESIC MCI;CILIATED CELLS;DELTA SOURCES;EEG RHYTHMS;GLUCOSE TRANSPORTERS;NEUROPATHIC PAIN;NITRIC OXIDE;ADHESION MOLECULES;ALPHA HZ;ALZHEIMERS DISEASE;ANTI-INFLAMMATORY EFFECTS;BETA HZ;CCM SPORADIC;CELL LINES;CELL TYPES;EXON DELETIONS;EXON Χ;GAG --;GLUT GLUT;GLUT SGLT;HAPLOTYPE GAG;HZ ALPHA;HZ BETA","5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2013,53,7.50943396226415,3.0188679245283,0.33125,0.584905660377358,0.509433962264151,0.113207547169811,0.264150943396226,0,17,12,7,15,0.32,0.23,0.13,0.28,21.09,0.604551136030532,0.264150943396226,0.660377358490566,4.45645645645646,0.638074042780805,0.510416666666667,0.588311688311688,0.510752688172043,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;RENATO IORI;MARIA GALUPPO;EMANUELA MAZZON;GINA ROSALINDA DE NICOLA;ANNALISA BAGLIERI;SIMONA DE SALVO;SABRINA GIACOPPO;LILLA BONANNO;LETTERIA SPADARO;DEMETRIO MILARDI;GIOVANNI B. FRISONI;GIUSEPPE ANASTASI;ROSELLA CIURLEO;ROSARIA DE LUCA;ANGELO FAVALORO;JORDAN MARROCCO;FRANCESCO CORALLO","32;18;11;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;2;2","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;RENATO IORI;MARIA GALUPPO;EMANUELA MAZZON;GINA ROSALINDA DE NICOLA;ONOFRIO TRIOLO;LILLA BONANNO;PATRIZIA POLLICINO;SIMONA DE SALVO;ANNALISA BAGLIERI;SABRINA GIACOPPO;VINCENZO BARONE;ROSARIA DE LUCA;ANTONINO LEO;ROSELLA CIURLEO;LETTERIA SPADARO;CARMELA CASELLA;DAVID MILITI","6.92;5.2;1.84;0.8;0.8;0.8;0.8;0.7;0.59;0.58;0.58;0.55;0.55;0.5;0.48;0.48;0.44;0.43;0.37;0.34","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;MARIA GALUPPO;EMANUELA MAZZON;ANNALISA BAGLIERI;SIMONA DE SALVO;SABRINA GIACOPPO;LILLA BONANNO;LETTERIA SPADARO;DEMETRIO MILARDI;GIUSEPPE ANASTASI;ROSELLA CIURLEO;ROSARIA DE LUCA;ANGELO FAVALORO;JORDAN MARROCCO;FRANCESCO CORALLO;FRANCESCO SALVO;ANGELA MARRA;DAVID MILITI","32;18;11;5;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;MARIA GALUPPO;EMANUELA MAZZON;LILLA BONANNO;PATRIZIA POLLICINO;SIMONA DE SALVO;ANNALISA BAGLIERI;SABRINA GIACOPPO;ROSARIA DE LUCA;ANTONINO LEO;ROSELLA CIURLEO;LETTERIA SPADARO;DAVID MILITI;SALVATORE CUZZOCREA;ANGELA MARRA;FABRIZIO SOTTILE;DEMETRIO MILARDI;FRANCESCO OSCULATI","6.92;5.2;1.84;0.8;0.8;0.59;0.58;0.58;0.55;0.55;0.48;0.48;0.44;0.43;0.34;0.34;0.31;0.31;0.29;0.28","PLACIDO BRAMANTI;DEMETRIO MILARDI;SILVIA MARINO;EMANUELA MAZZON;GINA ROSALINDA DE NICOLA;MARIA GALUPPO;RENATO IORI;GIOVANNI B. FRISONI;GIUSEPPE ANASTASI;MICHELE GAETA;ANDREA SORICELLI;CIRO MUNDI;CLAUDIO BABILONI;CLAUDIO DEL PERCIO;ELENA SALVATORE;FABRIZIO VERNIERI;FLAVIO NOBILI;FRANCESCA URSINI;GIOACCHINO TEDESCHI;GUIDO RODRIGUEZ","468;211;181;176;176;176;176;159;158;153;149;149;149;149;149;149;149;149;149;149","PLACIDO BRAMANTI;DEMETRIO MILARDI;EMANUELA MAZZON;MARIA GALUPPO;SILVIA MARINO;GIUSEPPE ANASTASI;SIMONA DE SALVO;FABIO TRIMARCHI;GIUSEPPE SANTORO;MICHELE GAETA;ANNALISA BAGLIERI;ROCCO SALVATORE CALABRÒ;FRANCESCO SALVO;PIA DELL’UTRI;SABRINA GIACOPPO;M. L. PUMO;ANGELO FAVALORO;MICHELE NAVARRA;GIUSEPPINA CUTRONEO;GIOVANNA VERMIGLIO","452;211;176;176;165;158;102;100;100;98;79;79;76;73;73;72;70;66;60;58","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SIMONA DE SALVO;SABRINA GIACOPPO;DEMETRIO MILARDI;GIUSEPPE ANASTASI;LILLA BONANNO;ROSELLA CIURLEO;ANGELO FAVALORO;ANNALISA BAGLIERI;ROSARIA DE LUCA;ANGELA MARRA;ANTONINO LEO;FABIO TRIMARCHI;FABRIZIO SOTTILE;FRANCESCO CORALLO;FRANCESCO OSCULATI","31;18;10;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2","MEDICINE;PSYCHOLOGY;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","45;24;17;8;7;5;2;2;2;1;1;1","INTERNAL MEDICINE;NEUROSCIENCE;PSYCHIATRY;PATHOLOGY;PHARMACOLOGY;GENETICS;BIOCHEMISTRY;CARDIOLOGY;AUDIOLOGY;BOTANY;CLINICAL PSYCHOLOGY;RADIOLOGY;SURGERY;ANESTHESIA;ENDOCRINOLOGY;IMMUNOLOGY;NURSING;PHYSICAL MEDICINE AND REHABILITATION;CANCER RESEARCH;CELL BIOLOGY;COMMUNICATION;COMPOSITE MATERIAL;DEVELOPMENTAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;FOOD SCIENCE;GASTROENTEROLOGY;MICROBIOLOGY;OPTICS;PALEONTOLOGY;PEDIATRICS;PHYSICAL THERAPY;PROGRAMMING LANGUAGE","24;18;15;12;9;7;6;6;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DISEASE;CONSCIOUSNESS;RECEPTOR;GENE;BRASSICA;COGNITION;INFLAMMATION;CENTRAL NERVOUS SYSTEM;DOPAMINE;SEXUAL DYSFUNCTION;VEGF RECEPTORS;ALTERNATIVE MEDICINE;APOPTOSIS;BACTERIA;CONFIDENCE INTERVAL;CORTEX (ANATOMY);ELECTROENCEPHALOGRAPHY;ENZYME;EPILEPSY;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;MEDICAL PRESCRIPTION;MULTIPLE SCLEROSIS;NEUROPATHIC PAIN;NEUROPROTECTION;NEUROVASCULAR BUNDLE;OLFACTION;PATHOLOGICAL;POPULATION;REHABILITATION;RESTING STATE FMRI;RHYTHM;SPINAL CORD;STIMULATION;TASTE","9;8;6;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GLUCOSINOLATE;MINIMALLY CONSCIOUS STATE;AGONIST;VASCULAR ENDOTHELIAL GROWTH FACTOR;ALZHEIMER'S DISEASE;BASAL GANGLIA;CONSTRUCT VALIDITY;PARKINSON'S DISEASE;PROINFLAMMATORY CYTOKINE;SPINAL CORD INJURY;STAPHYLOCOCCUS AUREUS;WHITE MATTER;ACETYLCHOLINE RECEPTOR;ACQUIRED BRAIN INJURY;ANTAGONIST;ANTIDEPRESSANT;ARTERIOLOSCLEROSIS;ATELECTASIS;BACTERIAL GROWTH;BETA RHYTHM;BIOFILM;BIPOLAR DISORDER;BITTER TASTE;BLOOD–BRAIN BARRIER;BLOT;BRONCHOSPASM;CANCER CELL;CAVERNOUS MALFORMATIONS;CELL ADHESION;CELL CYCLE;CLAUSTRUM;COGNITIVE IMPAIRMENT;CYTOTOXIC T CELL;DEMENTIA;DIAPHRAGM (ACOUSTICS);DIAPHRAGMATIC BREATHING;DIFFUSION MRI;DOPAMINE RECEPTOR D2;DOPAMINERGIC;EJECTA;EMISSION SPECTRUM;FOCAL ADHESION;GABAPENTIN;GENOME;GENOTYPE;GLIAL FIBRILLARY ACIDIC PROTEIN;GROWTH FACTOR;HALOPERIDOL;HYPERSEXUALITY;IMAGE SEGMENTATION;IN VITRO FERTILISATION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);ISCHAEMIC STROKE;KETOTIFEN;LACTIC ACID;LAMBERT-EATON MYASTHENIC SYNDROME;LUNG FUNCTION;LUNG VOLUMES;MAJOR DEPRESSIVE DISORDER;MOTOR CORTEX;MOVEMENT DISORDERS;MUTATION;NEURODEGENERATION;NEUROINFLAMMATION;NEUROPSYCHOLOGY;NICOTINIC AGONIST;NITRIC OXIDE SYNTHASE;NOCICEPTION;OPTIC NEURITIS;ORGASM;OVER-THE-COUNTER;PATENT FORAMEN OVALE;PHARMACOEPIDEMIOLOGY;PHENOTYPE;PHOTOMETRY (OPTICS);PREFRONTAL CORTEX;REAL-TIME POLYMERASE CHAIN REACTION;RELIABILITY (SEMICONDUCTOR);SEXUAL INTERCOURSE;SHORTEST PATH PROBLEM;SLEEP BRUXISM;SPHINGOSINE;SUPPLEMENTARY MOTOR AREA;TASTE DISORDER;TRANSCRIPTION FACTOR;TRANSFORMING GROWTH FACTOR BETA;TYROSINE HYDROXYLASE;WESTERN BLOT","4;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GLUCORAPHANIN;MYROSINASE;PERSISTENT VEGETATIVE STATE;VASCULAR ENDOTHELIAL GROWTH FACTOR A;ALPHA (FINANCE);GLOBUS PALLIDUS;BACLOFEN;BALMER SERIES;CANNABINOID RECEPTOR;CATALEPSY;CELL CYCLE CHECKPOINT;CONGENITAL MYASTHENIC SYNDROME;CORONAVIRUS DISEASE 2019 (COVID-19);CREB;DIFFUSING CAPACITY;DYSKINESIA;HYPERALGESIA;LEUKOARAIOSIS;LONGEST PATH PROBLEM;MPTP;MYR;NEURAL CELL ADHESION MOLECULE;NICOTINIC ACETYLCHOLINE RECEPTOR;NITROTYROSINE;ORBITOFRONTAL CORTEX;OVARIAN HYPERSTIMULATION SYNDROME;PAIR-INSTABILITY SUPERNOVA;PENETRANCE;SINGLE-NUCLEOTIDE POLYMORPHISM;SPHINGOSINE-1-PHOSPHATE;STAPHYLOCOCCUS EPIDERMIDIS;TRACTOGRAPHY","3;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;;CEREBRAL CORTEX;FEMALE;GLUCOSINOLATES;GLYCOSIDE HYDROLASES;ADULT;MIDDLE AGED;AGED;IMIDOESTERS;NEUROPROTECTIVE AGENTS;MAGNETIC RESONANCE IMAGING;MULTIPLE SCLEROSIS;COGNITIVE DYSFUNCTION;ANTI-BACTERIAL AGENTS;OLFACTION DISORDERS;ALZHEIMER DISEASE;EPILEPSIES, PARTIAL;YOUNG ADULT","27;22;20;17;17;15;14;13;13;12;12;10;9;9;8;7;7;6;6;6","EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;ROLE OF NRF2 SIGNALING IN OXIDATIVE STRESS RESPONSE;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;PATENT FORAMEN OVALE AND CEREBROVASCULAR EVENTS;PRENATAL EXPOSURE TO ANTIEPILEPTIC DRUGS;;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHRONIC CEREBRAL HYPOPERFUSION-RELATED NEURODEGENERATIVE DISEASES;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND MANAGEMENT OF TEMPOROMANDIBULAR DISORDERS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;DYNAMICS OF COMPLEX BIOLOGICAL AND PHYSICAL SYSTEMS","6;4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","COGNITIVE;CONSCIOUSNESS;GLUCORAPHANIN;MYROSINASE;NEUROIMAGING DATA ANALYSIS;NEUROLOGICAL;PERSISTENT VEGETATIVE STATE;ALPHA (FINANCE);CORTICAL CONTROL;CORTICAL PARCELLATION;DEEP LEARNING FOR EEG;EEG ANALYSIS;HYPOACTIVE SEXUAL DESIRE DISORDER;MACHINE OLFACTION;METABOLISM;NEUROINFLAMMATION;NEUROLOGICAL OUTCOME;NEUROPATHOLOGY;NEUROPROTECTION;NEUROVASCULAR BUNDLE","5;5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","CHRONIC DISORDERS;CONSCIOUSNESS DISORDERS;MULTIPLE SCLEROSIS;PARKINSONS DISEASE;ALZHEIMERS DISEASE;BRAIN INJURY;CORTICAL SOURCES;GROWTH FACTOR;LIFE STRESS;MOUSE MODEL;RS-GLUCORAPHANIN BIOACTIVATED;ACUTE MPTP-INDUCED;ADDON THERAPY;ALPHA RHYTHMS;AMNESIC MILD;ANTI-APOPTOTIC EFFECTS;ANTI-TUMORAL EFFECTS;ANTIBACTERIAL ACTIVITY;ANTIINFLAMMATORY DRUGS;ANTINOCICEPTIVE TOLERANCE;AUTOMATED METHOD;BACLOFEN THERAPY;BENEFICIAL EFFECTS;BERGAMIA JUICE;BIOETHICAL ISSUES;BIOFILM FORMATION;BOWEL DYSFUNCTION;CANNABINOID RECEPTOR;CAROTID ATHEROSCLEROSIS;CAVERNOUS MALFORMATIONS","3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MS PATIENTS;MCI SUBJECTS;WHITE MATTER;ALPHA SOURCES;ALZHEIMERS DISEASE;AMNESIC MCI;BIOACTIVE RS-GRA;EEG RHYTHMS;HYDROCHLORIC ACIDS;OTC USERS;PERIODONTAL DISEASE;SNE DD;TYPE II;AAT REPEATS;ALPHA HZ;AUTOIMMUNE ENCEPHALOMYELITIS;BETA HZ;BIOFILM FORMATION;BOUGHT DDD;CCM GENES;CLINICAL TRIALS;CNR GENE;CORTICAL SOURCES;DISEASE SUBJECTS;EEG RECORDINGS;EJECTED MASSES;ELECTROENCEPHALOGRAPHIC EEG;EXPERIMENTAL AUTOIMMUNE;GRAY MATTER;GROWTH REDUCTION","5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;4905 STATISTICS;5203 CLINICAL AND HEALTH PSYCHOLOGY","4;3;3;2;2;2;1;1;1;1;1",NA,NA,"NEUROLOGICAL;GENERIC HEALTH RELEVANCE","2;1",NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","2","NOT SITE-SPECIFIC CANCER","1","4 QUALITY EDUCATION","1"
"IRCCS_BONINOPULEJO",2014,68,8.16176470588235,2.77941176470588,0.35978835978836,0.455882352941176,0.397058823529412,0.147058823529412,0.264705882352941,1,20,26,8,5,0.29,0.38,0.12,0.07,32.57,0.861922816028296,0.220588235294118,0.794117647058823,4.38121546961326,0.581544679134234,0.4,0.564294631710362,0.506775067750677,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;PAOLO MARIA ROSSINI;MARIA GALUPPO;MARIA CRISTINA DE COLA;SIMONA DE SALVO;SILVIA MARINO;ANGELO QUARTARONE;LILLA BONANNO;SABRINA GIACOPPO;RENATO IORI;ANTONINO NARO;GINA ROSALINDA DE NICOLA;FABRIZIO VECCHIO;ANTONINO LEO;FRANCESCA MIRAGLIA;CRISTINA LORENZI;MARTA BOSIA;ROBERTO CAVALLARO","43;15;9;8;7;7;7;7;7;6;6;5;5;5;5;5;5;4;4;4","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;EMANUELA MAZZON;PAOLO MARIA ROSSINI;SILVIA MARINO;MARIA CRISTINA DE COLA;LILLA BONANNO;MARIA GALUPPO;ANTONINO LEO;SABRINA GIACOPPO;ANTONINO NARO;RENATO IORI;GINA ROSALINDA DE NICOLA;FRANCESCO CARLO MORABITO;SIMONA DE SALVO;FABRIZIO VECCHIO;FRANCESCA MIRAGLIA;ANGELO QUARTARONE;NADIA MAMMONE","6.64;2.68;1.38;1.36;1.12;1.1;1.06;1.05;1.02;0.92;0.92;0.88;0.87;0.87;0.86;0.85;0.83;0.83;0.81;0.75","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;MARIA GALUPPO;MARIA CRISTINA DE COLA;SIMONA DE SALVO;SILVIA MARINO;LILLA BONANNO;SABRINA GIACOPPO;ANTONINO NARO;ANTONINO LEO;GIUSEPPE GERVASI;MARGHERITA RUSSO;MICHELE NAVARRA;JORDAN MARROCCO;FRANCESCO CORALLO;ANGELA MARRA;DEMETRIO MILARDI;EDOARDO SESSA;ROSELLA CIURLEO","43;15;9;7;7;7;7;6;6;5;5;4;4;4;3;3;3;3;3;3","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;EMANUELA MAZZON;SILVIA MARINO;MARIA CRISTINA DE COLA;LILLA BONANNO;MARIA GALUPPO;ANTONINO LEO;SABRINA GIACOPPO;ANTONINO NARO;SIMONA DE SALVO;NADIA MAMMONE;GIUSEPPE GERVASI;MARGHERITA RUSSO;MICHELE NAVARRA;EDOARDO SESSA;ROSARIA DE LUCA;ROSELLA CIURLEO;DOMENICA NUNNARI","6.64;2.68;1.38;1.36;1.1;1.06;1.05;1.02;0.92;0.92;0.88;0.85;0.75;0.69;0.58;0.46;0.46;0.43;0.4;0.39","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;PAOLO MARIA ROSSINI;EMANUELA MAZZON;ANGELO QUARTARONE;SIMONA DE SALVO;FABRIZIO VECCHIO;FRANCESCA MIRAGLIA;MARIA GALUPPO;SABRINA GIACOPPO;LILLA BONANNO;MARIA CRISTINA DE COLA;GINA ROSALINDA DE NICOLA;RENATO IORI;SILVIA MARINO;ANGELA MARRA;ANTONINO NARO;ALESSANDRO ARRIGO;DEMETRIO MILARDI;ENRICOMARIA MORMINA","1454;442;365;337;331;325;316;316;281;265;220;212;204;204;195;186;173;165;165;165","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;SIMONA DE SALVO;MARIA GALUPPO;SABRINA GIACOPPO;LILLA BONANNO;MARIA CRISTINA DE COLA;ANGELA MARRA;SILVIA MARINO;ANTONINO NARO;DEMETRIO MILARDI;ANTONINO LEO;MARGHERITA RUSSO;JORDAN MARROCCO;EDOARDO SESSA;GIUSEPPE GERVASI;ALESSIA BRAMANTI;GIANGAETANO D’ALEO;ANNALISA BAGLIERI","1454;442;337;325;281;265;220;212;186;185;173;165;150;129;119;106;103;101;100;98","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;MARIA CRISTINA DE COLA;SIMONA DE SALVO;MARIA GALUPPO;SABRINA GIACOPPO;SILVIA MARINO;LILLA BONANNO;ANTONINO LEO;ANTONINO NARO;GIUSEPPE GERVASI;MARGHERITA RUSSO;ANGELA MARRA;DEMETRIO MILARDI;EDOARDO SESSA;FRANCESCO CORALLO;JORDAN MARROCCO;ROSARIA DE LUCA;ROSELLA CIURLEO","43;15;9;7;7;7;6;6;6;5;5;4;4;3;3;3;3;3;3;3","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;MATHEMATICS;PHYSICS;GEOGRAPHY;MATERIALS SCIENCE;ECONOMICS;POLITICAL SCIENCE","60;37;26;15;11;6;4;4;2;2;1;1","NEUROSCIENCE;INTERNAL MEDICINE;PSYCHIATRY;BIOCHEMISTRY;PATHOLOGY;PHYSICAL MEDICINE AND REHABILITATION;GENETICS;IMMUNOLOGY;PHYSICAL THERAPY;AUDIOLOGY;ARTIFICIAL INTELLIGENCE;CLINICAL PSYCHOLOGY;PHARMACOLOGY;ANESTHESIA;ENDOCRINOLOGY;MECHANICAL ENGINEERING;RADIOLOGY;ANATOMY;BOTANY;CELL BIOLOGY;SURGERY","34;29;22;13;11;11;10;10;10;9;8;8;8;6;6;6;6;5;5;5;5","COGNITION;DISEASE;ELECTROENCEPHALOGRAPHY;GENE;RECEPTOR;MULTIPLE SCLEROSIS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);STROKE (ENGINE);BRASSICA;MAGNETIC RESONANCE IMAGING;PATTERN RECOGNITION (PSYCHOLOGY);REHABILITATION;APOPTOSIS;CENTRAL NERVOUS SYSTEM;CLUSTER ANALYSIS;GRAPH;HIPPOCAMPUS;NEUROLOGY;NEUROPLASTICITY;STIMULATION","17;14;13;8;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4","NEUROPSYCHOLOGY;GLUCOSINOLATE;CLUSTERING COEFFICIENT;COGNITIVE IMPAIRMENT;DIFFUSION MRI;PARKINSON'S DISEASE;ALZHEIMER'S DISEASE;ANTIDEPRESSANT;CONSTRUCT VALIDITY;GENOTYPE;MOTOR CORTEX;NEURORADIOLOGY;PREFRONTAL CORTEX;TRANSCRANIAL MAGNETIC STIMULATION;WAKEFULNESS;COGNITIVE REHABILITATION THERAPY;COGNITIVE REMEDIATION THERAPY;CRANIOPLASTY;DEMENTIA;EXCITATORY POSTSYNAPTIC POTENTIAL;EXECUTIVE FUNCTIONS;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;MUTATION;NEURODEGENERATION;NITRIC OXIDE SYNTHASE;PLACEBO;PROGRAMMED CELL DEATH;PROINFLAMMATORY CYTOKINE;SEROTONIN;TRANSCRIPTION FACTOR","8;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ALPHA (FINANCE);FRACTIONAL ANISOTROPY;GLUCORAPHANIN;MYROSINASE;TRACTOGRAPHY;WISCONSIN CARD SORTING TEST;CATECHOL-O-METHYL TRANSFERASE;NEUROPSYCHOLOGICAL TEST;ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE;ANAPHYLACTIC SHOCK;BACLOFEN;BEHAVIOURAL DESPAIR TEST;BIOLOGICAL PATHWAY;BRAIN-DERIVED NEUROTROPHIC FACTOR;CABERGOLINE;CERAMIDE SYNTHASE;CLAUDICATION;COMPOUND HETEROZYGOSITY;DANIO;DEATH DOMAIN;DEEP BRAIN STIMULATION;DIRECT PATHWAY OF MOVEMENT;DORSOLATERAL;DORSOLATERAL PREFRONTAL CORTEX;DYSKINESIA;ENANTIOPURE DRUG;FLUOXETINE;FRONTOTEMPORAL DEMENTIA;GLOBUS PALLIDUS;GLUTAMATERGIC;INDIRECT PATHWAY OF MOVEMENT;JURKAT CELLS;LAFORA DISEASE;LEUCINE ZIPPER;LTP INDUCTION;MINI–MENTAL STATE EXAMINATION;MONOAMINE NEUROTRANSMITTER;MONOOXYGENASE;MONTREAL COGNITIVE ASSESSMENT;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NEUROPSYCHOLOGICAL ASSESSMENT;NEUROSCIENCE OF SLEEP;NITROTYROSINE;PLACEBO GROUP;POSTURAL INSTABILITY;PRENATAL STRESS;PROBAND;PROPIDIUM IODIDE;SINGLE-NUCLEOTIDE POLYMORPHISM;T-CELL RECEPTOR;TRK RECEPTOR;TROPOMYOSIN RECEPTOR KINASE A;TROPOMYOSIN RECEPTOR KINASE B","3;3;3;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;SCHIZOPHRENIA;STROKE;AGED;COGNITION DISORDERS;;BRAIN;ELECTROENCEPHALOGRAPHY;GLUCOSINOLATES;TREATMENT OUTCOME;YOUNG ADULT;ANIMALS;ANTI-INFLAMMATORY AGENTS;APHASIA;BRAIN MAPPING;DEPRESSION","46;42;34;24;19;18;16;15;14;13;13;11;10;10;10;9;9;9;9;9","ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;DIFFUSION MAGNETIC RESONANCE IMAGING;EFFECTS OF STRESS ON BRAIN FUNCTION AND HEALTH;SCHIZOPHRENIA RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;MANAGEMENT AND PATHOPHYSIOLOGY OF TRAUMATIC BRAIN INJURY;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;RESEARCH ON MORINGA OLEIFERA;BLIND SOURCE SEPARATION AND INDEPENDENT COMPONENT ANALYSIS;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE","4;4;4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","NEUROIMAGING DATA ANALYSIS;EEG ANALYSIS;DEEP LEARNING FOR EEG;EPILEPSY DETECTION;STROKE (ENGINE);BRAIN NETWORK DEVELOPMENT;CLUSTERING COEFFICIENT;CORTICAL CONTROL;NEUROIMAGING;ALPHA (FINANCE);CORTICAL EXCITABILITY;GLUCORAPHANIN;MYROSINASE;NEURORADIOLOGY;STRESS;ARTIFACT (ERROR);COGNITIVE REHABILITATION THERAPY;COGNITIVE REMEDIATION THERAPY;CRANIOPLASTY;DIFFUSION MRI","9;8;7;6;6;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2","ALZHEIMERS DISEASE;CORTICAL CONNECTIVITY;MULTIPLE SCLEROSIS;STRESSED RATS;ARTIFACT REMOVAL;AUTOIMMUNE ENCEPHALOMYELITIS;BLACK KALE;BRAIN INJURY;BRAIN NETWORKS;COGNITIVE REMEDIATION;CONSTRAINED SPHERICAL;CORD INJURY;DIFFUSION TENSOR;EEG DATA;ELECTROENCEPHALOGRAPHIC ARTIFACT;EXPERIMENTAL AUTOIMMUNE;GRAPH THEORETICAL;HUMAN BRAIN;MOUSE MODEL;OBSERVATIONAL STUDY;PREFRONTAL CORTEX;PRENATALLY RESTRAINT;RESTRAINT STRESSED;SPHERICAL DECONVOLUTION;SPINAL CORD;TENSOR IMAGING;THEORETICAL ANALYSIS;TUSCAN BLACK;UNRESPONSIVE WAKEFULNESS;WAKEFULNESS SYNDROME","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PRS RATS;GLUTAMATE RELEASE;VENTRAL HIPPOCAMPUS;EVENT RELATED;MATURE LYMPHOCYTES;MULTIPLE SCLEROSIS;OLFACTORY EVENT;RELATED POTENTIALS;SPINAL CORD;COGNITIVE IMPAIRMENT;FLAVIN-CONTAINING MONOOXYGENASE;IDEAL DISTANCE;ITK TXK;LIMBIC CONNECTIONS;LUNG CANCER;RESTRAINT STRESS;STRESS-RELATED DISORDERS;TISSUE DAMAGE;ALIGNMENT-FREE DISTANCE;ANXIETY-LIKE BEHAVIOR;BLACK KALE;BONE DEFECT;CEREBELLO-LIMBIC PATHWAY;CIRCADIAN RHYTHMS;CLINICAL IMPROVEMENT;CORTICOSTERONE LEVELS;CRT OUTCOMES;CSD TRACTOGRAPHY;DISABILITY STATUS;DISEASE DURATION","9;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;4901 APPLIED MATHEMATICS","3;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2015,67,7.56716417910448,3.98507462686567,0.250936329588015,0.656716417910448,0.626865671641791,0.313432835820896,0.343283582089552,1,14,25,14,10,0.21,0.37,0.21,0.15,29.73,0.797766916594006,0.17910447761194,0.73134328358209,3.78537735849057,0.620554555565979,0.468181818181818,0.477777777777778,0.461538461538462,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARGHERITA RUSSO;ANTONINO LEO;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SABRINA GIACOPPO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;ANGELO QUARTARONE;CARMELA RIFICI;FRANCESCO CORALLO;LILLA BONANNO;SIMONA DE SALVO;LAURA ROSA PISANI;VIVIANA LO BUONO;TINA BALLETTA;PAOLO MARIA ROSSINI","46;22;17;15;15;11;10;8;8;8;6;6;6;5;5;5;5;4;4;4","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARGHERITA RUSSO;ANTONINO LEO;SIMONA DE SALVO;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SABRINA GIACOPPO;ROSARIA DE LUCA;CARMELA RIFICI;LILLA BONANNO;MARIA CRISTINA DE COLA;PAOLO MARIA ROSSINI;FABRIZIO VECCHIO;FRANCESCA MIRAGLIA;LAURA ROSA PISANI;FRANCESCO CORALLO;ANGELO QUARTARONE","6.88;4.18;2.61;2.26;2.03;1.52;1.48;1.47;1.2;1.2;0.94;0.8;0.75;0.75;0.72;0.72;0.72;0.72;0.68;0.61","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARGHERITA RUSSO;ANTONINO LEO;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SABRINA GIACOPPO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;ANGELO QUARTARONE;CARMELA RIFICI;FRANCESCO CORALLO;LILLA BONANNO;SIMONA DE SALVO;LAURA ROSA PISANI;VIVIANA LO BUONO;TINA BALLETTA;ALESSIA BRAMANTI","46;22;17;15;15;11;10;8;8;8;6;6;6;5;5;5;5;4;4;4","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARGHERITA RUSSO;ANTONINO LEO;SIMONA DE SALVO;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SABRINA GIACOPPO;ROSARIA DE LUCA;CARMELA RIFICI;LILLA BONANNO;MARIA CRISTINA DE COLA;LAURA ROSA PISANI;FRANCESCO CORALLO;ANGELO QUARTARONE;EDOARDO SESSA;ANTONINA SIDOTI;VIVIANA LO BUONO","6.88;4.18;2.61;2.26;2.03;1.52;1.48;1.47;1.2;1.2;0.94;0.8;0.75;0.75;0.72;0.68;0.61;0.56;0.54;0.54","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO LEO;ANTONINO NARO;FABRIZIO VECCHIO;FRANCESCA MIRAGLIA;PAOLO MARIA ROSSINI;MARGHERITA RUSSO;EMANUELA MAZZON;SILVIA MARINO;ROSARIA DE LUCA;MARIA GALUPPO;SABRINA GIACOPPO;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;GIULIA GIOVAGNOLI;LAURA MARIA FATTA;LAVINIA DE PEPPO;LIA VASSENA;LUIGI MAZZONE","1350;492;422;392;356;356;356;353;281;236;220;218;218;182;166;151;151;151;151;151","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO LEO;ANTONINO NARO;MARGHERITA RUSSO;EMANUELA MAZZON;SILVIA MARINO;ROSARIA DE LUCA;MARIA GALUPPO;SABRINA GIACOPPO;MARIA CRISTINA DE COLA;LAURA MARIA FATTA;CARMELA RIFICI;ALESSIA BRAMANTI;TINA BALLETTA;ANGELO FAVALORO;ANTONIO CENTOFANTI;GIUSEPPINA CUTRONEO;GIUSEPPINA RIZZO;EDOARDO SESSA","1350;492;422;392;353;281;233;220;218;218;166;151;134;127;105;101;101;101;101;99","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARGHERITA RUSSO;ANTONINO LEO;SILVIA MARINO;EMANUELA MAZZON;MARIA GALUPPO;SABRINA GIACOPPO;ROSARIA DE LUCA;CARMELA RIFICI;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;LAURA ROSA PISANI;LILLA BONANNO;SIMONA DE SALVO;EDOARDO SESSA;VIVIANA LO BUONO;ALESSIA BRAMANTI;FRANCESCO BERTÈ","46;22;17;15;15;11;10;8;8;8;6;6;5;5;5;5;4;4;3;3","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;ECONOMICS;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY","54;39;16;10;8;8;7;4;1;1;1;1;1","NEUROSCIENCE;INTERNAL MEDICINE;PSYCHIATRY;PHYSICAL MEDICINE AND REHABILITATION;AUDIOLOGY;IMMUNOLOGY;BIOCHEMISTRY;PHARMACOLOGY;ANESTHESIA;PHYSICAL THERAPY;RADIOLOGY;CLINICAL PSYCHOLOGY;GENETICS;MECHANICAL ENGINEERING;PATHOLOGY;ANATOMY;ARTIFICIAL INTELLIGENCE;OPTICS;ALGORITHM;CANCER RESEARCH;CELL BIOLOGY;DEVELOPMENTAL PSYCHOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;SURGERY","30;23;21;18;11;10;9;9;8;8;7;6;6;5;5;4;4;4;3;3;3;3;3;3;3","COGNITION;ELECTROENCEPHALOGRAPHY;CONSCIOUSNESS;MULTIPLE SCLEROSIS;STIMULATION;MAGNETIC RESONANCE IMAGING;RECEPTOR;REHABILITATION;DISEASE;GENE;STROKE (ENGINE);EPILEPSY;NEUROPROTECTION;APOPTOSIS;BRASSICA;CANNABIS;COMA (OPTICS);ELECTROPHYSIOLOGY;GLASGOW COMA SCALE;INFLAMMATION;NEUROPHYSIOLOGY;PATTERN RECOGNITION (PSYCHOLOGY);POPULATION","16;12;11;10;8;7;7;7;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3","MINIMALLY CONSCIOUS STATE;WAKEFULNESS;TRANSCRANIAL MAGNETIC STIMULATION;DEMENTIA;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;NEUROPSYCHOLOGY;CANNABIDIOL;GLUCOSINOLATE;MOTOR CORTEX;NEUROREHABILITATION;NOCICEPTION;COGNITIVE IMPAIRMENT;COGNITIVE REHABILITATION THERAPY;CONSCIOUSNESS DISORDERS;DIFFUSION MRI;EFFECTS OF SLEEP DEPRIVATION ON COGNITIVE PERFORMANCE;ENCEPHALOMYELITIS;EPILEPTIC SEIZURE;GENOTYPE;MUTATION;POLYSOMNOGRAPHY;REPERFUSION INJURY;TELEMEDICINE;TRANSCRANIAL DIRECT-CURRENT STIMULATION;WHITE MATTER","11;7;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PERSISTENT VEGETATIVE STATE;COGNITIVE DECLINE;FRACTIONAL ANISOTROPY;MISSENSE MUTATION;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;MYROSINASE;TRACTOGRAPHY;BACLOFEN;BETA-CATENIN;BRAIN-DERIVED NEUROTROPHIC FACTOR;CATENIN;COGNITIVE DEFICIT;COGNITIVE RESERVE;COMET ASSAY;CORTICOSPINAL TRACT;DIHYDROTESTOSTERONE;EPITOPE MAPPING;ESTROGEN RECEPTOR;GENE MUTATION;GERIATRIC DEPRESSION SCALE;LEUCINE ZIPPER;LEVODOPA;MIGRAINE WITH AURA;MITOCHONDRIAL DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY;MITOCHONDRIAL MYOPATHY;N100;NEUROPSYCHOLOGICAL ASSESSMENT;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PACED AUDITORY SERIAL ADDITION TEST;PATTERN RECOGNITION RECEPTOR;PHARMACOGNOSY;PRIMARY MOTOR CORTEX;SH-SY5Y;SINGLE-NUCLEOTIDE POLYMORPHISM;SPLENIUM;SYNAPTIC PRUNING;TELECARE;TELEHEALTH;TETRAHYDROCANNABINOL;TOLL-LIKE RECEPTOR;TROPOMYOSIN RECEPTOR KINASE B;VASCULAR DEMENTIA;WNT3A","8;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;MULTIPLE SCLEROSIS;CONSCIOUSNESS DISORDERS;BRAIN;AGED;CEREBRAL CORTEX;PERSISTENT VEGETATIVE STATE;APOPTOSIS;BRAIN ISCHEMIA;ANIMALS;CANNABIDIOL;COGNITION DISORDERS;;PLANT EXTRACTS;COGNITION;NERVE NET","49;45;38;27;24;24;20;18;17;17;17;14;13;12;12;12;11;11;10;10","EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIFFUSION MAGNETIC RESONANCE IMAGING;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;RESEARCH ON MORINGA OLEIFERA;TELEMEDICINE IN GLOBAL HEALTHCARE;ANTIOXIDANTS AND FREE RADICALS IN HEALTH AND DISEASE;BIOLOGICAL ACTIVITIES OF DITERPENOIDS FROM MEDICINAL PLANTS;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CHRONIC CEREBRAL HYPOPERFUSION-RELATED NEURODEGENERATIVE DISEASES;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;EFFECTS OF STRESS ON BRAIN FUNCTION AND HEALTH;ENDODONTIC RESEARCH AND PRACTICE","7;5;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","PERSISTENT VEGETATIVE STATE;CONSCIOUSNESS;NEUROIMAGING DATA ANALYSIS;NEUROREHABILITATION;STROKE (ENGINE);BRAIN NETWORK DEVELOPMENT;DEEP LEARNING FOR EEG;EEG ANALYSIS;COMA (OPTICS);EPILEPSY DETECTION;NEURAL ENSEMBLE PHYSIOLOGY;NEUROMODULATION;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION;AGING;AXONAL TRACKING;BRAIN CONNECTIVITY;CANNABIS USE;COGNITIVE DECLINE;COGNITIVE IMPAIRMENT","8;5;5;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2","MINIMALLY CONSCIOUS;MULTIPLE SCLEROSIS;CHRONIC DISORDERS;COGNITIVE REHABILITATION;CONSTRAINED SPHERICAL;ABSENCE EPILEPSY;AUTOIMMUNE ENCEPHALOMYELITIS;CORTICAL CONNECTIVITY;CURRENT STIMULATION;DIRECT CURRENT;EVOKED POTENTIALS;EXPERIMENTAL AUTOIMMUNE;GRAPH THEORY;LASER EVOKED;MOUSE MODEL;NETWORK ARCHITECTURE;NOCICEPTIVE STIMULI;PARKINSONS DISEASE;SPHERICAL DECONVOLUTION;TRANSCRANIAL DIRECT;UNRESPONSIVE WAKEFULNESS;WAKEFULNESS SYNDROME;ACTIVITY MODIFICATION;ADVERSE EFFECTS;AGE-RELATED BRAIN;AMYOTROPHIC LATERAL;ANALYSE EPILEPTIC;ANTERIOR CHEST;ANTERIOR CINGULATE;ANTIFUNGAL SUSCEPTIBILITIES","5;5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","INI IPI;IZI INI;MS PATIENTS;MINIMALLY CONSCIOUS;MULTIPLE SCLEROSIS;PATIENTS AFFECTED;MCS PATIENTS;BDNF-TRKB SIGNALING;COGNITIVE FUNCTIONS;CONSTRAINED SPHERICAL;CORTICOSPINAL TRACT;SCLEROSIS MS;SPHERICAL DECONVOLUTION;VESTIBULAR SYSTEM;ANTIPROLIFERATIVE EFFECTS;APICAL ZONE;ARCUATE FASCICULUS;BIOACTIVE TBK-SE;BRAIN VOLUME;CHRONIC DISORDERS;CONSCIOUS PAIN;CONSCIOUSNESS DOC;CORTICAL PAIN;CORTICAL PLASTICITY;DECONVOLUTION TRACTOGRAPHY;IPI IZI;MOTOR FUNCTION;PAIN AROUSAL;PAIN PERCEPTION;PATIENTS SUFFERING","7;7;7;6;6;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2016,79,9.0506329113924,3.92405063291139,0.254838709677419,0.569620253164557,0.607594936708861,0.40506329113924,0.265822784810127,0,18,27,18,10,0.23,0.34,0.23,0.13,36.43,1.12152105381649,0.151898734177215,0.772151898734177,3.91006423982869,0.594741443547806,0.404186795491143,0.470381231671554,0.396871945259042,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;SILVIA MARINO;EMANUELA MAZZON;MARGHERITA RUSSO;ANTONINO LEO;ALESSIA BRAMANTI;THANGAVELU SOUNDARA RAJAN;SABRINA GIACOPPO;DEMETRIO MILARDI;ANGELO QUARTARONE;ADRIANO PIATTELLI;LILLA BONANNO;FRANCESCA DIOMEDE;ORIANA TRUBIANI;FRANCESCA GRANATA;ROSARIA DE LUCA;FRANCESCO CORALLO;ENRICOMARIA MORMINA","50;24;21;17;13;12;11;10;9;9;8;8;7;7;7;7;7;7;6;6","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;SILVIA MARINO;EMANUELA MAZZON;ANTONINO LEO;MARGHERITA RUSSO;SABRINA GIACOPPO;THANGAVELU SOUNDARA RAJAN;ALESSIA BRAMANTI;DEMETRIO MILARDI;ANGELO QUARTARONE;ROSARIA DE LUCA;FRANCESCO CORALLO;LILLA BONANNO;ADRIANO PIATTELLI;FRANCESCA DIOMEDE;ORIANA TRUBIANI;ALFREDO MANULI;VIVIANA LO BUONO","6.86;3.96;3.7;2.01;1.85;1.69;1.53;1.37;1.29;1.28;1.24;0.97;0.83;0.82;0.81;0.8;0.8;0.8;0.78;0.74","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;SILVIA MARINO;EMANUELA MAZZON;MARGHERITA RUSSO;ANTONINO LEO;ALESSIA BRAMANTI;THANGAVELU SOUNDARA RAJAN;SABRINA GIACOPPO;DEMETRIO MILARDI;ANGELO QUARTARONE;LILLA BONANNO;ROSARIA DE LUCA;FRANCESCO CORALLO;ALFREDO MANULI;SIMONA DE SALVO;VIVIANA LO BUONO;MARIA CRISTINA DE COLA;ANGELA MARRA","50;24;21;17;13;12;11;10;9;9;8;8;7;7;6;6;6;5;5;5","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;SILVIA MARINO;EMANUELA MAZZON;ANTONINO LEO;MARGHERITA RUSSO;SABRINA GIACOPPO;THANGAVELU SOUNDARA RAJAN;ALESSIA BRAMANTI;DEMETRIO MILARDI;ANGELO QUARTARONE;ROSARIA DE LUCA;FRANCESCO CORALLO;LILLA BONANNO;ALFREDO MANULI;VIVIANA LO BUONO;MARIA CRISTINA DE COLA;ANGELA MARRA;SIMONA DE SALVO","6.86;3.96;3.7;2.01;1.85;1.69;1.53;1.37;1.29;1.28;1.24;0.97;0.83;0.82;0.81;0.78;0.74;0.71;0.69;0.68","PLACIDO BRAMANTI;EMANUELA MAZZON;ROCCO SALVATORE CALABRÒ;SABRINA GIACOPPO;ANTONINO NARO;THANGAVELU SOUNDARA RAJAN;ADRIANO PIATTELLI;FRANCESCA DIOMEDE;ORIANA TRUBIANI;SILVIA MARINO;FEDERICA POLLASTRO;GIANPAOLO GRASSI;MARGHERITA RUSSO;ANTONINO LEO;DEMETRIO MILARDI;ALESSIA BRAMANTI;ANGELO QUARTARONE;FRANCESCO CARLO MORABITO;GINA ROSALINDA DE NICOLA;NADIA MAMMONE","2031;876;682;598;513;503;481;481;481;457;446;446;395;367;350;274;273;268;268;268","PLACIDO BRAMANTI;EMANUELA MAZZON;ROCCO SALVATORE CALABRÒ;SABRINA GIACOPPO;THANGAVELU SOUNDARA RAJAN;ANTONINO NARO;SILVIA MARINO;MARGHERITA RUSSO;ANTONINO LEO;DEMETRIO MILARDI;ANGELO QUARTARONE;NADIA MAMMONE;ALESSIA BRAMANTI;DOMENICO SCIONTI;SIMONA DE SALVO;LILLA BONANNO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;EDOARDO SESSA;ROSALIANA LIBRO","2004;876;682;598;501;486;418;368;367;321;246;245;240;229;196;192;187;183;177;161","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;SILVIA MARINO;EMANUELA MAZZON;ANTONINO LEO;MARGHERITA RUSSO;SABRINA GIACOPPO;ALESSIA BRAMANTI;THANGAVELU SOUNDARA RAJAN;DEMETRIO MILARDI;LILLA BONANNO;ANGELO QUARTARONE;ROSARIA DE LUCA;FRANCESCO CORALLO;SIMONA DE SALVO;ANGELA MARRA;ALFREDO MANULI;MARIA CRISTINA DE COLA;VIVIANA LO BUONO","49;24;20;16;13;11;11;9;8;8;7;7;7;7;6;6;5;5;5;5","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;MATHEMATICS;GEOLOGY;PHILOSOPHY;ECONOMICS;POLITICAL SCIENCE;GEOGRAPHY","67;41;22;13;11;6;5;5;3;3;2;2;1","NEUROSCIENCE;INTERNAL MEDICINE;PSYCHIATRY;PATHOLOGY;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;BIOCHEMISTRY;AUDIOLOGY;CANCER RESEARCH;IMMUNOLOGY;PHYSICAL THERAPY;CELL BIOLOGY;ARTIFICIAL INTELLIGENCE;PHARMACOLOGY;CLINICAL PSYCHOLOGY;SURGERY;ANESTHESIA;GENETICS;NUCLEAR MEDICINE;CARDIOLOGY;COGNITIVE PSYCHOLOGY","36;25;25;18;16;13;11;10;10;10;10;9;8;8;7;7;6;6;5;4;4","DISEASE;ELECTROENCEPHALOGRAPHY;MAGNETIC RESONANCE IMAGING;COGNITION;GENE;STIMULATION;CONSCIOUSNESS;CANNABIS;CENTRAL NERVOUS SYSTEM;MULTIPLE SCLEROSIS;MESENCHYMAL STEM CELL;REHABILITATION;STROKE (ENGINE);CEREBELLUM;ENZYME;INFLAMMATION;LESION;NEUROPLASTICITY;NEUROPROTECTION;RECEPTOR;SIGNAL TRANSDUCTION;STEM CELL","16;15;14;13;12;12;10;7;7;7;6;6;5;4;4;4;4;4;4;4;4;4","DIFFUSION MRI;MINIMALLY CONSCIOUS STATE;DEMENTIA;TRANSCRANIAL MAGNETIC STIMULATION;CANNABIDIOL;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;NEUROPSYCHOLOGY;WAKEFULNESS;COGNITIVE IMPAIRMENT;ALKALINE PHOSPHATASE;BRAIN STIMULATION;DOWNREGULATION AND UPREGULATION;NEUROREHABILITATION;ALLELE;ALZHEIMER'S DISEASE;DENTATE NUCLEUS;DIMORPHIC FUNGUS;ENCEPHALOMYELITIS;EXON;GAIT TRAINING;GENE EXPRESSION;GENOME;GENOTYPE;GLUCOSINOLATE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);LIMBIC SYSTEM;MUTATION;NEUROMODULATION;PARKINSON'S DISEASE;PI3K/AKT/MTOR PATHWAY;SPINAL CORD INJURY;SPOROTHRIX;SPOROTHRIX SCHENCKII;TEMPORAL LOBE;TRANSCRANIAL DIRECT-CURRENT STIMULATION;WHITE MATTER;WNT SIGNALING PATHWAY","10;8;7;7;6;6;6;6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PERSISTENT VEGETATIVE STATE;TRACTOGRAPHY;PERIODONTAL LIGAMENT STEM CELLS;CANNABINOID RECEPTOR;CORONAVIRUS DISEASE 2019 (COVID-19);FRACTIONAL ANISOTROPY;FRONTOTEMPORAL DEMENTIA;HAPLOTYPE;MYROSINASE;PRIMARY MOTOR CORTEX;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;WHOLE GENOME SEQUENCING;AXIN2;BECK ANXIETY INVENTORY;CAREGIVER BURDEN;CD90;CLADE;COGNITIVE RESERVE;DEEP BRAIN STIMULATION;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;GENOTYPING;GLOBUS PALLIDUS;HMG-COA REDUCTASE;MICROSATELLITE;MICROVESICLES;MISSENSE MUTATION;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;POINT MUTATION;PROMOTER;REMYELINATION;SILENT PERIOD;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME","8;5;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;AGED;;PERSISTENT VEGETATIVE STATE;NEURAL PATHWAYS;MULTIPLE SCLEROSIS;ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;TRANSCRANIAL MAGNETIC STIMULATION;BRAIN;CANNABIDIOL;ELECTROENCEPHALOGRAPHY;MESENCHYMAL STEM CELLS;ISOTHIOCYANATES;ANIMALS;CEREBRAL CORTEX;ANTI-INFLAMMATORY AGENTS","52;43;38;30;28;19;18;18;16;14;13;13;12;12;12;12;11;10;10;9","DIFFUSION MAGNETIC RESONANCE IMAGING;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF FUNGAL INFECTIONS;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MULTIPOTENT MESENCHYMAL STEM CELLS;NEURAL MECHANISMS OF LANGUAGE PROCESSING;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;RESEARCH ON MORINGA OLEIFERA;ROLE OF NRF2 SIGNALING IN OXIDATIVE STRESS RESPONSE;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CHOLESTEROL-LOWERING TREATMENT","7;7;6;4;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1","NEUROIMAGING DATA ANALYSIS;PERSISTENT VEGETATIVE STATE;BRAIN CONNECTIVITY;EEG ANALYSIS;CONSCIOUSNESS;PERFUSION IMAGING;STROKE (ENGINE);TRANSCRANIAL MAGNETIC STIMULATION;BRAIN NETWORK DEVELOPMENT;CANNABIS USE;DEEP LEARNING FOR EEG;EPILEPSY DETECTION;FIBER TRACTOGRAPHY;NEUROMODULATION;NEUROREHABILITATION;TRANSCRANIAL DIRECT CURRENT STIMULATION;BRAIN STIMULATION;CANNABINOID RECEPTORS;COMA (OPTICS);CORTICAL EXCITABILITY","9;8;6;6;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3","CONSTRAINED SPHERICAL;SPHERICAL DECONVOLUTION;STEM CELLS;ALZHEIMERS DISEASE;CHRONIC DISORDERS;DECONVOLUTION TRACTOGRAPHY;MULTIPLE SCLEROSIS;SPINAL CORD;CANNABIDIOL MODULATES;CHRONIC DISORDER;CORD INJURY;EEG DATA;HUMAN BRAIN;MESENCHYMAL STEM;MILD COGNITIVE;PERIODONTAL LIGAMENT;ACUTE STROKE;ALTERNATING CURRENT;ANTI-INFLAMMATORY ACTIVITY;AUTOIMMUNE ENCEPHALOMYELITIS;BRAIN CONNECTIVITY;BRAIN INJURY;CAVERNOUS MALFORMATIONS;CEREBRAL CAVERNOUS;COGNITIVE IMPAIRMENT;CONSCIOUSNESS DIFFERENTIAL;CORTICAL CONNECTIVITY;CROSS-SECTIONAL STUDY;CURRENT STIMULATION;DIFFERENTIAL DIAGNOSIS","5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CD CD;MULTIPLE SCLEROSIS;SERUM CHOLESTEROL;TOTAL SERUM;BASAL GANGLIA;SPINAL CORD;STEM CELLS;SUBSTANTIA NIGRA;CHOLESTEROL LEVELS;COMPLEX REGIONAL;MAGNETIC RESONANCE;MESENCHYMAL STEM;PAIN SYNDROME;REGIONAL PAIN;SCLEROSIS MS;SENSORIMOTOR PLASTICITY;SYNDROME TYPE;WNTΒ-CATENIN PATHWAY;AUTOIMMUNE ENCEPHALOMYELITIS;CBD TREATMENT;CONTROL SUBJECTS;EAE INDUCTION;EAE MICE;ENCEPHALOMYELITIS EAE;HEALTHY SUBJECTS;HUMAN BRAIN;IL-Β IL-;RESONANCE IMAGING;ROBOT TRAINING;ACHIEVED RESULTS","14;9;9;7;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2",1,0.01,23.1,21,5,0,0,2,0,0,0,24,0,0,14,0,0,0,2,9,3,0,0,177,177,1,0,2,0,0,0,0,0,0,0,0,0,2,0,0,6,5,3.23,1.5,0,1,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ACRI GIUSEPPE;BRAMANTI ALESSIA;BRAMANTI PLACIDO;TESTAGROSSA BARBARA;VERMIGLIO GIUSEPPE","2;2;2;2;2","IRCCS CENTRO NEUROLESI ""BONINO-PULEJO"";IRCCS CT NEUROLESI BONINO PULEJO","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;51 PHYSICAL SCIENCES","2;2;2","BIOMEDICAL IMAGING","2",NA,NA,"A61B6/00;A61B6/03;G01R33/58;A61B5/055","2;2;2;1","A61B5/055;A61B6/032;A61B6/583;G01R33/58","2;2;2;2",1,2,40,1.59,0,0,2,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","1;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;DRUG ABUSE (NIDA ONLY);NEURODEGENERATIVE;NEUROSCIENCES;PHYSICAL REHABILITATION;REHABILITATION;SUBSTANCE MISUSE","1;1;1;1;1;1;1;1","NEUROLOGICAL","1",NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","31 BIOLOGICAL SCIENCES;3105 GENETICS","2;1",NA,NA,NA,NA,NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2017,104,9.31730769230769,4.19230769230769,0.238532110091743,0.625,0.567307692307692,0.644230769230769,0.519230769230769,1,30,27,20,16,0.29,0.26,0.19,0.15,30.61,1.03836271728692,0.230769230769231,0.798076923076923,3.5018315018315,0.639049986233837,0.463260619977038,0.522419627749577,0.505395683453237,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;MARGHERITA RUSSO;LILLA BONANNO;ORIANA TRUBIANI;FRANCESCA DIOMEDE;SABRINA GIACOPPO;THANGAVELU SOUNDARA RAJAN;DEMETRIO MILARDI;ROSARIA DE LUCA;ANTONINO LEO;MASSIMO VILLARI;ANTONIO CELESTI;FRANCESCO CORALLO;VIVIANA LO BUONO;ALESSANDRO CALAMUNERI","61;32;26;26;24;16;16;13;11;10;10;9;9;9;9;7;7;6;6;6","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;ANTONINO NARO;ALESSIA BRAMANTI;SILVIA MARINO;SABRINA GIACOPPO;MARGHERITA RUSSO;LILLA BONANNO;ORIANA TRUBIANI;FRANCESCA DIOMEDE;MASSIMO VILLARI;ANTONIO CELESTI;THANGAVELU SOUNDARA RAJAN;ANTONINO LEO;MARIA FAZIO;DEMETRIO MILARDI;ROSARIA DE LUCA;AGNESE GUGLIANDOLO;ALFREDO MANULI","9;4.18;4.08;3.6;3.39;2.64;2.02;1.96;1.64;1.55;1.41;1.36;1.36;1.31;1.14;1.07;0.95;0.95;0.8;0.72","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;MARGHERITA RUSSO;LILLA BONANNO;SABRINA GIACOPPO;THANGAVELU SOUNDARA RAJAN;DEMETRIO MILARDI;ROSARIA DE LUCA;ANTONINO LEO;MASSIMO VILLARI;FRANCESCO CORALLO;VIVIANA LO BUONO;ALESSANDRO CALAMUNERI;ALFREDO MANULI;SIMONA DE SALVO;ALBERTO CACCIOLA","61;32;26;26;24;16;16;13;10;9;9;9;9;7;6;6;6;6;6;6","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;ANTONINO NARO;ALESSIA BRAMANTI;SILVIA MARINO;SABRINA GIACOPPO;MARGHERITA RUSSO;LILLA BONANNO;MASSIMO VILLARI;THANGAVELU SOUNDARA RAJAN;ANTONINO LEO;DEMETRIO MILARDI;ROSARIA DE LUCA;AGNESE GUGLIANDOLO;ALFREDO MANULI;ALBERTO CACCIOLA;SIMONA DE SALVO;NADIA MAMMONE;ROSALIANA LIBRO","9;4.18;4.08;3.6;3.39;2.64;2.02;1.96;1.64;1.36;1.31;1.14;0.95;0.95;0.8;0.72;0.72;0.69;0.69;0.67","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;EMANUELA MAZZON;MARGHERITA RUSSO;ROSARIA DE LUCA;ANTONINO LEO;ORIANA TRUBIANI;FRANCESCA DIOMEDE;SILVIA MARINO;THANGAVELU SOUNDARA RAJAN;SABRINA GIACOPPO;DEMETRIO MILARDI;ANTONIO BUDA;CARLO VITTORIO CANNISTRACI;LILLA BONANNO;GIANLUCA LA ROSA;PROVVIDENZA TOMASELLO;SIMONA LEONARDI","2031;1021;944;941;873;720;574;512;487;442;389;385;368;291;247;244;233;222;218;202","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;EMANUELA MAZZON;ALESSIA BRAMANTI;MARGHERITA RUSSO;ROSARIA DE LUCA;ANTONINO LEO;THANGAVELU SOUNDARA RAJAN;SABRINA GIACOPPO;SILVIA MARINO;DEMETRIO MILARDI;ANTONIO BUDA;CARLO VITTORIO CANNISTRACI;LILLA BONANNO;GIANLUCA LA ROSA;PROVVIDENZA TOMASELLO;SIMONA LEONARDI;TINA BALLETTA;AGNESE GUGLIANDOLO","1996;1008;931;873;757;720;574;512;385;368;313;269;247;244;233;222;218;202;199;183","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;EMANUELA MAZZON;ALESSIA BRAMANTI;MARGHERITA RUSSO;SILVIA MARINO;LILLA BONANNO;SABRINA GIACOPPO;ANTONINO LEO;ROSARIA DE LUCA;THANGAVELU SOUNDARA RAJAN;MASSIMO VILLARI;DEMETRIO MILARDI;FRANCESCO CORALLO;ALBERTO CACCIOLA;ALFREDO MANULI;VIVIANA LO BUONO;SIMONA DE SALVO;VINCENZO DATTOLA","60;31;25;24;20;16;15;13;10;9;9;9;7;7;6;6;6;6;6;5","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;CHEMISTRY;ECONOMICS;ENGINEERING;PHILOSOPHY;MATERIALS SCIENCE;ART;POLITICAL SCIENCE;SOCIOLOGY","79;43;37;29;13;10;9;9;7;4;3;1;1;1","NEUROSCIENCE;INTERNAL MEDICINE;PSYCHIATRY;PHYSICAL MEDICINE AND REHABILITATION;PATHOLOGY;BIOCHEMISTRY;IMMUNOLOGY;PHYSICAL THERAPY;GENETICS;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;RADIOLOGY;AUDIOLOGY;SURGERY;ANATOMY;OPTICS;CANCER RESEARCH;OPERATING SYSTEM;GEOMETRY;PALEONTOLOGY;PHARMACOLOGY;WORLD WIDE WEB","39;27;25;24;20;19;19;17;14;13;13;12;10;9;8;8;7;7;6;6;6;6","GENE;REHABILITATION;COGNITION;CONSCIOUSNESS;DISEASE;MAGNETIC RESONANCE IMAGING;MULTIPLE SCLEROSIS;ELECTROENCEPHALOGRAPHY;INFLAMMATION;MESENCHYMAL STEM CELL;STIMULATION;STEM CELL;CLOUD COMPUTING;RECEPTOR;STROKE (ENGINE);VIRTUAL REALITY;CONTEXT (ARCHAEOLOGY);ENZYME;HEALTH CARE;RANDOMIZED CONTROLLED TRIAL;SIGNAL TRANSDUCTION","15;14;13;11;10;10;10;9;9;9;8;7;6;6;6;6;5;5;5;5;5","MINIMALLY CONSCIOUS STATE;DIFFUSION MRI;TRANSCRANIAL MAGNETIC STIMULATION;WAKEFULNESS;ALKALINE PHOSPHATASE;GENE EXPRESSION;INFLAMMASOME;NEUROPSYCHOLOGY;NEUROREHABILITATION;BRAIN STIMULATION;COGNITIVE REHABILITATION THERAPY;CONSCIOUSNESS DISORDERS;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;NEURAL CREST;NEUROINFLAMMATION;NEUROMODULATION;PARKINSON'S DISEASE;PI3K/AKT/MTOR PATHWAY;PROTEIN KINASE B;REGENERATIVE MEDICINE;RNA","11;6;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","PERSISTENT VEGETATIVE STATE;PERIODONTAL LIGAMENT STEM CELLS;TRACTOGRAPHY;TRANSCRIPTOME;CATENIN;FRACTIONAL ANISOTROPY;KLEBSIELLA PNEUMONIAE;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;REVERSE TRANSCRIPTASE;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;ADULT STEM CELL;AMPLIFIED FRAGMENT LENGTH POLYMORPHISM;AUTOIMMUNE ENCEPHALITIS;BECK ANXIETY INVENTORY;BETA-CATENIN;BRAIN-DERIVED NEUROTROPHIC FACTOR;CANNABINOID RECEPTOR;CAREGIVER BURDEN;CASPASE 1;CEFTAZIDIME;CORONAVIRUS DISEASE 2019 (COVID-19);DENDROGRAM;DIRECT PATHWAY OF MOVEMENT;DNA METHYLATION;FRONTOTEMPORAL DEMENTIA;GENETICALLY MODIFIED MOUSE;GENOMICS;IMIPENEM;INDIRECT PATHWAY OF MOVEMENT;INTERFERON BETA-1A;IΚBΑ;METAPLASTICITY;MIGRAINE WITH AURA;MPTP;MYOTONIA CONGENITA;NALP3;NESTIN;NEUROPSYCHOLOGICAL ASSESSMENT;ONCOGENE;OPTIC RADIATION;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PIPERACILLIN;PYRIN DOMAIN;REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;RUNX2;SH-SY5Y;SOD1;SYBR GREEN I;WHOLE GENOME SEQUENCING;ZIDOVUDINE","9;5;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;BRAIN;;ADULT;MIDDLE AGED;AGED;CONSCIOUSNESS DISORDERS;MULTIPLE SCLEROSIS;COGNITION DISORDERS;STROKE;YOUNG ADULT;ANIMALS;COGNITIVE DYSFUNCTION;GINGIVA;MAGNETIC RESONANCE IMAGING;MESENCHYMAL STEM CELLS;NF-KAPPA B;STROKE REHABILITATION","60;46;44;35;33;32;31;19;19;19;17;17;15;11;11;11;11;11;11;11","EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;MULTIPOTENT MESENCHYMAL STEM CELLS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIFFUSION MAGNETIC RESONANCE IMAGING;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;QUANTITATIVE IMAGING OF LIVING CELLS WITH HOLOGRAPHY;RESEARCH ON MORINGA OLEIFERA;ROLES OF NEUROTROPHINS IN NERVOUS SYSTEM FUNCTION;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ASSISTIVE TECHNOLOGY AND DISABILITIES","10;6;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1","PERSISTENT VEGETATIVE STATE;NEUROIMAGING DATA ANALYSIS;STROKE (ENGINE);BRAIN NETWORK DEVELOPMENT;EEG ANALYSIS;MESENCHYMAL STEM CELLS;NEUROREHABILITATION;VIRTUAL REALITY REHABILITATION;CONSCIOUSNESS;CORTICAL EXCITABILITY;DEEP LEARNING FOR EEG;INFLAMMASOME;NEUROMODULATION;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION;BRAIN STIMULATION;COGNITIVE REHABILITATION THERAPY;COMA (OPTICS);COMPUTED TOMOGRAPHY;CONSCIOUSNESS DISORDERS","9;7;6;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3","MULTIPLE SCLEROSIS;STEM CELLS;CHRONIC DISORDERS;MESENCHYMAL STEM;PERIODONTAL LIGAMENT;HUMAN PERIODONTAL;LIGAMENT STEM;VIRTUAL REALITY;BRAIN CONNECTIVITY;BRAIN INJURY;COGNITIVE IMPAIRMENT;CONSTRAINED SPHERICAL;GINGIVAL MESENCHYMAL;SCLEROSIS PATIENTS;SPHERICAL DECONVOLUTION;TRAUMATIC BRAIN;ALTERNATING CURRENT;AMYOTROPHIC LATERAL;CANDIDA AFRICANA;CERVICAL DYSTONIA;CLINICAL TRIAL;CONSCIOUSNESS DIFFERENTIAL;CONTROLLED TRIAL;CURRENT STIMULATION;DECONVOLUTION TRACTOGRAPHY;DIFFERENTIAL DIAGNOSIS;DIFFUSION TENSOR;DIGITAL PATHOLOGY;GAIT TRAINING;INFLAMMASOME ACTIVATION","11;10;7;5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CPKO MICE;FERROXIDASE ACTIVITY;ITALY SEARCH;WT MICE;INSTITUTE MILAN;IRCCS-SAN RAFFAELE;MILAN ITALY;MULTIPLE SCLEROSIS;RAFFAELE SCIENTIFIC;SCIENTIFIC INSTITUTE;WESTERN BLOT;ADMINISTERED CP;BASAL GANGLIA;OXIDATIVE STRESS;STEM CELLS;BIOCHEMISTRY DIVISION;BIOLOGY IRCCS-SAN;CELL BIOLOGY;FUNCTIONAL CONNECTIVITY;IRON DEPOSITION;MICE FIG;PROTEOME BIOCHEMISTRY;STEM CELL;CP ADMINISTRATION;MOTOR COORDINATION;HUMAN CP;MESENCHYMAL STEM;PUBLIC HEALTH;PURIFIED CP;BRAIN HOMOGENATES","40;24;18;16;12;12;12;12;12;12;12;11;10;10;10;9;9;9;9;9;9;9;9;8;8;7;7;7;7;6",1,0.01,12.15,3,0,1,0,0,0,0,1,4,0,0,1,0,0,0,0,1,0,0,0,100,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,1.33,84,3.03,1,0.33,16.67,0,0,1,0,0,0,0,2,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;32 BIOMEDICAL AND CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","2;2;2;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;NEUROSCIENCES;AGING;NEURODEGENERATIVE;REHABILITATION;BIOENGINEERING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PARKINSON'S DISEASE;PHYSICAL REHABILITATION;STROKE","3;3;3;2;2;2;1;1;1;1;1","STROKE","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2018,123,9.15447154471545,4.23577235772358,0.236084452975048,0.536585365853659,0.463414634146341,0.51219512195122,0.585365853658537,3,39,49,14,12,0.32,0.4,0.11,0.1,27.68,0.907391376063061,0.300813008130081,0.821138211382114,3.82232704402516,0.617680311677951,0.508869395711501,0.506666666666667,0.579114697970164,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;ANTONINO NARO;FRANCESCO CORALLO;LILLA BONANNO;ALFREDO MANULI;ROSARIA DE LUCA;SIMONA PORTARO;VIVIANA LO BUONO;AGNESE GUGLIANDOLO;ANGELO QUARTARONE;SIMONA DE SALVO;NADIA MAMMONE;GIUSEPPA MARESCA;MARIA CRISTINA DE COLA;ROSA MORABITO;DEMETRIO MILARDI","44;37;33;24;22;20;14;13;13;13;12;10;9;9;8;8;7;7;7;7","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ALESSIA BRAMANTI;SILVIA MARINO;EMANUELA MAZZON;ANTONINO NARO;ALFREDO MANULI;SIMONA PORTARO;ROSARIA DE LUCA;FRANCESCO CORALLO;LILLA BONANNO;NADIA MAMMONE;CARLO VITTORIO CANNISTRACI;ROBERTO GIORGIANNI;AGNESE GUGLIANDOLO;ANGELO QUARTARONE;ALESSANDRO MUSCOLONI;VIVIANA LO BUONO;ALBERTO CACCIOLA;SIMONA DE SALVO","6.02;4.92;4.22;3.21;2.71;2.64;2.15;1.66;1.52;1.49;1.48;1.42;1.36;1.24;1.11;1.06;1;1;0.93;0.89","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;ANTONINO NARO;FRANCESCO CORALLO;LILLA BONANNO;ALFREDO MANULI;ROSARIA DE LUCA;SIMONA PORTARO;VIVIANA LO BUONO;AGNESE GUGLIANDOLO;ANGELO QUARTARONE;SIMONA DE SALVO;NADIA MAMMONE;GIUSEPPA MARESCA;MARIA CRISTINA DE COLA;ROSA MORABITO;DEMETRIO MILARDI","44;37;33;24;22;20;14;13;13;13;12;10;9;9;8;8;7;7;7;7","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ALESSIA BRAMANTI;SILVIA MARINO;EMANUELA MAZZON;ANTONINO NARO;ALFREDO MANULI;SIMONA PORTARO;ROSARIA DE LUCA;FRANCESCO CORALLO;LILLA BONANNO;NADIA MAMMONE;CARLO VITTORIO CANNISTRACI;ROBERTO GIORGIANNI;AGNESE GUGLIANDOLO;ANGELO QUARTARONE;VIVIANA LO BUONO;ALBERTO CACCIOLA;SIMONA DE SALVO;ANTONINO LEO","6.02;4.92;4.22;3.21;2.71;2.64;2.15;1.66;1.52;1.49;1.48;1.42;1.36;1.24;1.11;1.06;1;0.93;0.89;0.87","ALESSIA BRAMANTI;PLACIDO BRAMANTI;EMANUELA MAZZON;ROCCO SALVATORE CALABRÒ;AGNESE GUGLIANDOLO;FRANCESCA DIOMEDE;ORIANA TRUBIANI;ILARIA MERCIARO;FRANCESCO CARLO MORABITO;NADIA MAMMONE;COSIMO IERACITANO;SILVIA MARINO;DOMENICO SCIONTI;MARIA CRISTINA DE COLA;ALFREDO MANULI;ROSARIA DE LUCA;ANTONELLA FONTANA;VALERIA ETTORRE;LILLA BONANNO;FERDINANDO NICOLETTI","1458;1318;1106;731;615;523;523;460;427;427;424;391;382;356;337;333;313;313;301;295","PLACIDO BRAMANTI;EMANUELA MAZZON;ALESSIA BRAMANTI;ROCCO SALVATORE CALABRÒ;AGNESE GUGLIANDOLO;NADIA MAMMONE;DOMENICO SCIONTI;MARIA CRISTINA DE COLA;ALFREDO MANULI;ROSARIA DE LUCA;SILVIA MARINO;LILLA BONANNO;ANTONINO NARO;SIMONA DE SALVO;ANTONIO BUDA;MARGHERITA RUSSO;FRANCESCO CORALLO;CARLO VITTORIO CANNISTRACI;LUIGI CARIOTI;MARIA GRAZIA MAGGIO","1283;1106;1073;675;615;427;382;356;337;333;319;301;291;263;256;201;188;184;184;178","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;EMANUELA MAZZON;ANTONINO NARO;SILVIA MARINO;FRANCESCO CORALLO;LILLA BONANNO;ALFREDO MANULI;ROSARIA DE LUCA;SIMONA PORTARO;VIVIANA LO BUONO;AGNESE GUGLIANDOLO;ANGELO QUARTARONE;GIUSEPPE DI LORENZO;NADIA MAMMONE;SIMONA DE SALVO;MARIA CRISTINA DE COLA;GIUSEPPA MARESCA;ROSA MORABITO","42;35;27;24;20;16;14;13;13;13;12;10;9;8;8;8;8;7;7;7","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;GEOLOGY;GEOGRAPHY;POLITICAL SCIENCE","102;53;29;26;17;15;14;11;10;5;4;3;2;1;1","INTERNAL MEDICINE;PSYCHIATRY;NEUROSCIENCE;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;SURGERY;ARTIFICIAL INTELLIGENCE;BIOCHEMISTRY;AUDIOLOGY;IMMUNOLOGY;PATHOLOGY;GENETICS;CELL BIOLOGY;MECHANICAL ENGINEERING;CLINICAL PSYCHOLOGY;CARDIOLOGY;RADIOLOGY;DEVELOPMENTAL PSYCHOLOGY;OPERATING SYSTEM;PHARMACOLOGY","46;40;35;35;26;18;17;15;14;14;14;13;12;12;11;9;9;8;8;8","COGNITION;DISEASE;REHABILITATION;ELECTROENCEPHALOGRAPHY;STIMULATION;GENE;STROKE (ENGINE);PATTERN RECOGNITION (PSYCHOLOGY);MAGNETIC RESONANCE IMAGING;MULTIPLE SCLEROSIS;CONSCIOUSNESS;ENZYME;RANDOMIZED CONTROLLED TRIAL;GAIT;IN VITRO;MESENCHYMAL STEM CELL;STEM CELL;ANXIETY;DEPRESSION (ECONOMICS);IN VIVO;NEUROIMAGING;RECEPTOR","21;21;19;16;13;12;11;9;8;8;7;7;7;6;6;6;6;5;5;5;5;5","NEUROPSYCHOLOGY;DEMENTIA;PARKINSON'S DISEASE;COGNITIVE IMPAIRMENT;MINIMALLY CONSCIOUS STATE;NEUROREHABILITATION;TRANSCRANIAL MAGNETIC STIMULATION;ALKALINE PHOSPHATASE;AMYOTROPHIC LATERAL SCLEROSIS;COGNITIVE REHABILITATION THERAPY;DIFFUSION MRI;GENE EXPRESSION;WAKEFULNESS;BRAIN–COMPUTER INTERFACE;EXPANDED DISABILITY STATUS SCALE;GAIT TRAINING;NEUROMODULATION;SPINAL CORD INJURY;WHITE MATTER;BECK DEPRESSION INVENTORY;CELL CYCLE;CELLULAR DIFFERENTIATION;CHEMOKINE;CLINICAL ENDPOINT;COGNITIVE TRAINING;EXECUTIVE FUNCTIONS;FUNCTIONAL INDEPENDENCE MEASURE;GENOTYPE;INTRACEREBRAL HEMORRHAGE;MACROPHAGE MIGRATION INHIBITORY FACTOR;MOTOR CORTEX;NEURAL STEM CELL;NEUROINFLAMMATION;NOCICEPTION;PENUMBRA;PI3K/AKT/MTOR PATHWAY;POWERED EXOSKELETON;PROTEIN KINASE B;REGENERATIVE MEDICINE;REVASCULARIZATION;RNA;SIMILARITY (GEOMETRY);STREPTOCOCCUS;TELEMEDICINE;VERBAL MEMORY;VIABILITY ASSAY;WARFARIN","10;8;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PERSISTENT VEGETATIVE STATE;PERIODONTAL LIGAMENT STEM CELLS;FRACTIONAL ANISOTROPY;NEUROPSYCHOLOGICAL ASSESSMENT;VASCULAR DEMENTIA;BACTERIAL ADHESIN;COGNITIVE DECLINE;COGNITIVE DEFICIT;DYSKINESIA;ONCOGENE;STREPTOCOCCUS AGALACTIAE;TELEREHABILITATION;ADENOSINE RECEPTOR;ALTERNATIVE SPLICING;ANTIRETROVIRAL THERAPY;CAREGIVER BURDEN;CD40;CD86;CHEMOKINE RECEPTOR;CLADE;COMPOUND HETEROZYGOSITY;CONGENITAL DIAPHRAGMATIC HERNIA;CORONAVIRUS DISEASE 2019 (COVID-19);CXCR4;DIFFUSION IMAGING;DNA METHYLATION;HEPACIVIRUS;HOUSEKEEPING GENE;INTERFACE (MATTER);LEVODOPA;LIMBIC ENCEPHALITIS;MHC CLASS I;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MIGRAINE WITH AURA;MINIMUM BACTERICIDAL CONCENTRATION;MISSENSE MUTATION;MODIFIED RANKIN SCALE;MOLECULAR EPIDEMIOLOGY;MOTOR IMAGERY;MULTILOCUS SEQUENCE TYPING;MYOTONIA CONGENITA;NESTIN;NITROTYROSINE;NOXIOUS STIMULUS;NS3;PRIMARY MOTOR CORTEX;PYRIN DOMAIN;RIBAVIRIN;RNA INTERFERENCE;RNA SPLICING;SILENT PERIOD;SPONTANEOUS INTRACEREBRAL HEMORRHAGE;TIMI;TRACTOGRAPHY;TRANSCRIPTOME;VERBAL FLUENCY TEST;VIRAL QUASISPECIES;VITRONECTIN","5;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;BRAIN;ADULT;AGED;COGNITIVE DYSFUNCTION;STROKE;PARKINSON DISEASE;ANIMALS;MESENCHYMAL STEM CELLS;MULTIPLE SCLEROSIS;ALZHEIMER DISEASE;CONSCIOUSNESS DISORDERS;ISOTHIOCYANATES;ITALY;BRAIN INJURIES;MAGNETIC RESONANCE IMAGING","71;55;52;41;39;32;28;25;24;22;15;13;12;12;11;11;11;11;10;10","BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BONE TISSUE ENGINEERING AND BIOMATERIALS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;INTEROCEPTION AND SOMATIC SYMPTOMS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;NEURAL MECHANISMS OF LANGUAGE PROCESSING","9;9;6;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","STROKE (ENGINE);DEEP LEARNING FOR EEG;EPILEPSY DETECTION;VIRTUAL REALITY REHABILITATION;EEG ANALYSIS;NEUROIMAGING DATA ANALYSIS;REHABILITATION TECHNIQUES;BRAIN NETWORK DEVELOPMENT;NEUROREHABILITATION;PERSISTENT VEGETATIVE STATE;COGNITIVE REHABILITATION THERAPY;CONSCIOUSNESS;DEPRESSION (ECONOMICS);NEUROMODULATION;NEUROPHYSIOLOGICAL EFFECTS;TRANSCRANIAL DIRECT CURRENT STIMULATION;TREATMENT;BONE REGENERATION;BRAIN-COMPUTER INTERFACES;COGNITIVE DECLINE","11;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;3;3;3","MULTIPLE SCLEROSIS;PARKINSONS DISEASE;COGNITIVE IMPAIRMENT;NEUROLOGICAL DISORDERS;SPINAL CORD;AMYOTROPHIC LATERAL;CLINICAL TRIAL;CORD INJURY;EEG SIGNALS;LATERAL SCLEROSIS;PERIPERSONAL SPACE;PILOT STUDY;RANDOMIZED CLINICAL;STEM CELLS;VIRTUAL REALITY;ACQUIRED BRAIN;ADAPT TECHNIQUE;ALZHEIMERS DISEASE;BONE TISSUE;BRAIN INJURY;COGNITIVE REHABILITATION;DETECTING PERIPERSONAL;EXTRACELLULAR VESICLES;FUNCTIONAL RECOVERY;GAIT TRAINING;GINGIVAL STEM;HIGH-DENSITY EEG;INHIBITORY FACTOR;INTELLECTUAL DISABILITY;MACROPHAGE MIGRATION","8;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","STEM CELLS;MULTIPLE SCLEROSIS;COGNITIVE IMPAIRMENT;EEG SIGNALS;LATERAL TILT;MESENCHYMAL STEM;RISK FACTORS;BONE REGENERATION;D-PLA PEI-EVS;EPITHELIAL CELLS;HYPERBOLIC SPACE;NERVOUS SYSTEM;SPINAL CORD;YEAR-OLD WOMAN;ADVERSE REACTIONS;BONE TISSUE;CENTRAL NERVOUS;EVO ENRICHED;GENES INVOLVED;MOTOR NEURONS;RECOGNITION MEMORY;ROOT AVULSION;BV CELLS;CBG PRE-TREATMENT;COGNITIVE FUNCTION;COGNITIVE TRAINING;CORD INJURY;DISABILITY STATUS;EVOKED POTENTIALS;FEATURE EXTRACTION","13;8;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2.67,148.83,4.55,2,0.33,10.33,0,0,1,0,0,0,0,5,0,5,1,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"Italy","1","42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;32 BIOMEDICAL AND CLINICAL SCIENCES;4207 SPORTS SCIENCE AND EXERCISE;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;36 CREATIVE ARTS AND WRITING;3603 MUSIC;4203 HEALTH SERVICES AND SYSTEMS","4;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BRAIN DISORDERS;REHABILITATION;NEURODEGENERATIVE;PHYSICAL REHABILITATION;BIOENGINEERING;STROKE;AGING;ASSISTIVE TECHNOLOGY;BEHAVIORAL AND SOCIAL SCIENCE;CARDIOVASCULAR;COMPARATIVE EFFECTIVENESS RESEARCH;HEALTH SERVICES;HEART DISEASE;PARKINSON'S DISEASE;PATIENT SAFETY;PEDIATRIC;RARE DISEASES","5;5;5;4;4;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1","STROKE;CARDIOVASCULAR","2;1","6.7 PHYSICAL;6.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS","3;1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;KARGER PUBLISHERS","4;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;44 HUMAN SOCIETY;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;4904 PURE MATHEMATICS;3207 MEDICAL MICROBIOLOGY;4403 DEMOGRAPHY;5202 BIOLOGICAL PSYCHOLOGY;5205 SOCIAL AND PERSONALITY PSYCHOLOGY","4;4;3;3;2;2;1;1;1;1","BRAIN DISORDERS;CHRONIC LIVER DISEASE AND CIRRHOSIS;DEPRESSION;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;HIV/AIDS;INFECTIOUS DISEASES;LIVER DISEASE;MAJOR DEPRESSIVE DISORDER;MENTAL HEALTH;SERIOUS MENTAL ILLNESS","1;1;1;1;1;1;1;1;1;1;1;1;1","INFECTION;MENTAL HEALTH","1;1","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;6.1 PHARMACEUTICALS","1;1",NA,NA,"CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","2;1","LIVER CANCER","1","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_BONINOPULEJO",2019,161,9.55900621118012,4.33540372670808,0.230659025787966,0.546583850931677,0.472049689440994,0.453416149068323,0.577639751552795,1,45,50,25,16,0.28,0.31,0.16,0.1,24.7,1.01583163557797,0.236024844720497,0.782608695652174,4.26243093922651,0.594343076274719,0.475293255131965,0.487516087516087,0.544141914191419,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;ANTONINO NARO;SIMONA PORTARO;ROSARIA DE LUCA;FERDINANDO NICOLETTI;FRANCESCO CORALLO;MARIA SOFIA BASILE;LILLA BONANNO;PAOLO FAGONE;DEMETRIO MILARDI;VIVIANA LO BUONO;ALFREDO MANULI;MARIA CRISTINA PETRALIA;MARIA GRAZIA MAGGIO;GIUSEPPA MARESCA;EUGENIO CAVALLI","53;43;32;30;24;23;21;21;16;15;15;13;13;13;12;12;11;11;10;10","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;ALESSIA BRAMANTI;SILVIA MARINO;ANTONINO NARO;SIMONA PORTARO;ROSARIA DE LUCA;FRANCESCO CARLO MORABITO;FRANCESCO CORALLO;FERDINANDO NICOLETTI;ALFREDO MANULI;NADIA MAMMONE;MARIA SOFIA BASILE;LILLA BONANNO;VIVIANA LO BUONO;PAOLO FAGONE;AGNESE GUGLIANDOLO;DEMETRIO MILARDI;MARIA GRAZIA MAGGIO","6.51;6.11;3.71;3.59;3.11;2.9;2.7;2.45;1.77;1.63;1.58;1.54;1.52;1.48;1.48;1.34;1.29;1.27;1.26;1.25","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;EMANUELA MAZZON;SILVIA MARINO;ANTONINO NARO;SIMONA PORTARO;ROSARIA DE LUCA;FRANCESCO CORALLO;LILLA BONANNO;DEMETRIO MILARDI;VIVIANA LO BUONO;ALFREDO MANULI;MARIA CRISTINA PETRALIA;MARIA GRAZIA MAGGIO;GIUSEPPA MARESCA;EUGENIO CAVALLI;LUANA BILLERI;MARIA CRISTINA DE COLA;AGNESE GUGLIANDOLO","53;43;32;30;24;23;21;21;15;13;13;12;12;11;11;10;10;10;10;9","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;ALESSIA BRAMANTI;SILVIA MARINO;ANTONINO NARO;SIMONA PORTARO;ROSARIA DE LUCA;FRANCESCO CORALLO;ALFREDO MANULI;NADIA MAMMONE;LILLA BONANNO;VIVIANA LO BUONO;AGNESE GUGLIANDOLO;DEMETRIO MILARDI;MARIA GRAZIA MAGGIO;LUANA BILLERI;MARIA CRISTINA DE COLA;MARIA CRISTINA PETRALIA;GIUSEPPA MARESCA","6.51;6.11;3.71;3.59;3.11;2.9;2.7;2.45;1.63;1.54;1.52;1.48;1.34;1.27;1.26;1.25;1.2;1.16;1.14;1.06","PLACIDO BRAMANTI;EMANUELA MAZZON;ALESSIA BRAMANTI;ROCCO SALVATORE CALABRÒ;FERDINANDO NICOLETTI;AGNESE GUGLIANDOLO;ROSARIA DE LUCA;MARIA SOFIA BASILE;DEMETRIO MILARDI;PAOLO FAGONE;ANTONINO NARO;FRANCESCO CARLO MORABITO;SIMONA PORTARO;EUGENIO CAVALLI;NADIA MAMMONE;SANTA MAMMANA;FRANCESCA DIOMEDE;JACOPO PIZZICANNELLA;ALBERTO CACCIOLA;GIUSEPPE ANASTASI","1349;1256;880;824;462;460;445;443;413;380;378;372;365;355;355;345;329;307;302;300","PLACIDO BRAMANTI;EMANUELA MAZZON;ROCCO SALVATORE CALABRÒ;ALESSIA BRAMANTI;AGNESE GUGLIANDOLO;ROSARIA DE LUCA;ANTONINO NARO;DEMETRIO MILARDI;SIMONA PORTARO;NADIA MAMMONE;SANTA MAMMANA;EUGENIO CAVALLI;MARIA CRISTINA PETRALIA;SILVIA MARINO;SERENA SILVESTRO;MARIA GRAZIA MAGGIO;GIUSEPPA MARESCA;LUANA BILLERI;GIUSEPPE DI LORENZO;ALFREDO MANULI","1349;1256;824;703;460;445;378;376;365;355;345;327;281;278;265;245;243;231;196;181","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;ALESSIA BRAMANTI;ANTONINO NARO;ROSARIA DE LUCA;SIMONA PORTARO;SILVIA MARINO;FRANCESCO CORALLO;LILLA BONANNO;DEMETRIO MILARDI;ALFREDO MANULI;VIVIANA LO BUONO;MARIA GRAZIA MAGGIO;MARIA CRISTINA PETRALIA;LUANA BILLERI;GIUSEPPA MARESCA;MARIA CRISTINA DE COLA;AGNESE GUGLIANDOLO;MARIA ACCORINTI","53;43;30;27;23;21;21;21;15;13;12;12;12;11;11;10;10;9;9;9","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;ECONOMICS;MATHEMATICS;PHILOSOPHY;PHYSICS;MATERIALS SCIENCE;SOCIOLOGY;GEOGRAPHY;POLITICAL SCIENCE;ART;BUSINESS;GEOLOGY","133;68;46;30;16;15;14;13;8;8;4;3;2;2;1;1;1","INTERNAL MEDICINE;NEUROSCIENCE;PSYCHIATRY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;PATHOLOGY;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;AUDIOLOGY;RADIOLOGY;CELL BIOLOGY;ARTIFICIAL INTELLIGENCE;CANCER RESEARCH;CLINICAL PSYCHOLOGY;SURGERY;MECHANICAL ENGINEERING;ENVIRONMENTAL HEALTH;PHARMACOLOGY;CARDIOLOGY","60;44;44;43;36;25;21;19;18;17;17;16;14;14;13;13;12;11;11;9","DISEASE;COGNITION;REHABILITATION;GENE;MULTIPLE SCLEROSIS;MAGNETIC RESONANCE IMAGING;ELECTROENCEPHALOGRAPHY;POPULATION;STROKE (ENGINE);IMMUNE SYSTEM;STIMULATION;VIRTUAL REALITY;ANXIETY;HEALTH CARE;IN VITRO;MOOD;APOPTOSIS;CENTRAL NERVOUS SYSTEM;EPILEPSY;RECEPTOR","37;31;29;23;14;13;12;12;12;8;8;8;7;7;7;7;6;6;6;6","NEUROPSYCHOLOGY;PARKINSON'S DISEASE;DOWNREGULATION AND UPREGULATION;NEUROREHABILITATION;DEMENTIA;COGNITIVE REHABILITATION THERAPY;AMYOTROPHIC LATERAL SCLEROSIS;COGNITIVE IMPAIRMENT;TRANSCRANIAL MAGNETIC STIMULATION;ALZHEIMER'S DISEASE;COGNITIVE TRAINING;EXECUTIVE FUNCTIONS;GENE EXPRESSION;MOTOR CORTEX;ALKALINE PHOSPHATASE;BASAL GANGLIA;CANNABIDIOL;DIFFUSION MRI;GAIT TRAINING;GENOTYPE;NEUROBLASTOMA;NOSQL;PHENOTYPE;TEMPORAL LOBE","13;9;8;8;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","PERIODONTAL LIGAMENT STEM CELLS;TRANSCRIPTOME;ANTIRETROVIRAL THERAPY;COGNITIVE DECLINE;DORSOLATERAL PREFRONTAL CORTEX;MIGRAINE WITH AURA;MISSENSE MUTATION;PERSISTENT VEGETATIVE STATE;SOD1;TELEREHABILITATION;TRACTOGRAPHY;UNDERWEIGHT;AKKERMANSIA;ALPHA (FINANCE);AMYLOID PRECURSOR PROTEIN;AUTOIMMUNE THYROIDITIS;BECK ANXIETY INVENTORY;BIFIDOBACTERIUM;CADASIL;CANNABINOID RECEPTOR;CD11C;CD28;CEREBRAL AMYLOID ANGIOPATHY;CEREBRAL VASOSPASM;CLADE;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);CROSSMODAL;CROSSOVER STUDY;DABIGATRAN;DEEP BRAIN STIMULATION;DEEP CEREBELLAR NUCLEI;DIRECT PATHWAY OF MOVEMENT;DNA METHYLATION;EPWORTH SLEEPINESS SCALE;EXCESSIVE DAYTIME SLEEPINESS;EXOME SEQUENCING;FORMOTEROL;FRACTIONAL ANISOTROPY;FRONTOTEMPORAL DEMENTIA;GADOXETIC ACID;GENETIC HETEROGENEITY;GENOTYPE-PHENOTYPE DISTINCTION;GLOBUS PALLIDUS;HEREDITARY SPASTIC PARAPLEGIA;HETEROZYGOTE ADVANTAGE;HIPPOCAMPAL SCLEROSIS;HISTONE DEACETYLASE;IMMUNE CHECKPOINT;INDACATEROL;INDIRECT PATHWAY OF MOVEMENT;INTERNAL TRANSCRIBED SPACER;MHC CLASS I;MITOPHAGY;MOLECULAR EPIDEMIOLOGY;MOTOR SYMPTOMS;MULTILOCUS SEQUENCE TYPING;MUSCARINIC ANTAGONIST;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;MYOTONIA CONGENITA;NEUROPSYCHOLOGICAL ASSESSMENT;OLFACTORY NERVE;ORAL ANTICOAGULANT;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PANCREATIC ISLETS;PERIAQUEDUCTAL GRAY;PERMISSIVENESS;PHENOCOPY;PHONOPHOBIA;PITTSBURGH SLEEP QUALITY INDEX;PRIMARY MOTOR CORTEX;PRODROMAL STAGE;PROPIDIUM IODIDE;PROSTATECTOMY;REFERENCE GENOME;REFSEQ;REVERSE TRANSCRIPTASE;RIVAROXABAN;RUNX2;SENILE PLAQUES;SH-SY5Y;SIDA;SINGLE-NUCLEOTIDE POLYMORPHISM;SLEEP DEBT;SMALL INTERFERING RNA;STREPTOCOCCUS AGALACTIAE;SUPERIOR OLIVARY COMPLEX;SURROUND SUPPRESSION;TAU PROTEIN;TETRAHYDROCANNABINOL;TRINUCLEOTIDE REPEAT EXPANSION;UTILITY COMPUTING;VASCULAR DEMENTIA;VISUAL SPATIAL ATTENTION;VITAMIN K ANTAGONIST;WHOLE GENOME SEQUENCING;ZIDOVUDINE","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;MIDDLE AGED;ADULT;COGNITIVE DYSFUNCTION;MULTIPLE SCLEROSIS;STROKE;AGED;BRAIN;MAGNETIC RESONANCE IMAGING;MELANOMA;NEUROLOGICAL REHABILITATION;TRANSCRIPTOME;ALZHEIMER DISEASE;APHASIA;GENE EXPRESSION REGULATION;ITALY;MESENCHYMAL STEM CELLS","103;71;66;55;43;34;31;29;29;27;24;17;16;16;16;13;13;13;13;13","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;DIFFUSION MAGNETIC RESONANCE IMAGING;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;INTERNET OF THINGS AND EDGE COMPUTING;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;NEURAL BASIS OF SPATIAL NEGLECT AND RECOVERY;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ATRIAL FIBRILLATION;AUTISM SPECTRUM DISORDERS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;IMMUNOBIOLOGY OF DENDRITIC CELLS;MULTIPOTENT MESENCHYMAL STEM CELLS","7;7;7;6;5;5;5;5;4;3;3;3;3;2;2;2;2;2;2;2","STROKE (ENGINE);VIRTUAL REALITY REHABILITATION;EEG ANALYSIS;EPILEPSY DETECTION;NEUROREHABILITATION;COGNITIVE REHABILITATION THERAPY;DEEP LEARNING FOR EEG;BRAIN CONNECTIVITY;MULTIPLE SCLEROSIS;NEUROIMAGING DATA ANALYSIS;REHABILITATION TECHNIQUES;TRANSCRANIAL MAGNETIC STIMULATION;TREATMENT;BRAIN NETWORK DEVELOPMENT;COGNITIVE TRAINING;CORTICAL EXCITABILITY;MOTOR NEURON;NEURODEGENERATION;POST-STROKE DEPRESSION;ANTICOAGULANT THERAPY","12;10;8;8;8;6;6;5;5;5;5;5;5;4;4;4;4;4;4;3","MULTIPLE SCLEROSIS;ALZHEIMERS DISEASE;PILOT STUDY;VIRTUAL REALITY;STEM CELLS;PARKINSONS DISEASE;AMYOTROPHIC LATERAL;BRAIN INJURY;COGNITIVE FUNCTION;COGNITIVE REHABILITATION;HUMAN PERIODONTAL;LATERAL SCLEROSIS;MYOTONIC DYSTROPHY;NETWORK ANALYSIS;ORAL ANTICOAGULANTS;PERIODONTAL LIGAMENT;TRAUMATIC BRAIN;ACQUIRED BRAIN;ATAXIA TIME;ATRIAL FIBRILLATION;AUTISM SPECTRUM;BRAIN INJURIES;BRAIN NETWORK;CARE CONSIDERATIONS;CASE-CONTROL STUDY;CHRONIC STROKE;CITIES COMPARISON;CLINICAL TRIAL;CLINICAL TRIALS;CLOUD-BASED TELE-REHABILITATION","13;7;7;7;6;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","MULTIPLE SCLEROSIS;STEM CELLS;GAIT TRAINING;NERVOUS SYSTEM;SCLEROSIS MS;BOWEL OBSTRUCTION;MAGNETIC RESONANCE;MS PATIENTS;BONE REGENERATION;CENTRAL NERVOUS;GADOBENATE DIMEGLUMINE;GADOXETIC ACID;IMMUNE SYSTEM;NEURODEGENERATIVE DISEASES;RESONANCE IMAGING;COGNITIVE IMPAIRMENT;ESSENTIAL OIL;HEALTHY CONTROLS;HYPOXIA PRECONDITIONING;MESENCHYMAL STEM;RADIATION NECROSIS;SIGNIFICANT IMPROVEMENT;SPINAL CORD;AD PATIENTS;BASAL GANGLIA;CASP FC;COPING STRATEGIES;DIFFERENTIAL DIAGNOSIS;EXPRESSION LEVELS;FOLD CHANGE","12;12;10;10;10;9;9;9;8;8;8;8;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,1,0,0,0,0,0,0,1,1,1,1,6.33333333333333,2.72,1,0,0,3,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BRAMANTI ALESSIA;BRAMANTI PLACIDO;BONANNO LILLA;CAMPOLO MAURIZIO;IERACITANO COSIMO;MAMMONE NADIA;MORABITO FRANCESCO CARLO;ACRI GIUSEPPE;TESTAGROSSA BARBARA;VERMIGLIO GIUSEPPE","3;3;2;2;2;2;2;1;1;1","I R C C S CENTRO NEUROLESI BONINO PULEJO;IRCCS CENTRO NEUROLESI BONINO PULEJO;IRCCS CENTRO NEUROLESI BONINO-PULEJO","1;1;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;51 PHYSICAL SCIENCES","2;1;1;1;1","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BRAIN DISORDERS;CLINICAL RESEARCH;DEMENTIA;NEURODEGENERATIVE","1;1;1;1;1;1;1;1;1;1",NA,NA,"A61B5/00;A61B5/055;A61B6/00;A61B6/03;G01R33/58;G06F","1;1;1;1;1;1","A61B5/369;A61B5/4088;A61B5/7264;G06F18/22;G06F18/231;G06F2218/18;G16H50/20;A61B5/055;A61B6/032;A61B6/583","2;2;2;2;2;2;2;1;1;1",4,2.25,157.5,2.68,3,0.75,31.25,0,0,0,0,1,0,0,3,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;46 INFORMATION AND COMPUTING SCIENCES","2;2;2;1;1;1","CLINICAL RESEARCH;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;AGING;NEURODEGENERATIVE;PARKINSON'S DISEASE;REHABILITATION;PHYSICAL REHABILITATION;STROKE","4;3;3;3;2;2;2;2;1;1","NEUROLOGICAL;STROKE","2;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.6 PSYCHOLOGICAL AND BEHAVIOURAL","2;1;1",NA,NA,NA,NA,1,3287563,657512.6,4,5,4,1,19,164378.15,0.979448910941022,"CENTRO NEUROLESI BONINO PULEJO;JOHANNES KEPLER UNIVERSITY OF LINZ;NATIONAL RESEARCH COUNCIL;VRIJE UNIVERSITEIT BRUSSEL;VTT TECHNICAL RESEARCH CENTRE OF FINLAND","1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.1.2. - EXCELLENT SCIENCE - FUTURE AND EMERGING TECHNOLOGIES (FET) (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1","46 INFORMATION AND COMPUTING SCIENCES;4605 DATA MANAGEMENT AND DATA SCIENCE","1;1","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BRAIN DISORDERS;DEMENTIA;NEURODEGENERATIVE;NEUROSCIENCES","1;1;1;1;1;1;1;1","NEUROLOGICAL","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,"B12 ENGINEERING","1",NA,NA,11,"PUBLIC LIBRARY OF SCIENCE;SCIELO JOURNALS","10;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4905 STATISTICS;5203 CLINICAL AND HEALTH PSYCHOLOGY","11;2;2;2;2;2;1;1;1;1;1;1;1;1","BIOTECHNOLOGY;CLINICAL RESEARCH;GENETICS;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BRAIN DISORDERS;CANCER;DEMENTIA;EYE DISEASE AND DISORDERS OF VISION;HUMAN GENOME;NEURODEGENERATIVE;NEUROSCIENCES;VASCULAR COGNITIVE IMPAIRMENT/DEMENTIA","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1","CLINICAL;BIOMEDICAL","2;1","CLINICAL MEDICINE AND SCIENCE","5","EYE CANCER;MELANOMA","3;3",NA,NA
"IRCCS_BONINOPULEJO",2020,133,9.38345864661654,4.19548872180451,0.238351254480287,0.548872180451128,0.556390977443609,0.518796992481203,0.578947368421053,0,29,48,21,16,0.22,0.36,0.16,0.12,17.03,0.675835078147478,0.233082706766917,0.75187969924812,4.79245283018869,0.598168762994438,0.508424908424908,0.527059896625114,0.446343779677113,"PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;FRANCESCO CORALLO;LILLA BONANNO;EMANUELA MAZZON;SILVIA MARINO;SIMONA PORTARO;ALFREDO MANULI;MARIA GRAZIA MAGGIO;VIVIANA LO BUONO;MASSIMO VILLARI;ANTONIO CELESTI;MARIA FAZIO;MARCELLA DI CARA;SIMONA DE SALVO;ROSARIA DE LUCA;FERDINANDO NICOLETTI;AGNESE GUGLIANDOLO","37;36;21;21;16;16;16;16;14;14;12;11;9;9;8;8;8;8;8;7","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;ALESSIA BRAMANTI;SIMONA PORTARO;EMANUELA MAZZON;ALFREDO MANULI;MASSIMO VILLARI;ANTONIO CELESTI;FRANCESCO CORALLO;LILLA BONANNO;MARIA FAZIO;SILVIA MARINO;MARIA GRAZIA MAGGIO;AGNESE GUGLIANDOLO;ANTONINO GALLETTA;VIVIANA LO BUONO;ROSSELLA SPATARO;VINCENZO LA BELLA;SIMONA DE SALVO","6.1;4.9;3.3;2.41;2.16;2.15;2.01;1.87;1.87;1.77;1.67;1.67;1.61;1.54;1.17;1.17;1.11;0.99;0.99;0.91","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;FRANCESCO CORALLO;LILLA BONANNO;EMANUELA MAZZON;SILVIA MARINO;SIMONA PORTARO;ALFREDO MANULI;MARIA GRAZIA MAGGIO;VIVIANA LO BUONO;MASSIMO VILLARI;MARIA FAZIO;MARCELLA DI CARA;SIMONA DE SALVO;ROSARIA DE LUCA;FERDINANDO NICOLETTI;AGNESE GUGLIANDOLO;PAOLO FAGONE","37;36;21;21;16;16;16;16;14;14;12;11;9;8;8;8;8;8;7;7","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;ALESSIA BRAMANTI;SIMONA PORTARO;EMANUELA MAZZON;ALFREDO MANULI;MASSIMO VILLARI;FRANCESCO CORALLO;LILLA BONANNO;MARIA FAZIO;SILVIA MARINO;MARIA GRAZIA MAGGIO;AGNESE GUGLIANDOLO;ANTONINO GALLETTA;VIVIANA LO BUONO;ROSSELLA SPATARO;SIMONA DE SALVO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA","6.1;4.9;3.3;2.41;2.16;2.15;2.01;1.87;1.77;1.67;1.67;1.61;1.54;1.17;1.17;1.11;0.99;0.91;0.91;0.88","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;ALESSIA BRAMANTI;ANGELO QUARTARONE;PAOLA ORTELLI;ANTONINO NARO;ANTONIO OLIVIERO;DAVIDE FERRAZZOLI;GIACOMO KOCH;ILENIA BONINI;LEOPOLD SALTUARI;LUCA SEBASTIANELLI;MARKUS KOFLER;MICHAEL ENGL;RAFFAELE NARDONE;ROBERTO ROMANELLO;VIVIANA VERSACE;ALFREDO MANULI","548;507;356;316;307;292;285;264;253;253;253;253;253;253;253;253;253;253;253;218","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;ALESSIA BRAMANTI;ANTONINO NARO;ANGELO QUARTARONE;AGNESE GUGLIANDOLO;ALFREDO MANULI;SILVIA MARINO;ROSARIA DE LUCA;ANTONINO CANNAVÒ;MARIA FAZIO;FRANCESCO CORALLO;LILLA BONANNO;CHIARA SORBERA;DÈSIRÉÈ LATELLA;LUIGI CHIRICOSTA;TINA BALLETTA;VIVIANA LO BUONO","548;507;356;310;298;264;258;215;211;203;179;172;172;158;139;136;133;132;129;128","PLACIDO BRAMANTI;ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALESSIA BRAMANTI;FRANCESCO CORALLO;SILVIA MARINO;EMANUELA MAZZON;LILLA BONANNO;SIMONA PORTARO;ALFREDO MANULI;MARIA GRAZIA MAGGIO;VIVIANA LO BUONO;SIMONA DE SALVO;MARIA FAZIO;MARCELLA DI CARA;AGNESE GUGLIANDOLO;ROSELLA CIURLEO;ANTONINO CANNAVÒ;EDOARDO SESSA;LUANA BILLERI","37;36;21;19;17;17;16;16;14;12;11;11;9;8;8;7;7;7;7;7","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;CHEMISTRY;PHYSICS;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;SOCIOLOGY;GEOLOGY;HISTORY;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;MATHEMATICS","113;42;38;24;17;14;10;8;5;5;4;4;3;2;2;2;1;1","INTERNAL MEDICINE;PSYCHIATRY;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;NEUROSCIENCE;PATHOLOGY;SURGERY;NURSING;GENETICS;BIOCHEMISTRY;CLINICAL PSYCHOLOGY;IMMUNOLOGY;RADIOLOGY;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;MACROECONOMICS;MECHANICAL ENGINEERING;AUDIOLOGY;ECONOMIC GROWTH;PEDIATRICS","47;47;37;34;30;29;18;16;15;14;14;11;10;9;9;9;9;8;8;8","DISEASE;REHABILITATION;COGNITION;MULTIPLE SCLEROSIS;QUALITY OF LIFE (HEALTHCARE);GENE;NEUROLOGY;ANXIETY;DEPRESSION (ECONOMICS);STROKE (ENGINE);ELECTROENCEPHALOGRAPHY;HEALTH CARE;MAGNETIC RESONANCE IMAGING;MOOD;CENTRAL NERVOUS SYSTEM;CONSCIOUSNESS;CANNABIS;COHORT;DOPAMINE;GAIT;IMMUNE SYSTEM;NEUROPHYSIOLOGY;OBSERVATIONAL STUDY;RECEPTOR;STIMULATION","30;30;23;15;14;13;12;9;9;9;8;8;7;7;6;6;5;5;5;5;5;5;5;5;5","PARKINSON'S DISEASE;NEUROPSYCHOLOGY;DEMENTIA;GENE EXPRESSION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);COGNITIVE REHABILITATION THERAPY;NEUROREHABILITATION;CANNABIDIOL;GAIT TRAINING;MINIMALLY CONSCIOUS STATE;COGNITIVE IMPAIRMENT;DOPAMINERGIC;WAKEFULNESS;2019-20 CORONAVIRUS OUTBREAK;AMYOTROPHIC LATERAL SCLEROSIS;DIFFUSION MRI;EFFECTS OF SLEEP DEPRIVATION ON COGNITIVE PERFORMANCE;MICRORNA;NEUROMODULATION;NEURORADIOLOGY;TELEMEDICINE;TRANSCRANIAL MAGNETIC STIMULATION","12;8;7;7;7;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);PERSISTENT VEGETATIVE STATE;TRANSCRIPTOME;DEEP BRAIN STIMULATION;FRONTOTEMPORAL DEMENTIA;GENE EXPRESSION PROFILING;GLOBUS PALLIDUS;NEUROPSYCHOLOGICAL ASSESSMENT;PERIODONTAL LIGAMENT STEM CELLS;SUBSTANTIA NIGRA;SYSTEM USABILITY SCALE;TELEREHABILITATION;TERIFLUNOMIDE;TRACTOGRAPHY;AMYLOID PRECURSOR PROTEIN;APOMORPHINE;BECK ANXIETY INVENTORY;BLUETOOTH LOW ENERGY;BREAST RECONSTRUCTION;CAREGIVER BURDEN;CD28;COGNITIVE DECLINE;COGNITIVE RESERVE;CXCR4;CYTOKINESIS;DRY-POWDER INHALER;DYSKINESIA;ENDOTHELIAL PROGENITOR CELL;EXOME SEQUENCING;FEAR OF FALLING;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;FRAMESHIFT MUTATION;GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;GLOMERULOSCLEROSIS;HYDROXYDOPAMINE;IMMUNE CHECKPOINT;INTERFACE (MATTER);IΚBΑ;LEVODOPA;MALLEUS;MEMORY SPAN;MEMORY T CELL;MICROVESICLES;MOLECULAR MEDICINE;MONTREAL COGNITIVE ASSESSMENT;MYELIN BASIC PROTEIN;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;MYOD;MYOTONIA CONGENITA;NEUROGRANIN;NON-CODING RNA;ONCOGENE;PRIMARY MOTOR CORTEX;PROMOTER;PULMONARY REGURGITATION;PYROELECTRICITY;RUNX2;SACUBITRIL;SACUBITRIL, VALSARTAN;SENILE PLAQUES;SILENT PERIOD;SPECKLE TRACKING ECHOCARDIOGRAPHY;SPIRAL LIGAMENT;STROKE VOLUME;SUBEPENDYMAL GIANT CELL ASTROCYTOMA;TELEHEALTH;TRAIL MAKING TEST;TRANSLATION (BIOLOGY);TRPV1;VERBAL FLUENCY TEST","7;5;5;4;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;MULTIPLE SCLEROSIS;QUALITY OF LIFE;ADULT;STROKE;BRAIN;COGNITIVE DYSFUNCTION;ITALY;AGED;COVID-19;EXERCISE THERAPY;MAGNETIC RESONANCE IMAGING;PARKINSON DISEASE;STROKE REHABILITATION;ALZHEIMER DISEASE;ROBOTICS","81;51;31;31;22;22;20;19;18;15;14;13;12;11;11;11;10;10;8;8","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BLOCKCHAIN AND INTERNET OF THINGS INTEGRATION;BONE TISSUE ENGINEERING AND BIOMATERIALS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MECHANISMS OF ALZHEIMER'S DISEASE;ROLE OF MICROGLIA IN NEUROLOGICAL DISORDERS;TELEMEDICINE IN GLOBAL HEALTHCARE;TREATMENT AND MECHANISMS OF COMPLEX PAIN SYNDROMES","10;7;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","STROKE (ENGINE);DEPRESSION (ECONOMICS);VIRTUAL REALITY REHABILITATION;NEUROREHABILITATION;COGNITIVE REHABILITATION THERAPY;GAIT TRAINING;NEUROPHYSIOLOGY;PERSISTENT VEGETATIVE STATE;REHABILITATION;REHABILITATION TECHNIQUES;2019-20 CORONAVIRUS OUTBREAK;BRAIN CONNECTIVITY;CONSCIOUSNESS;NEURODEGENERATION;NEUROMODULATION;NEUROSTIMULATION;POST-STROKE DEPRESSION;REMOTE TREATMENT;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION","9;8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","MULTIPLE SCLEROSIS;PARKINSONS DISEASE;PILOT STUDY;CHRONIC STROKE;GAIT TRAINING;SPINAL CORD;TRANSCRIPTOMIC ANALYSIS;ALZHEIMERS DISEASE;CHRONIC DISORDERS;CORD STIMULATION;EXTRACELLULAR VESICLES;INNOVATION TECHNOLOGY;MOTOR OUTCOMES;STEM CELLS;AMYOTROPHIC LATERAL;ASSISTED THERAPY;AVOID PATIENT;BRAIN INJURY;BRAIN STIMULATION;CLINICAL STUDY;COGNITIVE IMPAIRMENT;COMPARATIVE STUDY;DEEP BRAIN;DISEASE PATIENTS;EXPLORATORY STUDY;EXPRESSION LEVELS;GLOBUS PALLIDUS;HUMAN PERIODONTAL;LATERAL SCLEROSIS;LIGAMENT STEM","15;8;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PD PATIENTS;MULTIPLE SCLEROSIS;DISCOMALLEOLAR LIGAMENT;MGKG IP;ALS PATIENTS;CONVENTIONAL PHYSIOTHERAPY;DISEASE PD;FACE-TO-FACE COGNITIVE;FUNCTIONAL OUTCOME;HEALTHY SUBJECTS;ISCHEMIC STROKE;PARKINSONS DISEASE;COGNITIVE IMPAIRMENT;DOPAMINERGIC MIDBRAIN;NERVOUS SYSTEM;SIGNIFICANT IMPROVEMENT;SPINAL CORD;STEM CELLS;VMT RESOLUTION;AIR POLLUTION;CHRONIC PAIN;COGNITIVE PERFORMANCE;COGNITIVE REHABILITATION;COGNITIVE TREATMENT;COGNITIVE VRRS;DUAL-TASK COSTS;FUNCTIONAL INDEPENDENCE;FUTURE STUDIES;GLOBUS PALLIDUS;INTENSIVE REHABILITATION","11;10;8;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4",1,0.01,10.25,22,1,0,0,0,0,0,0,25,0,0,21,0,0,4,5,5,7,0,0,46,46,3,0,0,2,1,1,0,0,0,0,0,0,2,1,1,1,7,5.02,1.25,0,1,3,0,0,2,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BRAMANTI ALESSIA;BRAMANTI PLACIDO;ACRI GIUSEPPE;TESTAGROSSA BARBARA;VERMIGLIO GIUSEPPE;CIURLEO ROSELLA;COSTA STEFANO;MARINO SILVIA;BONANNO LILLA;CAMPOLO MAURIZIO","4;4;3;3;3;2;2;2;1;1","IRCCS CENTRO NEUROLESI ""BONINO PULEJO"";IRCCS CENTRO NEUROLESI BONINO PULEJO;I R C C S CENTRO NEUROLESI BONINO PULEJO","2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;40 ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS","3;2;2;1;1","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CLINICAL RESEARCH;DEMENTIA;NEURODEGENERATIVE;NEUROSCIENCES","1;1;1;1;1;1;1;1;1;1",NA,NA,"A61B5/00;A61B5/055;A61B6/00;A61B6/03;G01J3/44;G01N21/65;G01N33/48;G01R33/58","1;1;1;1;1;1;1;1","G01N21/65;G01N2201/06113;G01N2800/24;G01N33/564;G01N33/6893;A61B5/055;A61B5/369;A61B5/4088;A61B5/7264;A61B6/032","2;2;2;2;2;1;1;1;1;1",5,3,54.8,2.96,2,0.4,14.8,0,0,0,0,1,0,0,4,0,4,1,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;3209 NEUROSCIENCES;46 INFORMATION AND COMPUTING SCIENCES","4;3;2;2;2;1;1","NEUROSCIENCES;AGING;BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEURODEGENERATIVE;REHABILITATION;PARKINSON'S DISEASE;PHYSICAL REHABILITATION;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CHRONIC PAIN;PAIN RESEARCH;PERIPHERAL NEUROPATHY;STROKE","4;3;3;3;3;3;3;2;2;1;1;1;1;1;1","NEUROLOGICAL;STROKE","2;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;6.7 PHYSICAL","1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS","8;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3202 CLINICAL SCIENCES;3203 DENTISTRY;4202 EPIDEMIOLOGY","4;2;2;1;1;1;1","STEM CELL RESEARCH;BIOTECHNOLOGY;DENTAL/ORAL AND CRANIOFACIAL DISEASE;GENETICS;REGENERATIVE MEDICINE","2;1;1;1;1","MUSCULOSKELETAL","1",NA,NA,"BIOMEDICAL","2","BASIC SCIENCE;PUBLIC HEALTH","1;1","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_BONINOPULEJO",2021,106,12.3018867924528,3.90566037735849,0.256038647342995,0.471698113207547,0.462264150943396,0.660377358490566,0.641509433962264,2,28,25,15,10,0.26,0.24,0.14,0.09,9.8,0.635631294724668,0.169811320754717,0.764150943396226,4.97014925373135,0.6134333299823,0.46034188034188,0.4145,0.489337822671156,"ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;MARIA GRAZIA MAGGIO;FRANCESCO CORALLO;EMANUELA MAZZON;ALESSIA BRAMANTI;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;SILVIA MARINO;LILLA BONANNO;LUIGI CHIRICOSTA;ROSELLA CIURLEO;ALFREDO MANULI;AGNESE GUGLIANDOLO;CARMELA RIFICI;CATERINA FORMICA;GLÓRIA PELIZZO;VIVIANA LO BUONO;MARCELLA DI CARA","33;28;18;14;13;13;12;12;11;11;10;9;9;8;7;7;6;6;6;6","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;MARIA GRAZIA MAGGIO;EMANUELA MAZZON;FRANCESCO CORALLO;ROSARIA DE LUCA;ALESSIA BRAMANTI;MARIA CRISTINA DE COLA;ALFREDO MANULI;LUIGI CHIRICOSTA;SILVIA MARINO;LILLA BONANNO;ROSELLA CIURLEO;AGNESE GUGLIANDOLO;SERENA SILVESTRO;CARMELA RIFICI;LOREDANA RACITI;VIVIANA LO BUONO;SIMONA PORTARO","6.72;3.06;2.66;1.86;1.64;1.45;1.38;1.3;1.28;1.2;1.1;1;0.95;0.93;0.91;0.73;0.7;0.68;0.67;0.65","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;MARIA GRAZIA MAGGIO;FRANCESCO CORALLO;EMANUELA MAZZON;ALESSIA BRAMANTI;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;SILVIA MARINO;LILLA BONANNO;LUIGI CHIRICOSTA;ROSELLA CIURLEO;ALFREDO MANULI;AGNESE GUGLIANDOLO;CARMELA RIFICI;CATERINA FORMICA;VIVIANA LO BUONO;MARCELLA DI CARA;SIMONA DE SALVO","33;28;18;14;13;13;12;12;11;11;10;9;9;8;7;7;6;6;6;6","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;MARIA GRAZIA MAGGIO;EMANUELA MAZZON;FRANCESCO CORALLO;ROSARIA DE LUCA;ALESSIA BRAMANTI;MARIA CRISTINA DE COLA;ALFREDO MANULI;LUIGI CHIRICOSTA;SILVIA MARINO;LILLA BONANNO;ROSELLA CIURLEO;AGNESE GUGLIANDOLO;SERENA SILVESTRO;CARMELA RIFICI;LOREDANA RACITI;VIVIANA LO BUONO;SIMONA PORTARO","6.72;3.06;2.66;1.86;1.64;1.45;1.38;1.3;1.28;1.2;1.1;1;0.95;0.93;0.91;0.73;0.7;0.68;0.67;0.65","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ANTONINO NARO;MARIA GRAZIA MAGGIO;ROSARIA DE LUCA;ALESSIA BRAMANTI;EMANUELA MAZZON;LUIGI CHIRICOSTA;ROSELLA CIURLEO;MARCO FRANCESCHINI;AGNESE GUGLIANDOLO;MICHELE TORRISI;FRANCO MOLTENI;MICHELA GOFFREDO;ALFREDO MANULI;MARIA CRISTINA DE COLA;ALBERTO LO GULLO;SERENA FILONI;FRANCESCA ANTONIA ARCADI;FRANCESCO FISICARO","422;252;210;181;156;149;126;98;97;94;90;86;85;82;81;79;74;71;68;66","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;ROSARIA DE LUCA;ANTONINO NARO;ALESSIA BRAMANTI;EMANUELA MAZZON;LUIGI CHIRICOSTA;ROSELLA CIURLEO;AGNESE GUGLIANDOLO;MICHELE TORRISI;MARIA CRISTINA DE COLA;ALBERTO LO GULLO;FRANCESCA ANTONIA ARCADI;MARIA GRAZIA MAGGIO;VINCENZO CIMINO;SILVIA MARINO;BRUNO PORCARI;LILLA BONANNO;SERENA SILVESTRO;SIMONA LEONARDI","422;252;156;136;128;126;98;97;90;81;78;74;68;66;62;57;54;53;51;49","ROCCO SALVATORE CALABRÒ;PLACIDO BRAMANTI;EMANUELA MAZZON;ANTONINO NARO;FRANCESCO CORALLO;ROSARIA DE LUCA;SILVIA MARINO;LILLA BONANNO;MARIA CRISTINA DE COLA;ALESSIA BRAMANTI;LUIGI CHIRICOSTA;ROSELLA CIURLEO;CARMELA RIFICI;AGNESE GUGLIANDOLO;CATERINA FORMICA;MICHELE TORRISI;VIVIANA LO BUONO;ALBERTO LO GULLO;SIMONA DE SALVO;CLEMENTE GIUFFRIDA","33;28;13;13;13;12;12;10;10;10;9;9;7;7;6;6;6;6;6;6","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;PHYSICS;SOCIOLOGY;PHILOSOPHY;MATERIALS SCIENCE;MATHEMATICS;BUSINESS;CHEMISTRY","100;36;27;18;14;10;10;8;5;3;2;2;1;1","INTERNAL MEDICINE;PSYCHIATRY;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;PATHOLOGY;NEUROSCIENCE;SURGERY;CLINICAL PSYCHOLOGY;MECHANICAL ENGINEERING;NURSING;GENETICS;LAW;IMMUNOLOGY;ANESTHESIA;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;ARTIFICIAL INTELLIGENCE;BIOINFORMATICS;ENVIRONMENTAL HEALTH;OPTICS","52;42;35;31;26;19;18;14;13;13;12;10;9;8;8;7;6;6;6;6","REHABILITATION;DISEASE;COGNITION;ANXIETY;STROKE (ENGINE);GENE;MOOD;QUALITY OF LIFE (HEALTHCARE);ALTERNATIVE MEDICINE;MULTIPLE SCLEROSIS;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;GAIT;HEALTH CARE;VIRTUAL REALITY;CONSCIOUSNESS;ELECTROENCEPHALOGRAPHY;INFLAMMATION;POPULATION;CELL;COMA (OPTICS);DEPRESSION (ECONOMICS);EXOSKELETON;OUTBREAK","33;28;19;13;13;12;9;8;7;7;7;7;6;6;6;5;5;5;5;4;4;4;4;4","NEUROREHABILITATION;NEUROPSYCHOLOGY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);GENE EXPRESSION;COGNITIVE REHABILITATION THERAPY;DEMENTIA;PARKINSON'S DISEASE;2019-20 CORONAVIRUS OUTBREAK;DOWNREGULATION AND UPREGULATION;GAIT TRAINING;MINIMALLY CONSCIOUS STATE;POWERED EXOSKELETON;TELEMEDICINE;ACQUIRED BRAIN INJURY;COGNITIVE TRAINING;CONSCIOUSNESS DISORDERS;ALZHEIMER'S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS;ANTIDEPRESSANT;BRAIN–COMPUTER INTERFACE;COCHRANE LIBRARY;COGNITIVE IMPAIRMENT;CROSSBITE;FINGOLIMOD;FUNCTIONAL ELECTRICAL STIMULATION;NEUROINFLAMMATION;PREFRONTAL CORTEX;SPINAL CORD INJURY;SYSTEMATIC REVIEW;WAKEFULNESS;WARFARIN;WATER INTOXICATION;WHITE MATTER","13;10;9;8;6;5;5;4;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);TRANSCRIPTOME;PERSISTENT VEGETATIVE STATE;CAREGIVER BURDEN;TELEHEALTH;TELEREHABILITATION;TERIFLUNOMIDE;TRACTOGRAPHY;AGRAPHIA;BOSTON NAMING TEST;CELL CYCLE CHECKPOINT;CHEMOKINE RECEPTOR;CHILD ABUSE;CLINICAL PHENOTYPE;COGNITIVE DECLINE;COGNITIVE DEFICIT;DEEP BRAIN STIMULATION;DORSOLATERAL PREFRONTAL CORTEX;DYSKINESIA;ENALAPRIL;EPLERENONE;EXOME SEQUENCING;FIBROMUSCULAR DYSPLASIA;FUNCTIONAL NEAR-INFRARED SPECTROSCOPY;GENE EXPRESSION PROFILING;GERIATRIC DEPRESSION SCALE;HEART DEVELOPMENT;INTERNAL CAPSULE;KLEBSIELLA PNEUMONIAE;KNEE PAIN;KRAS;LEVODOPA;LOSARTAN;LOW LEVEL LASER THERAPY;MICROARRAY;MICROCHIMERISM;MICROVESICLES;MONOAMINE NEUROTRANSMITTER;MONOAMINE OXIDASE A;MONOAMINE OXIDASE B;MONTREAL COGNITIVE ASSESSMENT;MOTOR IMAGERY;NRF1;ORAL ANTICOAGULANT;PDGFRA;REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;SEROTONIN REUPTAKE INHIBITOR;TAKAYASU ARTERITIS;TLR2;VERTEPORFIN","9;8;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;COVID-19;FEMALE;MALE;SARS-COV-2;MIDDLE AGED;AGED;BRAIN;COGNITION;DEPRESSION;STROKE;TRANSCRIPTOME;ALZHEIMER DISEASE;PERSISTENT VEGETATIVE STATE;ANXIETY;CHRONIC PAIN;CONSCIOUSNESS DISORDERS;GENE EXPRESSION PROFILING;NEURONS","59;47;30;21;20;18;14;12;11;9;9;9;9;8;8;7;7;7;7;7","PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF TEMPOROMANDIBULAR DISORDERS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ATRIAL FIBRILLATION;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GLOBAL BURDEN OF CHRONIC PAIN;IMPACT OF COVID-19 ON MENTAL HEALTH;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;NEURAL MECHANISMS OF LANGUAGE PROCESSING;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;TELEMEDICINE IN GLOBAL HEALTHCARE;ADVANCED CRYPTOGRAPHIC SCHEMES AND PROTOCOLS;ADVANCED TECHNIQUES IN BIOIMAGE ANALYSIS AND MICROSCOPY;AGE-RELATED MACULAR DEGENERATION RESEARCH","10;7;7;6;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1","NEUROREHABILITATION;STROKE (ENGINE);VIRTUAL REALITY REHABILITATION;ROBOT-ASSISTED THERAPY;COGNITIVE REHABILITATION THERAPY;REHABILITATION;REHABILITATION TECHNIQUES;COMA (OPTICS);DEPRESSION (ECONOMICS);GAIT TRAINING;MOTOR RECOVERY;NEUROINFLAMMATION;PANDEMIC;PERSISTENT VEGETATIVE STATE;POWERED EXOSKELETON;TELEHEALTH;2019-20 CORONAVIRUS OUTBREAK;ACQUIRED BRAIN INJURY;CAREGIVER BURDEN;COGNITIVE TRAINING","13;12;11;8;6;6;6;4;4;4;4;4;4;4;4;4;3;3;3;3","MULTIPLE SCLEROSIS;VIRTUAL REALITY;BRAIN INJURY;EXPLORATORY STUDY;RETROSPECTIVE STUDY;TRANSCRIPTOMIC ANALYSIS;ALZHEIMERS DISEASE;COGNITIVE RECOVERY;PILOT STUDY;STUDY FOCUSING;ACQUIRED BRAIN;OBSERVATIONAL STUDY;UPPER LIMB;ALLEGED MALPRACTICE;AMYOTROPHIC LATERAL;ANALYSIS DUE;CAREGIVERS BURDEN;CASE-CONTROL STUDY;CHIROPRATIC PRESCRIPTION;COMMON PATHOGENETIC;CONTROLLED TRIAL;CORD INJURY;COVID- PANDEMIC;DETECT ALZHEIMERS;DIABETES MELLITUS;DISEASE BIOMARKERS;FET-OPEN PROJECT;IMPROVING COGNITIVE;LATERAL SCLEROSIS;MASSETER MUSCLE","9;6;5;5;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MD PHD;RATING SCALE;ACQUIRED BRAIN;CELL CYCLE;SARS-COV- INFECTION;CHRONIC PAIN;MUSCLE ACTIVATION;NEUROLOGICAL HEALTH;RESEARCH CENTRE;RESEARCH INSTITUTE;SIGNIFICANT DIFFERENCES;TNF-Α ANTAGONISTS;AD PATIENTS;ANKLE REHABILITATION;CENTRE MOLECULAR;CLINICAL SCIENCES;COVID- PANDEMIC;ENTERAL NUTRITION;GEORGES UNIVERSITY;INSTITUTE ST;LONDON UNITED;NEUROSCIENCES RESEARCH;SCIENCES RESEARCH;SEVERE ACQUIRED;ST GEORGES;STROKE PATIENTS;THALAMIC NUCLEI;ALZHEIMERS DISEASE;BRAIN INJURIES;CD CELLS","16;10;9;9;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5",1,0.01,0.5,2,0,0,0,0,0,0,0,2,0,0,2,0,0,1,0,1,0,0,0,32,32,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,7,1.69,2,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BONANNO LILLA;BRAMANTI ALESSIA;BRAMANTI PLACIDO;CAMPOLO MAURIZIO;IERACITANO COSIMO;MAMMONE NADIA;MORABITO FRANCESCO CARLO","1;1;1;1;1;1;1","IRCCS CENTRO NEUROLESI ""BONINO- PULEJO"";IRCCS CENTRO NEUROLESI ""BONINO-PULEJO""","1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;1","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CLINICAL RESEARCH;DEMENTIA;MENTAL HEALTH;NEURODEGENERATIVE","1;1;1;1;1;1;1;1;1;1",NA,NA,"A61B5/00;G06K9/00;G06K9/62;G16H50/20","1;1;1;1","A61B5/0476;A61B5/369;A61B5/4088;A61B5/7264;G06F18/22;G06F18/231;G06F2218/18;G06K9/00557;G06K9/6215;G06K9/6219","1;1;1;1;1;1;1;1;1;1",3,3,127.33,2.33,3,1,2,0,0,0,0,0,0,0,3,0,1,2,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4207 SPORTS SCIENCE AND EXERCISE;52 PSYCHOLOGY","3;2;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;NEURODEGENERATIVE;NEUROSCIENCES;MULTIPLE SCLEROSIS;AGING;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;OSTEOPOROSIS;PHYSICAL REHABILITATION;REHABILITATION;SLEEP RESEARCH;SPINAL CORD INJURY","3;3;3;3;2;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;MUSCULOSKELETAL","3;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.7 PHYSICAL","1;1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,"PUBLIC LIBRARY OF SCIENCE;ZENODO;SPRINGER NATURE","6;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;50 PHILOSOPHY AND RELIGIOUS STUDIES;3208 MEDICAL PHYSIOLOGY;37 EARTH SCIENCES;44 HUMAN SOCIETY;4403 DEMOGRAPHY;46 INFORMATION AND COMPUTING SCIENCES;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","8;3;2;1;1;1;1;1;1",NA,NA,"NEUROLOGICAL","2",NA,NA,"CLINICAL","2","CLINICAL MEDICINE AND SCIENCE","4","CERVICAL CANCER","2",NA,NA
"IRCCS_BONINOPULEJO",2022,91,9.37362637362637,3.91208791208791,0.25561797752809,0.593406593406593,0.626373626373626,0.472527472527473,0.747252747252747,3,22,15,3,17,0.24,0.16,0.03,0.19,6.77,0.758303574627681,0.21978021978022,0.736263736263736,4.9054054054054,0.564644754652137,0.508768472906404,0.483153210425938,0.481461286804798,"ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;VIVIANA LO BUONO;EMANUELA MAZZON;ANTONINO NARO;LILLA BONANNO;MARIA CRISTINA DE COLA;MARIA GRAZIA MAGGIO;LUIGI CHIRICOSTA;ALFREDO MANULI;ALESSIA BRAMANTI;ROSARIA DE LUCA;AGNESE GUGLIANDOLO;DÈSIRÉÈ LATELLA;MIRJAM BONANNO;SILVIA MARINO;ANGELO QUARTARONE;GIUSEPPA MARESCA;CATERINA FORMICA;FRANCESCA CUCINOTTA","37;17;12;12;12;11;10;9;8;8;8;8;7;7;6;6;6;5;5;5","ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;ANTONINO NARO;EMANUELA MAZZON;VIVIANA LO BUONO;LUIGI CHIRICOSTA;LILLA BONANNO;MARIA CRISTINA DE COLA;ROSARIA DE LUCA;ALFREDO MANULI;MARIA GRAZIA MAGGIO;AGNESE GUGLIANDOLO;NICOLA FIORENTE;LORIS PIGNOLO;MIRJAM BONANNO;ALESSIA BRAMANTI;LOREDANA RACITI;DÈSIRÉÈ LATELLA;ANGELO QUARTARONE;SIMONE D’ANGIOLINI","9.05;2.43;2.04;1.77;1.72;1.4;1.39;1.23;1.21;1.16;1.08;1.02;1;0.99;0.89;0.85;0.79;0.76;0.7;0.69","ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;VIVIANA LO BUONO;EMANUELA MAZZON;ANTONINO NARO;LILLA BONANNO;MARIA CRISTINA DE COLA;MARIA GRAZIA MAGGIO;LUIGI CHIRICOSTA;ALFREDO MANULI;ALESSIA BRAMANTI;ROSARIA DE LUCA;AGNESE GUGLIANDOLO;DÈSIRÉÈ LATELLA;MIRJAM BONANNO;SILVIA MARINO;ANGELO QUARTARONE;GIUSEPPA MARESCA;CATERINA FORMICA;FRANCESCA CUCINOTTA","37;17;12;12;12;11;10;9;8;8;8;8;7;7;6;6;6;5;5;5","ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;ANTONINO NARO;EMANUELA MAZZON;VIVIANA LO BUONO;LUIGI CHIRICOSTA;LILLA BONANNO;MARIA CRISTINA DE COLA;ROSARIA DE LUCA;ALFREDO MANULI;MARIA GRAZIA MAGGIO;AGNESE GUGLIANDOLO;NICOLA FIORENTE;MIRJAM BONANNO;ALESSIA BRAMANTI;LOREDANA RACITI;DÈSIRÉÈ LATELLA;ANGELO QUARTARONE;SIMONE D’ANGIOLINI;CARMELA RIFICI","9.05;2.43;2.04;1.77;1.72;1.4;1.39;1.23;1.21;1.16;1.08;1.02;1;0.89;0.85;0.79;0.76;0.7;0.69;0.68","ROCCO SALVATORE CALABRÒ;MARIA CRISTINA DE COLA;ANGELO QUARTARONE;ANTONINO NARO;GIAN LUCA VITA;GIUSEPPE VITA;LORENZO MAGGI;ADNAN MANZUR;ANDREA GANGFUß;ANNE‐MARIE CHILDS;ASHUTOSH KUMAR;BARBARA E. HERR;BASIL T. DARRAS;CHRIS SPEED;CRAIG CAMPBELL;CRAIG M. MCDONALD;EKKEHARD WILICHOWSKI;ELAINE MCCOLL;ELENA PEGORARO;EMMA CIAFALONI","219;93;88;74;71;70;69;68;68;68;68;68;68;68;68;68;68;68;68;68","ROCCO SALVATORE CALABRÒ;MARIA CRISTINA DE COLA;ANGELO QUARTARONE;GIAN LUCA VITA;ROSARIA DE LUCA;FRANCESCO CORALLO;EMANUELA MAZZON;LUIGI CHIRICOSTA;MIRJAM BONANNO;SIMONA DE SALVO;DÈSIRÉÈ LATELLA;AGNESE GUGLIANDOLO;GIUSEPPA MARESCA;CARMELA RIFICI;ANGELO CAMINITI;ANTONINO NARO;PATRIZIA POLLICINO;ROSELLA CIURLEO;LOREDANA RACITI;FRANCESCA CUCINOTTA","219;93;85;71;64;60;58;45;44;44;40;35;35;34;33;33;33;30;29;28","ROCCO SALVATORE CALABRÒ;FRANCESCO CORALLO;EMANUELA MAZZON;VIVIANA LO BUONO;LILLA BONANNO;MARIA CRISTINA DE COLA;LUIGI CHIRICOSTA;ANTONINO NARO;ROSARIA DE LUCA;AGNESE GUGLIANDOLO;DÈSIRÉÈ LATELLA;CARMELA RIFICI;MIRJAM BONANNO;FRANCESCA CUCINOTTA;GIUSEPPA MARESCA;ROSELLA CIURLEO;SILVIA MARINO;CATERINA FORMICA;ANDREA VALERI;ANGELO CAMINITI","37;17;12;11;10;10;8;7;7;7;7;6;6;5;5;5;5;5;4;4","MEDICINE;PSYCHOLOGY;COMPUTER SCIENCE;BIOLOGY;PHYSICS;ECONOMICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;POLITICAL SCIENCE;BUSINESS;MATHEMATICS;PHILOSOPHY;SOCIOLOGY;ART;ENVIRONMENTAL SCIENCE;GEOGRAPHY","86;30;22;17;10;9;7;6;4;4;3;3;2;2;1;1;1","PSYCHIATRY;PHYSICAL THERAPY;INTERNAL MEDICINE;PHYSICAL MEDICINE AND REHABILITATION;PATHOLOGY;NEUROSCIENCE;CLINICAL PSYCHOLOGY;ARTIFICIAL INTELLIGENCE;SURGERY;RADIOLOGY;NURSING;BIOINFORMATICS;IMMUNOLOGY;PEDIATRICS;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GENETICS;HUMAN–COMPUTER INTERACTION;MACROECONOMICS;CELL BIOLOGY;MECHANICAL ENGINEERING;OPTICS;PHARMACOLOGY","38;36;35;31;23;19;13;12;12;11;10;7;7;7;6;6;6;6;6;5;5;5;5","REHABILITATION;DISEASE;COGNITION;MAGNETIC RESONANCE IMAGING;ANXIETY;GAIT;QUALITY OF LIFE (HEALTHCARE);VIRTUAL REALITY;DEPRESSION (ECONOMICS);GENE;RANDOMIZED CONTROLLED TRIAL;COHORT;PATTERN RECOGNITION (PSYCHOLOGY);POPULATION;RECEPTOR;STIMULATION;CEREBRAL PALSY;HEALTH CARE;MOOD;MULTIPLE SCLEROSIS;STROKE (ENGINE)","28;25;18;9;8;8;8;8;6;6;6;5;5;5;5;5;4;4;4;4;4","INFECTIOUS DISEASE (MEDICAL SPECIALTY);NEUROREHABILITATION;NEUROPSYCHOLOGY;DEMENTIA;GAIT TRAINING;PARKINSON'S DISEASE;AGONIST;GENE EXPRESSION;AUTISM SPECTRUM DISORDER;COGNITIVE REHABILITATION THERAPY;DIFFUSION MRI;SPINAL CORD INJURY;TRANSCRANIAL MAGNETIC STIMULATION;WHITE MATTER;2019-20 CORONAVIRUS OUTBREAK;ALZHEIMER'S DISEASE;APATHY;ATAXIC GAIT;BIG FIVE PERSONALITY TRAITS;CANNABINOID;ELECTROHYDRODYNAMICS;FETUS;HUMAN CONNECTOME PROJECT;HUNTINGTON'S DISEASE;MINIMALLY CONSCIOUS STATE;NEURODEVELOPMENTAL DISORDER;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;SPASTIC;SYNOVIAL SARCOMA","9;9;8;6;6;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);CANNABINOID RECEPTOR;TRANSCRIPTOME;COGNITIVE DECLINE;DEEP BRAIN STIMULATION;PERSISTENT VEGETATIVE STATE;TRACTOGRAPHY;CARDIAC RESYNCHRONIZATION THERAPY;CHILDHOOD OBESITY;CILIOPATHIES;CILIOPATHY;CLINICAL GLOBAL IMPRESSION;CONGENITAL DIAPHRAGMATIC HERNIA;ENHANCER;EXECUTIVE DYSFUNCTION;EXTRAVERSION AND INTROVERSION;FUNCTIONAL NEAR-INFRARED SPECTROSCOPY;INTERFACE (MATTER);JC VIRUS;LIMBIC ENCEPHALITIS;NEPHRONOPHTHISIS;NEUROPSYCHOLOGICAL ASSESSMENT;PERIODONTAL LIGAMENT STEM CELLS;PERSONALITY PATHOLOGY;PERVASIVE DEVELOPMENTAL DISORDER;PHENYLPYRUVIC ACID;RASAGILINE;SELEGILINE;SILENT PERIOD;SPASTIC CEREBRAL PALSY;SUICIDAL IDEATION;TAKOTSUBO SYNDROME;TELECARE;VENTRICULOMEGALY","9;4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;COVID-19;FEMALE;MALE;MULTIPLE SCLEROSIS;GAIT;QUALITY OF LIFE;ALZHEIMER DISEASE;BRAIN;CEREBRAL PALSY;PARKINSON DISEASE;SLEEP WAKE DISORDERS;ADULT;COGNITIVE DYSFUNCTION;COGNITION;MAGNETIC RESONANCE IMAGING;WHITE MATTER;CANNABINOIDS;CHILD","49;39;14;11;10;9;8;8;7;7;7;7;7;6;6;5;5;5;4;4","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;IMPACT OF COVID-19 ON MENTAL HEALTH;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;AUTISM SPECTRUM DISORDERS;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIFFUSION MAGNETIC RESONANCE IMAGING;ELECTROHYDRODYNAMIC JET PRINTING AND NANOPARTICLE ENCAPSULATION;PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1","NEUROREHABILITATION;VIRTUAL REALITY REHABILITATION;DEPRESSION (ECONOMICS);GAIT TRAINING;NEUROIMAGING DATA ANALYSIS;REHABILITATION;PANDEMIC;PSYCHOLOGICAL IMPACT;REHABILITATION TECHNIQUES;CANNABINOID RECEPTORS;CANNABIS USE;CEREBRAL PALSY;COGNITIVE REHABILITATION THERAPY;CONSTRAINT-INDUCED THERAPY;MENTAL HEALTH;PANDEMICS;PSYCHOLOGICAL DISTRESS;ROBOT-ASSISTED THERAPY;STROKE (ENGINE);AFFECT (LINGUISTICS)","10;9;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2","PILOT STUDY;VIRTUAL REALITY;BRAIN INJURY;GAIT TRAINING;CEREBRAL PALSY;CLINICAL TRIAL;COGNITIVE REHABILITATION;HUNTINGTONS DISEASE;MULTIPLE SCLEROSIS;PARKINSON DISEASE;PATIENTS AFFECTED;RANDOMIZED CLINICAL;SEXUAL DYSFUNCTION;SPINAL CORD;ALZHEIMERS DISEASE;AORTIC WALL;ARTERY DISSECTION;CERVICAL ARTERY;CHRONIC PAIN;COHORT STUDY;COMPARATIVE STUDY;COMPLETE IMAGING;CORD INJURY;COVID- ERA;COVID- PANDEMIC;FUNCTIONAL RECOVERY;HISTOLOGICAL DIAGNOSIS;IMAGING PATHWAY;INNOVATIVE REHABILITATION;JET SENSOR","8;7;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","VIRTUAL REALITY;INTELLECTUAL DISABILITY;INTERMITTENT PREDNISONE;AUTISM SPECTRUM;DAILY DEFLAZACORT;DAILY PREDNISONE;SIGNIFICANT DIFFERENCES;ALZHEIMERS DISEASE;MAGNETIC RESONANCE;MOTOR FUNCTION;SPECTRUM DISORDER;SPINAL CORD;WHITE MATTER;COGNITIVE REHABILITATION;CORD INJURY;COVID- PANDEMIC;NURSING STUDENTS;P-JET SENSOR;RAR NIBS;REHABILITATION TRAINING;CENTRO NEUROLESI;CEREBRAL PALSY;COGNITIVE DIFFICULTIES;DUCHENNE MUSCULAR;IRCCS CENTRO;MESSINA ITALY;OXIDATIVE STRESS;PARKINSONS DISEASE;PD PATIENTS;PSYCHOLOGICAL DISTRESS","13;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,2,1,0,0,0,0,0,0,0,3,0,1,0,8.5,9.55,1.25,0,1,4,0,0,1,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ACRI GIUSEPPE;BRAMANTI ALESSIA;CIURLEO ROSELLA;COSTA STEFANO;TESTAGROSSA BARBARA;BRAMANTI PLACIDO;CRUPI VINCENZA;DENARO FABRIZIO;MAJOLINO DOMENICO;MARINO SILVIA","4;4;4;4;4;2;2;2;2;2","I R C C S CENTRO NEUROLESI BONINO PULEJO;IRCCS CENTRO NEUROLESI ""BONINO PULEJO"";IRCCS CENTRO NEUROLESI ""BONINO-PULEJO"";IRCCS CENTRO NEUROLESI BONINO PULEJO;IRCCS CENTRO NEUROLESI BONINO-PULEJO","1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;34 CHEMICAL SCIENCES","3;3;2;1","AUTOIMMUNE DISEASE;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;NUTRITION","1;1;1;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1","G01N21/65;G01J3/44;G01N;G01N33/48;G01N33/68","3;1;1;1;1","G01N21/65;G01N33/564;G01N2201/06113;G01N2800/065;G01N2800/24;G01N33/6893","4;4;2;2;2;2",4,1.5,50.25,3.28,0,0,2.25,0,0,0,0,0,0,0,4,0,2,2,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,NA,NA,"42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3210 NUTRITION AND DIETETICS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;46 INFORMATION AND COMPUTING SCIENCES;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","3;2;1;1;1;1;1;1;1","BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;MENTAL HEALTH;NEUROSCIENCES;BRAIN DISORDERS;PEDIATRIC;PREVENTION;REHABILITATION;ACQUIRED COGNITIVE IMPAIRMENT;ASSISTIVE TECHNOLOGY;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);AUTISM;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEMENTIA;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MIND AND BODY;NEURODEGENERATIVE","4;4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MENTAL HEALTH;NEUROLOGICAL","2;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.6 PSYCHOLOGICAL AND BEHAVIOURAL;6.6 PSYCHOLOGICAL AND BEHAVIOURAL","1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"FRONTIERS","3","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;2;2;2;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;BIOMEDICAL IMAGING;NEUROSCIENCES;CARDIOVASCULAR;HEALTH SERVICES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;STROKE","3;3;2;2;1;1;1;1;1","NEUROLOGICAL","2","2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);7.3 MANAGEMENT AND DECISION MAKING;8.1 ORGANISATION AND DELIVERY OF SERVICES","2;1;1","HEALTH SERVICES & SYSTEMS","1","HEALTH SERVICES RESEARCH","1",NA,NA,NA,NA
"IRCCS_BONINOPULEJO",2023,93,14.6236559139785,4.25806451612903,0.234848484848485,0.494623655913978,0.559139784946237,0.473118279569892,0.838709677419355,0,22,10,3,12,0.24,0.11,0.03,0.13,3.22,0.73351315644612,0.193548387096774,0.774193548387097,4.39054470709147,0.598402975886235,0.517045454545454,0.434285714285714,0.443533697632058,"ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;MIRJAM BONANNO;LILLA BONANNO;VIVIANA LO BUONO;EMANUELA MAZZON;SILVIA MARINO;DAVIDE CARDILE;ROSARIA DE LUCA;AUGUSTO IELO;PLACIDO BRAMANTI;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;GIANGAETANO D’ALEO;MARCELLA DI CARA;PAOLO TONIN;FEDERICA POLLASTRO;STEFANO SALAMONE","34;27;19;15;14;11;10;10;9;8;8;7;7;6;6;6;6;6;6;6","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;MIRJAM BONANNO;EMANUELA MAZZON;FRANCESCO CORALLO;VIVIANA LO BUONO;LILLA BONANNO;SIMONE D’ANGIOLINI;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;FEDERICA POLLASTRO;STEFANO SALAMONE;DAVIDE CARDILE;AUGUSTO IELO;ROSARIA DE LUCA;PAOLO TONIN;PLACIDO BRAMANTI;SILVIA MARINO;ANTONIO GANGEMI","4.47;3.19;2.12;2.02;1.93;1.7;1.27;1.15;1.08;1.08;0.99;0.91;0.91;0.91;0.89;0.88;0.75;0.73;0.67;0.63","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;MIRJAM BONANNO;LILLA BONANNO;VIVIANA LO BUONO;EMANUELA MAZZON;SILVIA MARINO;DAVIDE CARDILE;ROSARIA DE LUCA;AUGUSTO IELO;PLACIDO BRAMANTI;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;GIANGAETANO D’ALEO;MARCELLA DI CARA;FRANCESCA CUCINOTTA;SIMONE D’ANGIOLINI;ROSELLA CIURLEO","34;27;19;15;14;11;10;10;9;8;8;7;7;6;6;6;6;5;5;5","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;MIRJAM BONANNO;EMANUELA MAZZON;FRANCESCO CORALLO;VIVIANA LO BUONO;LILLA BONANNO;SIMONE D’ANGIOLINI;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;DAVIDE CARDILE;AUGUSTO IELO;ROSARIA DE LUCA;PLACIDO BRAMANTI;SILVIA MARINO;ANTONIO GANGEMI;GIANGAETANO D’ALEO;MARCELLA DI CARA;ROSELLA CIURLEO","4.47;3.19;2.12;2.02;1.93;1.7;1.27;1.15;1.08;1.08;0.99;0.91;0.89;0.88;0.73;0.67;0.63;0.63;0.59;0.55","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MIRJAM BONANNO;ROSARIA DE LUCA;RAFFAELLA VALENTI;CARMELA RIFICI;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;LILLA BONANNO;EMANUELA MAZZON;MARCO FRANCESCHINI;MICHELA GOFFREDO;ALESSANDRO PADOVANI;ANDREA PILOTTO;GIORGIO GELOSA;MARIA SESSA;SANAZ POURNAJAF;SILVIA MARINO;ANDREA ZINI;M. BRAGA","135;96;53;49;40;39;39;35;34;33;31;31;30;30;30;30;30;28;27;27","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MIRJAM BONANNO;ROSARIA DE LUCA;CARMELA RIFICI;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;LILLA BONANNO;EMANUELA MAZZON;SILVIA MARINO;ANGELA MARRA;AGNESE GUGLIANDOLO;DAVIDE CARDILE;LUIGI CHIRICOSTA;AUGUSTO IELO;CHIARA SORBERA;PATRIZIA POLLICINO;SILVIA PRADELLA;MARCELLA DI CARA;SANTINO BLANDO","135;96;53;49;39;39;35;34;33;28;26;23;22;22;21;21;20;20;19;18","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MARIA CRISTINA DE COLA;FRANCESCO CORALLO;MIRJAM BONANNO;LILLA BONANNO;EMANUELA MAZZON;VIVIANA LO BUONO;CARMELA RIFICI;ROSARIA DE LUCA;SILVIA MARINO;DAVIDE CARDILE;AUGUSTO IELO;PLACIDO BRAMANTI;AGNESE GUGLIANDOLO;MARCELLA DI CARA;LUIGI CHIRICOSTA;GIANGAETANO D’ALEO;ROSELLA CIURLEO;FRANCESCA CUCINOTTA","34;27;19;15;14;11;10;10;9;9;9;8;7;7;6;6;6;6;5;5","MEDICINE;PSYCHOLOGY;COMPUTER SCIENCE;BIOLOGY;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;PHYSICS;BUSINESS;CHEMISTRY;MATHEMATICS;GEOGRAPHY;GEOLOGY;HISTORY;SOCIOLOGY","85;37;29;25;15;14;8;7;7;6;6;6;1;1;1;1","PSYCHIATRY;INTERNAL MEDICINE;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;NEUROSCIENCE;SURGERY;NURSING;ARTIFICIAL INTELLIGENCE;MECHANICAL ENGINEERING;PATHOLOGY;CLINICAL PSYCHOLOGY;BIOCHEMISTRY;AUDIOLOGY;ECONOMIC GROWTH;HUMAN–COMPUTER INTERACTION;PALEONTOLOGY;LAW;RADIOLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;EPISTEMOLOGY;GENETICS;MACHINE LEARNING;PHARMACOLOGY","37;36;35;33;22;16;14;13;13;13;12;10;8;8;8;8;7;7;6;5;5;5;5;5","REHABILITATION;DISEASE;COGNITION;HEALTH CARE;ANXIETY;STROKE (ENGINE);GENE;PSYCHOLOGICAL INTERVENTION;VIRTUAL REALITY;INTERVENTION (COUNSELING);QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;CONTEXT (ARCHAEOLOGY);AUDIT;GAIT;BALANCE (ABILITY);ELECTROENCEPHALOGRAPHY;POPULATION;APOPTOSIS;COHORT;INFLAMMATION;MIGRAINE;MULTIPLE SCLEROSIS;QUALITY (PHILOSOPHY);RECEPTOR;STIMULATION","30;21;16;12;11;11;9;9;9;8;8;8;7;6;6;5;5;5;4;4;4;4;4;4;4;4","NEUROREHABILITATION;PARKINSON'S DISEASE;GENE EXPRESSION;NEUROPSYCHOLOGY;TELEMEDICINE;DEMENTIA;COGNITIVE IMPAIRMENT;COGNITIVE REHABILITATION THERAPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);ACQUIRED BRAIN INJURY;ALZHEIMER'S DISEASE;AUTISM SPECTRUM DISORDER;BECK DEPRESSION INVENTORY;BRAIN ACTIVITY AND MEDITATION;COGNITIVE TRAINING;DOPAMINERGIC;DOWNREGULATION AND UPREGULATION;EFFECTS OF SLEEP DEPRIVATION ON COGNITIVE PERFORMANCE;EXECUTIVE FUNCTIONS;FOCUSED ULTRASOUND;INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH;MINIMALLY CONSCIOUS STATE;MOTOR CORTEX;MULTICENTER STUDY;NEUROCOGNITIVE;NEURODEGENERATION;NEUROPEPTIDE;NEURORADIOLOGY;PROGRAMMED CELL DEATH;SOMATIZATION;TEMPORAL LOBE;TINETTI TEST;TOLERABILITY","12;9;8;8;6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TRANSCRIPTOME;TELEREHABILITATION;CORONAVIRUS DISEASE 2019 (COVID-19);BECK ANXIETY INVENTORY;CALCITONIN GENE-RELATED PEPTIDE;COGNITIVE DECLINE;DEEP BRAIN STIMULATION;EXECUTIVE DYSFUNCTION;MONTREAL COGNITIVE ASSESSMENT;ACTION LEARNING;CARDIAC RESYNCHRONIZATION THERAPY;CLINICAL DEMENTIA RATING;CLINICAL PHENOTYPE;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;DEMENTIA WITH LEWY BODIES;DEPERSONALIZATION;DOPAMINERGIC PATHWAYS;EXTRAVERSION AND INTROVERSION;FRONTOTEMPORAL DEMENTIA;GLUTAMATERGIC;HES1;KRAS;LEVODOPA;MENTAL ARITHMETIC;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MITOPHAGY;MOTOR SYMPTOMS;MULTICENTER TRIAL;NEUROPSYCHOLOGICAL ASSESSMENT;NONALCOHOLIC FATTY LIVER DISEASE;OSTEOCYTE;OSTEONECROSIS OF THE JAW;OSTEOPENIA;PARADOXICAL EMBOLISM;PARKIN;PERSISTENT VEGETATIVE STATE;POSTURAL INSTABILITY;QUANTITATIVE COMPUTED TOMOGRAPHY;RASAGILINE;SERVICE DESIGN;SH-SY5Y;STEATOHEPATITIS;SUBSTANTIA NIGRA;SYNTHETIC CANNABINOIDS;SYSTEMIC CANDIDIASIS;TLR2;VAGUS NERVE STIMULATION","7;5;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;ALZHEIMER DISEASE;PARKINSON DISEASE;FEMALE;QUALITY OF LIFE;RETROSPECTIVE STUDIES;STROKE;ADULT;BRAIN INJURIES;COVID-19;MALE;NEUROBLASTOMA;TELEREHABILITATION;AMYLOID BETA-PEPTIDES;AUTISM SPECTRUM DISORDER;BURNOUT, PROFESSIONAL;COGNITIVE DYSFUNCTION;CROSS-SECTIONAL STUDIES;HEALTH PERSONNEL","55;37;9;9;6;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3","PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MORTALITY AND SEQUELAE OF PRETERM BIRTH;AUTISM SPECTRUM DISORDERS;DEVELOPMENT AND EVALUATION OF CLINICAL GUIDELINES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;IMPACT OF COVID-19 ON MENTAL HEALTH;IMPACT OF HEALTHCARE ACCREDITATION ON QUALITY IMPROVEMENT;MECHANISMS OF ALZHEIMER'S DISEASE;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA","8;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","NEUROREHABILITATION;VIRTUAL REALITY REHABILITATION;STROKE (ENGINE);REHABILITATION TECHNIQUES;REHABILITATION;TELEREHABILITATION;DEPRESSION (ECONOMICS);REMOTE TREATMENT;CANNABINOID RECEPTORS;CANNABIS USE;COGNITIVE REHABILITATION THERAPY;DEEP BRAIN STIMULATION;DISABILITY ASSESSMENT;MULTIPLE SCLEROSIS;NEURODEGENERATION;NEUROMODULATION;POSTURAL STABILITY;TELEHEALTH;TELEPSYCHIATRY;ACQUIRED BRAIN INJURY","13;13;11;6;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;2","VIRTUAL REALITY;PARKINSONS DISEASE;PILOT STUDY;BRAIN INJURY;MULTIPLE SCLEROSIS;RANDOMIZED CONTROLLED;ACQUIRED BRAIN;COGNITIVE IMPAIRMENT;CONTROLLED TRIAL;MACHINE LEARNING;MULTICENTER RANDOMIZED;REALITY COGNITIVE;RETROSPECTIVE STUDY;TRANSCRIPTOMIC ANALYSIS;ALZHEIMERS DISEASE;ARTERY DISSECTION;BODY IMAGE;CERVICAL ARTERY;CLINICAL PRACTICE;CLINICAL TRIAL;COGNITIVE TRAINING;CONTROLLED PILOT;COPING STRATEGIES;CORD INJURY;CROSS-SECTIONAL STUDY;CYTOSKELETAL REMODELING;DEVELOPMENTAL DELAY;DISEASE PATIENTS;DUCHENNE MUSCULAR;DYSTROPHY PATIENTS","11;8;7;5;5;5;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BODY IMAGE;VIRTUAL REALITY;PARKINSONS DISEASE;ISCHEMIC STROKE;MULTIPLE SCLEROSIS;COGNITIVE IMPAIRMENT;STATISTICALLY SIGNIFICANT;--- NA;BRAIN INJURY;DISEASE PD;COGNITIVE TRAINING;GENES INVOLVED;PD PATIENTS;SIGNIFICANT DIFFERENCES;SIGNIFICANT IMPROVEMENT;ABI PATIENTS;BARTHEL INDEX;MAGNETIC RESONANCE;NEUROLOGICAL DISORDERS;PSYCHOLOGICAL WELL-BEING;SIGNALING PATHWAY;SPINAL CORD;STROKE SURVIVORS;SUBACUTE STROKE;TEST CORRECTNESS;COPING STRATEGIES;GAIT TRAINING;GAMMA ERS;HEALTHCARE WORKERS;HEALTHY CONTROLS","17;13;11;10;10;9;9;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5",2,0.02,18.48,17.5,2,0,0,2,0,0,0,22,0,0,14.5,0,0,0,3,9.25,4,0,0,14.25,14.25,3,0,0,0,2,3,0,0,0,0,0,0,2,2,1,0,8.2,10.35,1.4,0,2,2,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BRAMANTI ALESSIA;ACRI GIUSEPPE;CIURLEO ROSELLA;COSTA STEFANO;TESTAGROSSA BARBARA;BRAMANTI PLACIDO;CRUPI VINCENZA;DENARO FABRIZIO;MAJOLINO DOMENICO;MARINO SILVIA","5;4;4;4;4;3;2;2;2;2","IRCCS CENTRO NEUROLESI ""BONINO PULEJO"";IRCCS CENTRO NEUROLESI ""BONINO-PULEJO"";IRCCS CENTRO NEUROLESI BONINO PULEJO;IRCCS CENTRO NEUROLESI BONINO-PULEJO;SONY CORP","2;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;2;2;2;1","AUTOIMMUNE DISEASE;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;NUTRITION;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE","2;2;2;2;2;1;1;1;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2","G01N21/65;G01N33/564;G01J3/44;G01N33/48;A61B5/00;A61B5/369;G06F18/22;G06F18/231;G16H50/20","4;3;2;2;1;1;1;1;1","G01N21/65;G01N33/564;G01N2201/06113;G01N2800/065;G01N2800/24;G01N33/6893;A61B5/369;A61B5/4088;A61B5/7264;G06F18/22","4;4;2;2;2;2;1;1;1;1",2,2.5,83,1.6,0,0,4,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS","2;1;1","BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;REHABILITATION;ASSISTIVE TECHNOLOGY;BIOENGINEERING;BRAIN DISORDERS;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS;PHYSICAL REHABILITATION;STROKE;TRAUMATIC HEAD AND SPINE INJURY","2;2;2;2;2;1;1;1;1;1;1;1","NEUROLOGICAL;STROKE","1;1","6.7 PHYSICAL","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS","4","44 HUMAN SOCIETY;4409 SOCIAL WORK;52 PSYCHOLOGY;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING","3;3;3;2;1","AUTISM;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CLINICAL RESEARCH;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MENTAL HEALTH;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);PEDIATRIC","4;4;4;4;4;4;3;3;1;1;1",NA,NA,NA,NA,"CLINICAL","4",NA,NA,NA,NA,"4 QUALITY EDUCATION","4"
"IRCCS_BONINOPULEJO",2024,83,11.3132530120482,4.48192771084337,0.223118279569892,0.55421686746988,0.578313253012048,0.409638554216867,0.819277108433735,0,16,11,4,4,0.19,0.13,0.05,0.05,0.71,0.743789896704958,0.180722891566265,0.819277108433735,3.47478991596638,0.590045455907993,0.394432773109244,0.505263157894737,0.494248466257669,"ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MIRJAM BONANNO;FRANCESCO CORALLO;ROSARIA DE LUCA;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;LILLA BONANNO;MARIA CRISTINA DE COLA;DAVIDE CARDILE;AUGUSTO IELO;CATERINA FORMICA;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;VIVIANA LO BUONO;FRANCESCA CUCINOTTA;ANTONIO CERASA;ANTONIO GANGEMI;IRENE CAPPADONA;SILVIA MARINO","37;34;15;12;12;11;11;9;9;9;8;7;6;6;6;6;6;6;5;5","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;EMANUELA MAZZON;MIRJAM BONANNO;FRANCESCO CORALLO;MARIA GRAZIA MAGGIO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;MARCO CALABRÒ;DAVIDE CARDILE;VIVIANA LO BUONO;CATERINA FORMICA;LILLA BONANNO;AUGUSTO IELO;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;ANTONIO GANGEMI;ALFREDO MANULI;MARIA LUI;FRANCESCA CUCINOTTA","4.2;3.97;1.91;1.76;1.41;1.32;1.29;1.23;0.96;0.94;0.89;0.88;0.88;0.87;0.81;0.81;0.78;0.7;0.64;0.63","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MIRJAM BONANNO;FRANCESCO CORALLO;ROSARIA DE LUCA;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;LILLA BONANNO;MARIA CRISTINA DE COLA;DAVIDE CARDILE;AUGUSTO IELO;CATERINA FORMICA;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;VIVIANA LO BUONO;FRANCESCA CUCINOTTA;ANTONIO GANGEMI;IRENE CAPPADONA;SILVIA MARINO;PLACIDO BRAMANTI","37;34;15;12;12;11;11;9;9;9;8;7;6;6;6;6;6;5;5;5","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;EMANUELA MAZZON;MIRJAM BONANNO;FRANCESCO CORALLO;MARIA GRAZIA MAGGIO;ROSARIA DE LUCA;MARIA CRISTINA DE COLA;MARCO CALABRÒ;DAVIDE CARDILE;VIVIANA LO BUONO;CATERINA FORMICA;LILLA BONANNO;AUGUSTO IELO;LUIGI CHIRICOSTA;AGNESE GUGLIANDOLO;ANTONIO GANGEMI;MARIA LUI;FRANCESCA CUCINOTTA;SIMONE D’ANGIOLINI","4.2;3.97;1.91;1.76;1.41;1.32;1.29;1.23;0.96;0.94;0.89;0.88;0.88;0.87;0.81;0.81;0.78;0.64;0.63;0.62","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;MIRJAM BONANNO;FRANCESCO CORALLO;ROSARIA DE LUCA;ALFREDO MANULI;DAVIDE CARDILE;ALESSIA BRAMANTI;GIOVANNI LUCA CIPRIANO;GIOVANNI SCHEPICI;IVAN ANCHESI;IVANA RAFFAELE;MARINA GAROFANO;SERENA SILVESTRO;AGNESE GUGLIANDOLO;ALBERTO CACCIOLA;ANTONIO CERASA;LUIGI CHIRICOSTA","26;24;19;17;11;10;9;7;7;6;6;6;6;6;6;6;5;5;5;5","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;EMANUELA MAZZON;MARIA GRAZIA MAGGIO;MIRJAM BONANNO;FRANCESCO CORALLO;ROSARIA DE LUCA;DAVIDE CARDILE;GIOVANNI LUCA CIPRIANO;GIOVANNI SCHEPICI;IVAN ANCHESI;IVANA RAFFAELE;SERENA SILVESTRO;AGNESE GUGLIANDOLO;LUIGI CHIRICOSTA;OSVALDO ARTIMAGNELLA;ANDREA CALDERONE;FABIO MAURO GIAMBÒ;IRENE CAPPADONA;ANNA ANSELMO","26;24;19;17;11;10;9;7;6;6;6;6;6;5;5;5;4;4;4;3","ROCCO SALVATORE CALABRÒ;ANGELO QUARTARONE;MIRJAM BONANNO;MARIA GRAZIA MAGGIO;ROSARIA DE LUCA;FRANCESCO CORALLO;EMANUELA MAZZON;MARIA CRISTINA DE COLA;DAVIDE CARDILE;LILLA BONANNO;AUGUSTO IELO;CATERINA FORMICA;AGNESE GUGLIANDOLO;LUIGI CHIRICOSTA;ANTONIO GANGEMI;IRENE CAPPADONA;PLACIDO BRAMANTI;SILVIA MARINO;ANGELA MARRA;CARMELA RIFICI","37;34;15;14;12;12;10;9;9;9;8;7;6;6;6;5;5;5;4;4","MEDICINE;PSYCHOLOGY;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;POLITICAL SCIENCE;ECONOMICS;MATHEMATICS;PHYSICS;BUSINESS;CHEMISTRY;PHILOSOPHY;SOCIOLOGY;GEOLOGY","68;36;20;20;12;10;7;6;6;5;4;3;3;1","PSYCHIATRY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;INTERNAL MEDICINE;NEUROSCIENCE;PATHOLOGY;CLINICAL PSYCHOLOGY;LAW;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;DEVELOPMENTAL PSYCHOLOGY;GENETICS;MECHANICAL ENGINEERING;SURGERY;NURSING;AUDIOLOGY;BIOCHEMISTRY;BIOINFORMATICS;HUMAN–COMPUTER INTERACTION;PSYCHOTHERAPIST","36;29;27;24;23;13;11;10;8;8;8;8;8;8;7;6;6;6;5;5","REHABILITATION;COGNITION;DISEASE;GENE;PSYCHOLOGICAL INTERVENTION;STROKE (ENGINE);HEALTH CARE;GAIT;INTERVENTION (COUNSELING);MEDLINE;MULTIPLE SCLEROSIS;AUTISM;COHORT;CONTEXT (ARCHAEOLOGY);MOOD;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;RECEPTOR;TRAUMATIC BRAIN INJURY;VIRTUAL REALITY","25;20;18;11;11;7;6;5;5;5;5;4;4;4;4;4;4;4;4;4","PARKINSON'S DISEASE;NEUROREHABILITATION;GENE EXPRESSION;AUTISM SPECTRUM DISORDER;TELEMEDICINE;COGNITIVE REHABILITATION THERAPY;DEMENTIA;INTRACEREBRAL HEMORRHAGE;NEUROPSYCHOLOGY;SPINAL CORD INJURY;TRANSCRANIAL DIRECT-CURRENT STIMULATION;ACQUIRED BRAIN INJURY;BRAIN STIMULATION;COGNITIVE IMPAIRMENT;DOWNREGULATION AND UPREGULATION;EPIGENETICS;GAIT TRAINING;ION CHANNEL;MINIMALLY CONSCIOUS STATE;NEUROTRANSMISSION;PHENOTYPE;SCOPUS;SENSORY PROCESSING","8;7;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","TELEREHABILITATION;TRANSCRIPTOME;ACROMEGALY;CANNABINOL;CAREGIVER BURDEN;CAREGIVER STRESS;CELL CYCLE CHECKPOINT;CHILDHOOD AUTISM RATING SCALE;CIRCULAR RNA;COGNITIVE EVALUATION THEORY;CONGENITAL MYASTHENIC SYNDROME;CORONAVIRUS DISEASE 2019 (COVID-19);DEEP BRAIN STIMULATION;DNA METHYLATION;FACIAL EXPRESSION RECOGNITION;FOLD CHANGE;FUNCTIONAL NEAR-INFRARED SPECTROSCOPY;KEAP1;MEMORY CLINIC;MOTOR IMAGERY;NECROPTOSIS;NFAT;NON-CODING RNA;SOD1;STROKE VOLUME;SUBSTANTIA NIGRA;SYSTEM USABILITY SCALE;TELEHEALTH;TETRAPLEGIA;TOLL-LIKE RECEPTOR;TRANSLATION (BIOLOGY);VASCULAR DEMENTIA","4;4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;AGED;ITALY;BIOMARKERS;BRAIN;GENE EXPRESSION PROFILING;MIDDLE AGED;MULTIPLE SCLEROSIS;TRANSCRIPTOME;ADOLESCENT;ADULT;ANIMALS;CANNABINOIDS;CHILD;CHILD, PRESCHOOL;COGNITIVE DYSFUNCTION;FEEDBACK","63;20;8;7;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","AUTISM SPECTRUM DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;ASSISTIVE TECHNOLOGY AND DISABILITIES;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;ROLE OF NRF2 SIGNALING IN OXIDATIVE STRESS RESPONSE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ANALYSIS OF CARDIAC AND RESPIRATORY SOUNDS;ANALYSIS OF GENE INTERACTION NETWORKS;ARTIFICIAL INTELLIGENCE IN MEDICINE;BIOGENESIS AND FUNCTIONS OF CIRCULAR RNAS","5;5;4;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1","NEUROREHABILITATION;VIRTUAL REALITY REHABILITATION;REHABILITATION;STROKE (ENGINE);REHABILITATION TECHNIQUES;NEURAL PLASTICITY;NEURODEGENERATION;TELEREHABILITATION;CANNABINOID RECEPTORS;COGNITIVE REHABILITATION THERAPY;DEPRESSION (ECONOMICS);DISABILITY ASSESSMENT;ENDOCANNABINOID SYSTEM;FUNCTIONAL RECOVERY;MOTOR RECOVERY;PARKINSON'S DISEASE;SPINAL CORD INJURY;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION;ACQUIRED BRAIN INJURY","9;9;7;7;6;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2","PARKINSONS DISEASE;MULTIPLE SCLEROSIS;PILOT STUDY;VIRTUAL REALITY;ACQUIRED BRAIN;AUTISM SPECTRUM;BRAIN INJURY;CORD INJURY;RETROSPECTIVE STUDY;SPINAL CORD;CLINICAL TRIAL;COGNITIVE IMPAIRMENT;CURRENT STIMULATION;DIRECT CURRENT;MILD COGNITIVE;SEVERE ACQUIRED;SPECTRUM DISORDER;TRANSCRANIAL DIRECT;TRANSCRIPTOMIC STUDY;CASECONTROL STUDY;CELL LINE;COGNITIVE TELEREHABILITATION;EASY-NET PROGRAMME;FACTORS AFFECTING;FOCUSED ULTRASOUND;INTRACEREBRAL HAEMORRHAGE;ION CHANNELS;LONG-TERM RISK;MAGNETIC-RESONANCE-GUIDED FOCUSED;MINIMALLY CONSCIOUS","7;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","PARKINSONS DISEASE;DISEASE PD;VIRTUAL REALITY;BRAIN INJURY;FAMILY HISTORY;MULTIPLE SCLEROSIS;RETROSPECTIVE STUDY;RISK FACTORS;SIGNIFICANT DIFFERENCES;SIGNIFICANT IMPROVEMENTS;SPINAL CORD;ANALYSIS REVEALED;CLINICAL PRACTICE;COGNITIVE FOG;NERVOUS SYSTEM;PD PATIENTS;PILOT STUDY;REMOTE MONITORING;AUTISM SPECTRUM;BENEFICIAL EFFECTS;CENTRAL NERVOUS;COGNITIVE DECLINE;COGNITIVE REHABILITATION;CORD INJURY;DISORDER ASD;FTF VRRS;G-EO SYSTEM;GAIT TRAINING;GENES INVOLVED;GENES RELATED","10;9;9;8;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
